1) Naidech AM, Weaver B, Maas M et al : Early seizures are predictive of worse health-related quality of life at follow-up after intracerebral hemorrhage. Crit Care Med 49 : e578-e584, 2021
集中治療医学レビュー 2022-'23
特記事項：
- 最新版→「集中治療医学レビュー 2025-'26」
商品紹介
集中治療医学分野のエキスパートによって厳選された、直近2年間を中心に国内外で発表された最新の文献レビューです。
広く集中治療医学関連の最近のトピックスを把握でき、専門医だけでなく、専門医を目指す方にも必携の1冊です。
目次
- I章 集中治療管理
1．神経集中治療
2．鎮痛・鎮静・せん妄管理
3．呼吸管理
4．循環管理
5．心臓・大血管術後管理
6．消化管管理
7．肝胆膵管理
8．腎臓管理
9．電解質管理
10．内分泌管理
11．凝固・線溶系の管理：COVID-19を中心に
12．輸液管理（代用血漿を含む
13．輸血管理
14．感染管理（予防と治療）
15．Critical Care Nutrition：個別化の時代
16．小児集中治療
II章 集中治療 検査・技術
1．集中治療のモニタリング
2．脳低温療法・脳保護療法
3．気道確保・気道確保困難症
4．人工呼吸管理
5．非侵襲的人工呼吸と経鼻交流量療法
6．心肺停止と心肺蘇生
7．カテーテル
8．補助循環（ECMO，IABP，Impella）
9．エコー診断
10．TAVI，MitraClip
11．IVR
12．急性血液浄化
13．体温管理
14.「ドレナージ
15．血液・生化学検査
16．バイオマーカー
III章 特有の病態と治療
1．COVID-19の病態と治療
2．ARDSの病態と治療
3．人工呼吸器関連肺炎
4．ショックの病態と治療
5．急性冠症候群の診断と治療
6．心不全の診断と治療
7．不整脈の診断と治療
8．重症感染症の診断と治療
9．敗血症の診断と治療
10．播種性血管内凝固の診断と治療
11．集中治療後症候群（PICS）の病態と治療
12．熱傷の病態と治療
IV章 トピックス
1．集中治療室における医療倫理
2．Rapid Response System
3．集中治療室における看護
4．集中治療室における臨床工学
5．集中治療における薬剤師の役割
6．集中治療室におけるリハビリテーション
7．抗菌薬の適正使用
この書籍の参考文献
参考文献のリンクは、リンク先の都合等により正しく表示されない場合がありますので、あらかじめご了承下さい。
本参考文献は電子書籍掲載内容を元にしております。
I章 集中治療管理
P.2 掲載の参考文献
P.3 掲載の参考文献
2) Struck AF, Tabaeizadeh M, Schmitt SE et al : Assessment of the validity of the 2HELPS2B score for inpatient seizure risk prediction. JAMA Neurol 77 : 500-507, 2020
P.4 掲載の参考文献
3) Rossetti AO, Schindler K, Sutter R et al : Continuous vs routine electroencephalogram in critically ill adults with altered consciousness and no recent seizure : a multicenter randomized clinical trial. JAMA Neurol 77 : 1225-1232, 2020
4) Vespa PM, Olson DM, John S et al : Evaluating the clinical impact of rapid response electroencephalography : the DECIDE multicenter prospective observational clinical study. Crit Care Med 48 : 1249-1257, 2020
P.5 掲載の参考文献
P.6 掲載の参考文献
6) Tas J, Beqiri E, van Kaam RC et al : Targeting autoregulation-guided cerebral perfusion pressure after traumatic brain injury (COGiTATE) : a feasibility randomized controlled clinical trial. J Neurotrauma 38 : 2790-2800, 2021
7) Jeanette T, Melisa B, Peter S et al : Antidecubitus bed mattress may interfere with cerebrovascular pressure reactivity measures due to induced ICP and ABP cyclic peaks. J Clin Monit Comput 35 : 423-425, 2021
P.7 掲載の参考文献
8) CRASH-3 trial collaborators : Effects of tranexamic acid on death, disability, vascular occlusive events and other morbidities in patients with acute traumatic brain injury (CRASH-3) : a randomised, placebo-controlled trial. Lancet 394 : 1713-1723, 2019
9) Aoun SG, Stutzman SE, Vo PN et al : Detection of delayed cerebral ischemia using objective pupillometry in patients with aneurysmal subarachnoid hemorrhage. J Neurosurg 132 : 27-32, 2019
P.8 掲載の参考文献
10) Gollwitzer S, Muller TM, Hopfengartner R et al : Quantitative EEG after subarachnoid hemorrhage predicts long-term functional outcome. J Clin Neurophysiol 36 : 25-31, 2019
11) Ruijter BJ, Tjepkema-Cloostermans MC, Tromp SC et al : Early electroencephalography for outcome prediction of postanoxic coma : a prospective cohort study. Ann Neurol 86 : 203-214, 2019
P.9 掲載の参考文献
12) Bongiovanni F, Romagnosi F, Barbella G et al : Standardized EEG analysis to reduce the uncertainty of outcome prognostication after cardiac arrest. Intensive Care Med 46 : 963-972, 2020
P.10 掲載の参考文献
13) Elmer J, Coppler PJ, May TL et al : Unsupervised learning of early post-arrest brain injury phenotypes. Resuscitation 153 : 154-160, 2020
14) Sekhon MS, Griesdale DE, Ainslie PN et al : Intracranial pressure and compliance in hypoxic ischemic brain injury patients after cardiac arrest. Resuscitation 141 : 96-103, 2019
P.11 掲載の参考文献
16) Riker RR, Sawyer ME, Fischman VG et al : Neurological pupil index and pupillary light reflex by pupillometry predict outcome early after cardiac arrest. Neurocrit Care 32 : 152-161, 2020
P.12 掲載の参考文献
17) Rey A, Rossetti AO, Miroz JP et al : Late awakening in survivors of postanoxic coma : early neurophysiologic predictors and association with ICU and long-term neurologic recovery. Crit Care Med 47 : 85-92, 2019
18) Rosenblatt K, Walker KA, Goodson C : Cerebral autoregulation-guided optimal blood pressure in sepsis-associated encephalopathy : a case series. Intensive Care Med 35 : 1453-1464, 2020
P.13 掲載の参考文献
19) Nielsen RM, Urdanibia-Centelles O, Vedel-Larsen E et al : Continuous EEG monitoring in a consecutive patient cohort with sepsis and delirium. Neurocrit Care 32 : 121-130, 2020
P.14 掲載の参考文献
20) Ehler J, Petzold A, Wittstock M et al : The prognostic value of neurofilament levels in patients with sepsis-associated encephalopathy-a prospective, pilot observational study. PLoS One 14 : e0211184, 2019
21) Czempik PF, Gasiorek J, Bak A et al : Ultrasonic assessment of optic nerve sheath diameter in patients at risk of sepsis-associated brain dysfunction : a preliminary report. Int J Environ Res Public Health 17 : 3656, 2020
P.15 掲載の参考文献
1) 江木盛時, 小倉裕司, 矢田部智昭他 : 日本版敗血症診療ガイドライン 2020. 日集中医誌 28 : S1-S411, 2021
P.16 掲載の参考文献
3) Puntillo KA, Max A, Timsit J-F et al : Determinants of procedural pain intensity in the intensive care unit : the Europain(R) study. Am J Respir Crit Care Med 189 : 39-47, 2014
4) Kalfon P, Boucekine M, Estagnasie P et al : Risk factors and events in the adult intensive care unit -associated with pain as self-reported at the end of the intensive care unit stay. Crit Care 24 : 685, 2020
P.17 掲載の参考文献
5) Yang S, Zhao H, Wang H et al : Comparison between remifentanil and other opioids in adult critically ill patients : a systematic review and meta-analysis. Medicine 100 : 38, 2021
6) Harvin JA, Kao LS : Pain management in the surgical ICU patient. Curr Opin Crit Care 26 : 628-633, 2020
7) Zhao H, Yang S, Wang H et al : Nonopioid analgesics as adjuvants to opioid for pain management in adult patients in the ICU : a systematic review and meta-analysis. J Crit Care 54 : 136-144, 2019
8) Duprey MS, Dijkstra-Kersten SMA, Zaal IJ et al : Opioid use increases the risk of delirium in critically ill adults independently of pain. Am J Respir Crit Care Med 204 : 566-572, 2021
9) Taggart S, Skylas K, Brannelly A et al : Using a clinical judgement model to understand the impact of validated pain assessment tools for burn clinicians and adult patients in the ICU : a multi-methods study. BURNS 47 : 110-126, 2021
P.18 掲載の参考文献
10) Blondonnet R, Begard M, Jabaudon M et al : Blunt chest trauma and regional anesthesia for analgesia of multitrauma patients in French intensive care units : a national survey. Anesth Analg 133 : 723-730, 2021
11) Curtis K, Kourouche S, Asha S et al : Impact of a care bundle for patients with blunt chest injury (ChIP) : a multicenter controlled implementation evaluation. PLoS ONE 16 : e0256027, 2021
12) Bachoumas K, Levrat A, Le Thuaut A et al : Epidural analgesia in ICU chest trauma patients with fractured ribs : retrospective study of pain control and intubation requirements. Ann Intensive Care 10 : 116, 2020
13) Tanios M, Nguyen HM, Park H et al : Analgesia-first sedation in critically ill adults : a U.S. pilot, randomized controlled trial. J Crit Care 53 : 107-113, 2019
14) Olsen HT, Nedergaard HK, Strom T et al : Nonsedation or light sedation in critically ill, mechanically ventilated patients. N Engl J Med 382 : 1103-1011, 2020
P.19 掲載の参考文献
15) Shehabi Y, Neto AS, Howe BD et al : Early sedation with dexmedetomidine in ventilated critically ill patients and heterogeneity of treatment effect in the SPICE III randomised controlled trial. Intensive Care Med 47 : 455-466, 2021
16) Cioccari L, Luethi N, Bailey M et al : The effect of dexmedetomidine on vasopressor requirements in patients with septic shock : a subgroup analysis of the Sedation Practice in lntensive Care Evaluation [SPICE III] Trial. Ctit Care 24 : 441, 2020
17) Chanques G, Constantin J-M, Devlin JW et al : Analgesia and sedation in patients with ARDS. Intensive Care Med 46 : 2342-2356, 2020
18) Pearson SD, Patel BK : Evolving targets for sedation during mechanical ventilation. Curr Opin Crit Care 26 : 47-52, 2020
19) Fuller BM, Roberts BW, Mohr NM et al : The ED-SED study : a multicenter, prospective cohort study of practice patterns and clinical outcomes -associated with Emergency Department SEDation for mechanically ventilated patients. Crit Care Med 47 : 1539-1548, 2019
20) Cinotti R, Besnard N, Desmedt L et al : Feasibility and impact of the implementation of a clinical scale-based sedation-analgesia protocol in severe burn patients undergoing mechanical ventilation. a before-after bi-center study. BURNS 46 : 1310-1317, 2020
P.20 掲載の参考文献
21) Kaplan JB, Eiferman DS, Porter K et al : Impact of a nursing-driven sedation protocol with criteria for infusion initiation in the surgical intensive care unit. J Crit Care 50 : 195-200, 2019
22) Rosenthal M, Grunow JJ, Spies CD et al : Critical care guidelines on pain, agitation and delirium management : which one to use? a systematic literature search and quality appraisal with AGREE II. J Crit Care 59 : 124-129, 2020
23) Oh ES, Needham DM, Nikooie R et al : Antipsychotics for preventing delirium in hospitalized adults : a systematic review. Ann Intern Med 171 : 474-484, 2019
24) Jaiswal SJ, Vyas AD, Heisel AJ et al : Ramelteon for prevention of postoperative delirium : a randomized controlled trial in patients undergoing elective pulmonary thromboendarterectomy. Crit Care Med 47 : 1751-1758, 2019
25) Gandolfi JV, Di Bernardo APA, Valverde DA et al : The effects of melatonin supplementation on sleep quality and assessment of the serum melatonin in ICU patients : a randomized controlled trial. Crit Care Med 48 : e1286-e1293, 2020
26) Smit L, Dijkstra-Kersten SMA, Zaal IJ et al : Haloperidol, clonidine and resolution of delirium in critically ill patients : a prospective cohort study. Intensive Care Med 47 : 316-324, 2021
27) Rose L, Agar M, Burry L et al : Reporting of outcomes and outcome measures in studies of interventions to prevent and/or treat delirium in the critically ill : a systematic review. Crit Care Med 48 : e316-e324, 2020
P.21 掲載の参考文献
28) Duprey MS, van den Boogaard M, van der Hoeven JG et al : Association between incident delirium and 28- and 90-day mortality in critically ill adults : a secondary analysis. Critical Care 24 : 161, 2020
30) Khan BA, Perkins AJ, Prasad NK et al : Biomarkers of delirium duration and delirium severity in the ICU. Crit Care Med 48 : 353-361, 2020
31) Favre E, Bernini A, Morelli B et al : Neuromonitoring of delirium with quantitative pupillometry in sedated mechanically ventilated critically ill patients. Crit Care 24 : 66, 2020
32) 櫻本秀明, 卯野木健, 白坂雅子 : 鎮静・鎮痛・せん妄・睡眠管理, ICU diaryに関する実態- Webアンケート調査の結果から-. 日集中医誌 27 : 429-432, 2020
P.22 掲載の参考文献
1) Kyo M, Shimatani T, Hosokawa K et al : Patient-ventilator asynchrony, impact on clinical outcomes and effectiveness of interventions : a systematic review and meta-analysis. J Intensive Care 9 : 50-62, 2021
P.23 掲載の参考文献
3) Torbic H, Krishnan S, Harnegie MP et al : Neuromuscular blocking agents for ARDS : a systematic review and meta-analysis. Respir Care 66 : 120-128, 2021
4) Hua Y, Ou X, Li Q et al : Neuromuscular blockers in the acute respiratory distress syndrome : a meta-analysis. PLoS One 15 : e0227664, 2020
5) Tarazan N, Alshehri M, Sharif S et al : Neuromuscular blocking agents in acute respiratory distress syndrome : updated systematic review and meta-analysis of randomized trials. Intensive Care Med Exp 8 : 61-75, 2020
6) Santa Cruz R, Villarejo F, Irrazabal C et al : High versus low positive end-expiratory pressure (PEEP) levels for mechanically ventilated adult patients with acute lung injury and acute respiratory distress syndrome. Cochrane Database Syst Rev 3 : CD009098, 2021
7) Writing Committee and Steering Committee for the RELAx Collaborative Group, Algera AG, Pisani L, Serpa Neto A et al : Effect of a lower vs higher positive end-expiratory pressure strategy on ventilator-free days in ICU patients without ARDS : a randomized clinical trial. JAMA 324 : 2509-2520, 2020
8) Lim J, Litton E : Airway pressure release ventilation in adult patients with acute hypoxemic respiratory failure : a systematic review and meta-analysis. Crit Care Med 47 : 1794-1799, 2019
P.24 掲載の参考文献
9) Yuan X, Lu X, Chao Y et al : Neurally adjusted ventilatory assist as a weaning mode for adults with invasive mechanical ventilation : a systematic review and meta-analysis. Crit Care 25 : 222-232, 2021
10) Weber J, Schmidt J, Straka L et al : Flow-controlled ventilation improves gas exchange in lung-healthy patients-a randomized interventional cross-over study. Acta Anaesthesiol Scand 64 : 481-488, 2020
11) Weber J, Straka L, Borgmann S et al : Flow-controlled ventilation (FCV) improves regional ventilation in obese patients-a randomized controlled crossover trial. BMC Anesthesiol 20 : 24-33, 2020
12) Towner JE, Rahmani R, Zammit CG et al : Mechanical ventilation in aneurysmal subarachnoid hemorrhage : systematic review and recommendations. Crit Care 24 : 575-582, 2020
P.25 掲載の参考文献
13) Pensier J, de Jong A, Hajjej Z et al : Effect of lung recruitment maneuver on oxygenation, physiological parameters and mortality in acute respiratory distress syndrome patients : a systematic review and meta-analysis. Intensive Care Med 45 : 1691-1702, 2019
14) Rozencwajg S, Guihot A, Franchineau G et al : Ultra-protective ventilation reduces biotrauma in patients on venovenous extracorporeal membrane oxygenation for severe acute respiratory distress syndrome. Crit Care Med 47 : 1505-1512, 2019
15) Sud S, Friedrich JO, Adhikari NKJ et al : Comparative effectiveness of protective ventilation strategies for moderate and severe acute respiratory distress syndrome. a network meta-analysis. Am J Respir Crit Care Med 203 : 1366-1377, 2021
16) Deng QW, Tan WC, Zhao BC et al : Intraoperative ventilation strategies to prevent postoperative pulmonary complications : a network meta-analysis of randomised controlled trials. Br J Anaesth 124 : 324-335, 2020
17) Zhao T, Wu X, Zhang Q et al : Oral hygiene care for critically ill patients to prevent ventilator-associated pneumonia. Cochrane Database Syst Rev 12 : CD008367, 2020
P.26 掲載の参考文献
18) Pozuelo-Carrascosa DP, Herraiz-Adillo A, Alvarez-Bueno C et al : Subglottic secretion drainage for preventing ventilator-associated pneumonia : an overview of systematic reviews and an updated meta-analysis. Eur Respir Rev 29 : 190107, 2020
19) Batra P, Soni KD, Mathur P : Efficacy of probiotics in the prevention of VAP in critically ill ICU patients : an updated systematic review and meta-analysis of randomized control trials. J Intensive Care 8 : 81-94, 2020
20) Anan K, Oshima Y, Ogura T et al : Safety and harms of bronchoalveolar lavage for acute respiratory failure : a systematic review and meta-analysis. Respir Investig 60 : 68-81, 2022
21) Wang Y, Ye Z, Ge L et al : Efficacy and safety of gastrointestinal bleeding prophylaxis in critically ill patients : systematic review and network meta-analysis. BMJ 368 : l6744, 2020
22) Giordano G, Pugliese F, Bilotta F : Neuroinflammation, neuronal damage or cognitive impairment-associated with mechanical ventilation : a systematic review of evidence from animal studies. J Crit Care 62 : 246-255, 2021
P.27 掲載の参考文献
23) Al Duhailib Z, Hegazy AF, Lalli R et al : The use of central venous to arterial carbon dioxide tension gap for outcome prediction in critically ill patients : a systematic review and meta-analysis. Crit Care Med 48 : 1855-1861, 2020
24) Trivedi V, Chaudhuri D, Jinah R et al : The usefulness of the rapid shallow breathing index in predicting successful extubation : a systematic review and meta-analysis. Chest 161 : 97-111, 2022
25) Sanfilippo F, Di Falco D, Noto A et al : Association of weaning failure from mechanical ventilation with transthoracic echocardiography parameters : a systematic review and meta-analysis. Br J Anaesth 126 : 319-330, 2021
26) Buckley MS, Smithburger PL, Wong A et al : Dexmedetomidine for facilitating mechanical ventilation extubation in difficult-to-wean ICU patients : systematic review and meta-analysis of clinical trials. J Intensive Care Med 36 : 925-936, 2021
P.28 掲載の参考文献
27) Wang S, Hong Y, Li S et al : Effect of dexmedetomidine on delirium during sedation in adult patients in intensive care units : a systematic review and meta-analysis. J Clin Anesth 69 : 110157, 2021
28) Pereira JV, Sanjanwala RM, Mohammed MK et al : Dexmedetomidine versus propofol sedation in reducing delirium among older adults in the ICU : a systematic review and meta-analysis. Eur J Anaesthesiol 37 : 121-131, 2020
29) Lewis K, Piticaru J, Chaudhuri D et al : Safety and efficacy of dexmedetomidine in acutely ill adults requiring noninvasive ventilation : a systematic review and meta-analysis of randomized trials. Chest 159 : 2274-2288, 2021
30) Tang G, Lin J, Zhang Y et al : The effects and safety of continuous positive airway pressure in children With bronchiolitis : a systematic review and meta-analysis. J Trop Pediatr 67 : fmaa128, 2021
31) Yasuda H, Okano H, Mayumi T et al : Post-extubation oxygenation strategies in acute respiratory failure : a systematic review and network meta-analysis. Crit Care 25 : 135-150, 2021
32) Vaschetto R, Pecere A, Perkins GD et al : Effects of early extubation followed by noninvasive ventilation versus standard extubation on the duration of invasive mechanical ventilation in hypoxemic non-hypercapnic patients : a systematic review and individual patient data meta-analysis of randomized controlled trials. Crit Care 25 : 189-201, 2021
P.29 掲載の参考文献
33) Tallo FS, Vendrame LS, Baitello AL : Comparison of three methods for teaching mechanical ventilation in an emergency setting to sixth-year medical students : a randomized trial. Rev Assoc Med Bras (1992) 66 : 1409-1413, 2020
P.30 掲載の参考文献
1) Vincent JL, Joosten A, Saugel B : Hemodynamic monitoring and support. Crit Care Med 49 : 638-1650, 2021
2) Shoemaker WC, Appel PL, Kram HB : Tissue oxygen debt as a determinant of lethal and nonlethal postoperative organ failure. Crit Care Med 16 : 1117-1120, 1988
3) Shoemaker WC, Appel PL, Kram HB : Oxygen transport measurements to evaluate tissue perfusion and titrate therapy : dobutamine and dopamine effects. Crit Care Med 19 : 672-688, 1991
4) Ronco JJ, Fenwick JC, Tweeddale MG et al : Identification of the critical oxygen delivery for anaerobic metabolism in critically ill septic and nonseptic humans. JAMA 270 : 1724-1730, 1993
P.31 掲載の参考文献
5) Hayes MA, Timmins AC, Yau EH et al : Elevation of systemic oxygen delivery in the treatment of critically ill patients. N Engl J Med 330 : 1717-1722, 1994
6) Vincent JL, De Backer D : My paper 20 years later : effects of dobutamine on the VO2/DO2 relationship. Intensive Care Med 40 : 1643-1648, 2014
7) Monnet X, Saugel B : Could resuscitation be -based on microcirculation data? We are not sure. Intensive Care Med 44 : 950-953, 2018
8) Vincent JL, Bakker J : Blood lactate levels in sepsis : in 8 questions. Curr Opin Crit Care 27 : 298-302, 2021
9) Vincent JL, Cecconi M, De Backer D : The fluid challenge. Crit Care 24 : 703, 2020
10) Silversides JA, Perner A, Malbrain MLNG : Liberal versus restrictive fluid therapy in critically ill patients. Intensive Care Med 45 : 1440-1442, 2019
11) Monge Garcia MI, Guijo Gonzalez P, Gracia Romero M et al : Effects of fluid administration on arterial load in septic shock patients. Intensive Care Med 41 : 1247-1255, 2015
12) Ince C : Hemodynamic coherence and the rationale for monitoring the microcirculation. Crit Care 19 Suppl 3 : S8, 2015
P.32 掲載の参考文献
13) Messmer AS, Zingg C, Muller M : Fluid overload and mortality in adult critical care patients-a systematic review and meta-analysis of observational studies. Crit Care Med 48 : 1862-1870, 2020
14) Vaara ST, Ostermann M, Bitker L et al : Restrictive fluid management versus usual care in acute kidney injury (REVERSEAKI) : a pilot randomized controlled feasibility trial. Intensive Care Med 47 : 665-673, 2021
16) Hamzaoui O, Jozwiak M, Geffriaud T et al : Norepinephrine exerts an inotropic effect during the early phase of human septic shock. Br J Anaesth 120 : 517-524, 2018
17) Jhanji S, Stirling S, Patel N et al : The effect of increasing doses of norepinephrine on tissue oxygenation and microvascular flow in patients with septic shock. Crit Care Med 37 : 1961-1966, 2009
18) Sennoun N, Montemont C, Gibot S et al : Comparative effects of early versus delayed use of norepinephrine in resuscitated endotoxic shock. Crit Care Med 35 : 1736-1740, 2007
19) Morimatsu H, Singh K, Uchino S et al : Early and exclusive use of norepinephrine in septic shock. Resuscitation 62 : 249-254, 2004
20) Hamzaoui O, Georger JF, Monnet X et al : Early administration of norepinephrine increases cardiac preload and cardiac output in septic patients with life-threatening hypotension. Crit Care 14 : R142, 2010
21) Bai X, Yu W, Ji W et al : Early versus delayed administration of norepinephrine in patients with septic shock. Crit Care 18 : 532, 2014
22) Permpikul C, Tongyoo S, Viarasilpa T et al : Early use of norepinephrine in septic shock resuscitation (CENSER). a randomized trial. Am J Respir Crit Care Med 199 : 1097-1105, 2019
23) Ospina-Tascon GA, Hernandez G, Alvarez I et al : Effects of very early start of norepinephrine in patients with septic shock : a propensity score-based analysis. Crit Care 24 : 52, 2020
P.33 掲載の参考文献
P.34 掲載の参考文献
24) Corl KA, Prodromou M, Merchant RC et al : The restrictive IV fluid trial in severe sepsis and septic shock (RIFTS) : a randomized pilot study. Crit Care Med 47 : 951-959, 2019
25) Ducrocq G, Gonzalez-Juanatey JR, Puymirat E et al : Effect of a restrictive vs liberal blood transfusion strategy on major cardiovascular events among patients with acute myocardial infarction and anemia : the REALITY randomized clinical trial. JAMA 325 : 552-560, 2021
26) Sabatine MS, Morrow DA, Giugliano RP et al : Association of hemoglobin levels with clinical outcomes in acute coronary syndromes. Circulation 111 : 2042-2049, 2005
27) Mazer CD, Whitlock RP, Fergusson DA et al : Six-month outcomes after restrictive or liberal transfusion for cardiac surgery. N Engl J Med 379 : 1224-1233, 2018
28) Docherty AB, O'Donnell R, Brunskill S et al : Effect of restrictive versus liberal transfusion strategies on outcomes in patients with cardiovascular disease in a non-cardiac surgery setting : systematic review and meta-analysis. BMJ 352 : i1351, 2016
P.36 掲載の参考文献
1) Engelman DT, Ben Ali W, Williams JB et al : Guidelines for perioperative care in cardiac surgery : enhanced recovery after surgery society recommendations. JAMA Surg 154 : 755-766, 2019
2) Grant MC, Isada T, Ruzankin P et al : Results from an enhanced recovery program for cardiac surgery. J Thorac Cardiovasc Surg 159 : 1393-1402.e7, 2020
3) Grant MC, Isada T, Ruzankin P et al : Opioid-sparing cardiac anesthesia : secondary analysis of an enhanced recovery program for cardiac surgery. Anesth Analg 131 : 1852-1861, 2020
P.37 掲載の参考文献
4) Subramaniam B, Shankar P, Shaefi S et al : Effect of intravenous acetaminophen vs placebo combined with propofol or dexmedetomidine on postoperative delirium among older patients following cardiac surgery. the DEXACET randomized clinical trial. JAMA 321 : 686-691, 2019
5) Barnes-Daly MA, Phillips G, Ely EW : Improving hospital survival and reducing brain dysfunction at seven California community hospitals : implementing PAD guidelines via the ABCDEF bundle. Crit Care Med 45 : 171-178, 2017
6) Ruetzler K, Khanna AK, Sessler DI : Myocardial injury after noncardiac surgery : preoperative, intraoperative and postoperative aspects, implications, and directions. Anesth Analg 131 : 173-186, 2020
7) Brown CH, Neufeld KJ, Tian J et al : Effect of targeting mean arterial pressure during cardiopulmonary bypass by monitoring cerebral autoregulation on postsurgical delirium among older patients : a nested randomized clinical trial. JAMA surg 154 : 819-826, 2019
8) Eertmans W, De Deyne C, Genburgge C et al : Association between postoperative delirium and postoperative cerebral oxygen desaturation in older patients after cardiac surgery. Br J Anesth 124 : 146-153, 2020
9) Maheshwari K, Ahuja S, Khanna AK et al : Association between perioperative hypotension and delirium in postoperative critically ill patients : a retrospective cohort analysis. Anesth Analg 130 : 636-643, 2020
P.38 掲載の参考文献
10) Ngu JMC, Jabagi H, Chung AM et al : Defining an intraoperative hypotension threshold in association with de novo renal replacement therapy after cardiac surgery. Anesthesiology 132 : 1477-1457, 2020
11) Kullmar M, Saadat-Gilani K, Weiss R et al : Kinetic changes of plasma renin concentration predict acute kidney injury in cardiac surgery patients. Am J Respir Crit Care Med 203 : 1196-1126, 2021
12) Hu J, Rezoagki E, Zadek F et al : Free hemoglobin ratio as a novel biomarker of acute kidney injury after on-pump cardiac surgery : secondary analysis of a randomized controlled trial. Anesth Analg 132 : 1548-1558, 2021
13) Hong SK, Boylan JW, Tannenberg AM et al : Total and partial gas tensions of human bladder urine. J Appl Physiol 15 : 115-120, 1960
14) Kainuma M, Yamada M, Miyake T : Continuous urine oxygen monitoring in patients undergoing cardiac surgery. J Cardiothorac Vasc Anesth 10 : 603-608, 1996
15) Silverstone NA, Lofgren LR, Stoddard GJ et al : Noninvasive urine oxygen monitoring and the risk of acute kidney injury in cardiac surgery. Anesthesiology 135 : 406-418, 2021
16) Kato T, Kawasaki Y, Koyama K : Intermittent urine oxygen tension monitoring for predicting acute kidney injury after cardiovascular surgery : a preliminary prospective observational study. Cureus 13 : e16135, 2021
P.39 掲載の参考文献
17) Matsuura C, Kato T, Koyama K : Successful management of refractory torsades pointes due to drug-induced long QT syndrome guided by point-of-care monitoring of ionized magnesium. Cureus 13 : e13939, 2021
18) Wilkes NJ, Mallett SV, Peschey T et al : Correction of ionized plasma magnesium during cardiopulmonary bypass reduces the risk of postoperative cardiac arrhythmia. Anesth Analg 95 : 828-834, 2002
19) 浅野麻由, 加藤崇央, 黒川右基他 : 冠動脈血行再建術後の心房細動発症因子に関する検討. Cardiovascular Anesthesia 24 : 41-47, 2020
20) Hizuka K, Kato K, Shiko Y et al : Ionized hypomagnesium is associated with increased incidence of postoperative atrial fibrillation after esophageal resection : a retrospective study, Cureus 13 : e17105, 2021
P.40 掲載の参考文献
21) Nakayama T, Umehara K, Shirozu K et al : Association between ionized magnesium and postopetative shivering. J Anesth 35 : 412-419, 2021
22) Lagier D, Fisher F, Huynh TM et al : Effect of open-lung vs conventional perioperative ventilation strategies on postoperative pulmonary complications after on-pump cardiac surgery : the PROVECS randomized clinical trial. Intensive Care Med 45 : 1401-1412, 2019
23) Lagier D, Velly LJ, Guinard B et al : Perioperative open-lung approach, regionak ventilation, and lung injury in cardiac surgery. Anesthesiology 133 : 1029-1045, 2020
P.41 掲載の参考文献
24) Martinsson A, Houltz E, Wallinder A et al : Lung recruitment in the prone position after cardiac surgery : a randomized controlled study. Brit J Anaeesth 126 : 1067-1074, 2021
25) Society of Thoracic Surgeons Task Force on Resuscitation After Cardiac Surgery : The society of thoracic surgeons expert consensus for the Resuscitation of patients who arrest after cardiac surgery. Ann Thorac Surg 103 : 1005-1020, 2017
P.42 掲載の参考文献
1) Laine L, Barkun AN, Saltzman JR et al : ACG Clinical Guideline : Upper Gastrointestinal and Ulcer Bleeding. Am J Gastroenterol 116 : 899-917, 2021
2) Kelly CR, Fischer M, Allegretti JR et al : ACG Clinical Guidelines : Prevention, Diagnosis, and Treatment of Clostridioides difficile Infections. Am J Gastroenterol 116 : 1124-1147, 2021
P.43 掲載の参考文献
3) Holbrook A, Schulman S, Witt DM et al : Evidence ‐ -based management of anticoagulant therapy : antithrombotic therapy and prevention of thrombosis, American College of Chest Physicians Evidence-Based Clinical Practice Guidelines. Chest 141 (suppl) : e152S-184S, 2012
4) Abraham NS, Hlatky MA, Antman EM et al : ACCF/ACG/AHA2010 expert consensus document on the concomitant use of proton pump inhibitors and thienopyridines : a focused update of the ACCF/ACG/AHA 2008 expert consensus document on reducing the gastrointestinal risks of antiplatelet therapy and NSAID use. Am J Gastroenterol 105 : 2533-2549, 2010
5) Sostres C, Marcen B, Laredo V et al : Risk of rebleeding, vascular events and death after gastrointestinal bleeding in anticoagulant and/or antiplatelet users. Aliment Pharmacol Ther 50 : 919-929, 2019
6) Willems RPJ, van Dijk K, Ket JCF et al : Evaluation of the association between gastric acid suppression and risk of intestinal colonization with multidrug-resistant microorganisms : a systematic review and meta-analysis. JAMA Intern Med 180 : 561-571, 2020
P.44 掲載の参考文献
7) Stanley AJ, Laine L, Dalton HR et al : Comparison of risk scoring systems for patients presenting with upper gastrointestinal bleeding : international multicentre prospective study. BMJ 356 : i6432, 2017
8) Shung DL, Au B, Taylor RA et al : Validation of a machine learning model that outperforms clinical risk scoring systems for upper gastrointestinal bleeding. Gastroenterology 158 : 160-167, 2020
9) Laine L, Jensen DM : Management of patients with ulcer bleeding. Am J Gastroenterol 107 : 345-360, 2012
10) Gralnek IM, Dumonceau JM, Kuipers EJ et al : Diagnosis and management of non-variceal upper gastrointestinal hemorrhage : European Society of Gastrointestinal Endoscopy (ESGE) Guideline. Endoscopy 47 : a1-46, 2015
11) Laursen SB, Leontiadis GI, Stanley AJ et al : Relationship between timing of endoscopy and mortality in patients with peptic ulcer bleeding : a nationwide cohort study. Gastrointest Endosc 85 : 936-944, 2017
12) Lau JYW, Yu Y, Tang RSY et al : Timing of endoscopy for acute upper gastrointestinal bleeding. N Engl J Med 382 : 1299-1308, 2020
P.45 掲載の参考文献
13) Tarasconi A, Baiocchi GL, Pattonieri V et al : Transcatheter arterial embolization versus surgery for refractory non-variceal upper gastrointestinal bleeding : a meta-analysis. World J Emerg Surg 14 : 3, 2019
14) Sverden E, Mattsson F, Lindstrom D et al : Transcatheter arterial embolization compared with surgery for uncontrolled peptic ulcer bleeding : a population-based cohort study. Ann Surg 269 : 304-309, 2019
P.46 掲載の参考文献
17) Tsay C, Shung D, Stemmer Frumento K et al : Early colonoscopy does not improve outcomes of patients with lower gastrointestinal bleeding : systematic review of randomized trials. Clin Gastroenterol Hepatol 18 : 1696-1703, 2020
18) Niikura R, Nagata N, Yamada A et al : Efficacy and safety of early vs elective colonoscopy for acute lower gastrointestinal bleeding. Gastroenterology 158 : 168-175.e6, 2020
19) Crobach MJ, Planche T, Eckert C et al ; European Society of Clinical Microbiology and Infectious Diseases : Update of the diagnostic guidance document for Clostridium difficile infection. Clin Microbiol Infect 22 Suppl 4 : S63-81, 2016
20) Kraft CS, Parrott JS, Cornish NE et al : A laboratory medicine best practices systematic review and meta-analysis of nucleic acid amplification tests (NAATs) and algorithms including NAATs for the diagnosis of Clostridioides (Clostridium) difficile in adults. Clin Microbiol Rev 32 : e00032-18, 2019
21) Sandlund J, Estis J, Katzenbach P et al : Increased clinical specificity with ultrasensitive detection of Clostridioides difficile toxins : reduction of overdiagnosis compared to nucleic acid amplification tests. J Clin Microbiol 57 : e00945-19, 2019
P.47 掲載の参考文献
22) McDonald LC, Gerding DN, Johnson S et al : Clinical Practice Guidelines for Clostridium difficile Infection in Adults and Children : 2017 Update by the Infectious Diseases Society of America (IDSA) and Society for Healthcare Epidemiology of America (SHEA). Clin Infect Dis 66 : e1-e48, 2018
23) Cornely OA, Vehreschild MJGT, Adomakoh N et al : Extended-pulsed fidaxomicin versus vancomycin for Clostridium difficile infection : EXTEND study subgroup analyses. Eur J Clin Microbiol Infect Dis 38 : 1187-1194, 2019
24) Hocquart M, Lagier JC, Cassir N et al : Early fecal microbiota transplantation improves survival in severe clostridium difficile infections. Clin Infect Dis 66 : 645-650, 2018
25) NICE guidance. Faecal microbiota transplant for recurrent Clostridium difficile infection https://www.nice.org.uk/guidance/ipg485 (2022年2月14 日閲覧)
P.48 掲載の参考文献
26) 國島広之, 大毛宏喜, 鈴木広道他 : Clostridioides (Clostridium) difficile感染症診療ガイドライン. 感染症学雑誌 92 : 819-854, 2018
27) DeFilipp Z, Bloom PP, Torres Soto M et al : Drug-resistant E. coli bacteremia transmitted by fecal microbiota transplant. N Engl J Med 381 : 2043-2050, 2019
28) Allegretti JR, Mehta SR, Kassam Z et al : Risk factors that predict the failure of multiple fecal microbiota transplantations for clostridioides difficile Infection. Dig Dis Sci 66 : 213-217, 2021
29) Hall J, Hardiman K, Lee S et al ; Prepared on behalf of the Clinical Practice Guidelines Committee of the American Society of Colon and Rectal Surgeons : The American Society of Colon and Rectal Surgeons Clinical Practice Guidelines for the Treatment of Left-Sided Colonic Diverticulitis. Dis Colon Rectum 63 : 728-747, 2020
30) Mora-Lopez L, Ruiz-Edo N, Estrada-Ferrer O et al ; DINAMO-study Group : Efficacy and safety of nonantibiotic outpatient treatment in mild acute diverticulitis (DINAMO-study) : a multicentre, randomised, open-label, noninferiority trial. Ann Surg 274 : e435-e442, 2021
P.49 掲載の参考文献
1) Nanchal R, Subramanian R, Karvellas CJ et al : Guidelines for the management of adult acute and acute-on-chronic liver failure in the ICU : cardiovascular, endocrine, hematologic, pulmonary and renal considerations. Crit Care Med 48 : e173-e191, 2020
2) Nanchal R, Subramanian R, Karvellas CJ et al : Guidelines for the management of adult acute and acute-on-chronic liver failure in the ICU : cardiovascular, endocrine, hematologic, pulmonary and renal considerations : executive summary. Crit Care Med 48 : 415-419, 2020
P.50 掲載の参考文献
3) Devarbhavi H, Aithal G, Treeprasertsuk S et al : Drug-induced liver injury : Asia Pacific Association of Study of Liver consensus guidelines. Hepatol Int 15 : 258-282, 2021
4) Chen C, Ke R, Yang F et al : Risk factors for recurrent autoimmune liver diseases after liver transplantation : a meta-analysis. Medicine (Baltimore) 99 : e20205, 2020
P.51 掲載の参考文献
5) Du L, Cen M, Zheng X et al : Timing of performing endoscopic retrograde cholangiopancreatography and inpatient mortality in acute cholangitis : a systematic review and meta-analysis. Clin Transl Gastroenterol 11 : e00158, 2020
6) Iqbal U, Khara HS, Hu Y et al : Emergent versus urgent ERCP in acute cholangitis : a systematic review and meta-analysis. Gastrointest Endosc 91 : 753-760.e4, 2020
7) Miura F, Okamoto K, Takada T et al : Tokyo Guidelines 2018 : initial management of acute biliary infection and flowchart for acute cholangitis. J Hepatobiliary Pancreat Sci 25 : 31-40, 2018
8) Tufo A, Pisano M, Ansaloni L et al : Risk prediction in acute calculous cholecystitis : a systematic review and meta-analysis of prognostic factors and predictive models. J Laparoendosc Adv Surg Tech A 31 : 41-53, 2021
P.52 掲載の参考文献
9) Khan SM, Emile SH, Barsom SH et al : Accuracy of pre-operative parameters in predicting severe cholecystitis-a systematic review. Surgeon 19 : 219-225, 2021
10) Sagami R, Hayasaka K, Nishikiori H et al : Current status in the treatment of acute cholecystitis patients receiving antithrombotic therapy : is endoscopic drainage feasible? -a systematic review. Clin Endosc 53 : 176-188, 2020
11) Huang H, Zhang H, Yang D et al : Percutaneous cholecystostomy versus emergency cholecystectomy for the treatment of acute calculous cholecystitis in high-risk surgical patients : a meta-analysis and systematic review. Updates Surg, 2021 [online ahead of print]
P.53 掲載の参考文献
12) Crucitti A, La Greca A, Pepe G et al : Percutaneous cholecystostomy in the treatment of acute cholecystitis : is there still a role? a 20-year literature review. Eur Rev Med Pharmacol Sci 24 : 10696-10702, 2020
13) Huang SZ, Chen HQ, Liao WX et al : Comparison of emergency cholecystectomy and delayed cholecystectomy after percutaneous transhepatic gallbladder drainage in patients with acute cholecystitis : a systematic review and meta-analysis. Updates Surg 73 : 481-494, 2021
14) Chen H, Jorissen R, Walcott J et al : Incidence and predictors of common bile duct stones in patients with acute cholecystitis : a systematic literature review and meta-analysis. ANZ J Surg 90 : 1598-1603, 2020
15) 急性膵炎診療ガイドライン2021改訂出版委員会編 : 急性膵炎診療ガイドライン 2021 [第5版]. 金原出版, 東京, 2021
P.54 掲載の参考文献
16) Schepers NJ, Hallensleben NDL, Besselink MG et al : Urgent endoscopic retrograde cholangiopancreatography with sphincterotomy versus conservative treatment in predicted severe acute gallstone pancreatitis (APEC) : a multicentre randomised controlled trial. Lancet 396 : 167-176, 2020
17) Xiao J, Quan X, Liu F et al : Comparison of different surgical methods for necrotizing pancreatitis : a meta-analysis. Front Surg 8 : 723605, 2021
P.56 掲載の参考文献
1) Messmer AS, Zingg C, Muller M et al : Fluid overload and mortality in adult critical care patients-a systematic review and meta-analysis of observational studies. Crit Care Med 48 : 1862-1870, 2020
3) Vaara ST, Ostermann M, Bitker L et al : Restrictive fluid management versus usual care in acute kidney injury (REVERSEAKI) : a pilot randomized controlled feasibility trial. Intensive Care Med 47 : 665-673, 2021
P.57 掲載の参考文献
4) Self WH, Semler MW, Wanderer JP et al : Balanced crystalloids versus saline in non critically ill adults. N Engl J Med 378 : 819-828, 2018
5) Self WH, Semler MW, Wanderer JP et al : Balanced crystalloids versus saline in noncritically ill adults. N Engl J Med 378 : 829-839, 2018
6) Zampieri FG, Machado FR, Biondi RS et al : Effect of intravenous fluid treatment with a balanced solution vs 0.9% saline solution on mortality in critically ill patients : the BaSICS randomized clinical trial. JAMA 326 : 1-12, 2021
P.58 掲載の参考文献
7) Hammon NE, Bellomo R, Gallagher M et al : The plasma-lyte 148 v saline (PLUS) study protocol : a multicentre, randomised controlled trial of the effect of intensive care fluid therapy on mortality. Crit Care Resusc. Sep 19 : 239-246, 2017
8) Gaudry S, Hajage D, Schortgen F et al : Initiation strategies for renal replacement therapy in the intensive care unit. N Engl J Med 375 : 122-133, 2016
9) Zarbock A, Kellum JA, Schmidt C et al : Effect of early vs delayed initiation of renal replacement therapy on mortality in critically ill patients with acute kidney injury : the ELAIN randomized clinical trial. JAMA 315 : 2190-2199, 2016
10) Barber SD, Clere-Jehl R, Bourredjem A et al : Timing of renal-replacement therapy in patients with acute kidney injury and sepsis. N Engl J Med 379 : 1431-1442, 2018
11) Gaudry S, Hajage D, Benichou N : Delayed versus early initiation of renal replacement therapy for severe acute kidney injury : a systematic review and individual patient data meta-analysis of randomised clinical trials. Lancet 395 : 1506-1515, 2020
12) Bagshaw SM, Wald R, Adhikari NK et al : Timing of initiation of renal-replacement therapy in acute kidney injury. N Engl J Med 383 : 240-251, 2020
P.59 掲載の参考文献
14) Futier E, Lefrant J, Guinot P et al : Effect of individualized vs standard blood pressure management strategies on postoperative organ dysfunction among high-risk patients undergoing major surgery : a randomized clinical trial. JAMA 318 : 1346-1357, 2017
15) Panwar R, Tarvade S, Lanyon N et al : Relative hypotension and adverse kidney-related outcomes among critically ill patients with shock. a multicenter, prospective cohort study. Am J Respir Crit Care Med 202 : 1407-1418, 2020
P.60 掲載の参考文献
16) AKI (急性腎障害) 診療ガイドライン作成委員会 : AKI (急性腎障害) 診療ガイドライン 2016. 日腎会誌 59 : 419-533, 2017
17) Kullmar M, Saadat-Gilani K, Weiss R et al : Kinetic changes of plasma renin concentrations predict acute kidney injury in cardiac surgery patients. Am J Respir Crit Care Med 203 : 1119-1126, 2021
18) Hoste E, Bihorac A, Al-Khafaji A et al : Identification and validation of biomarkers of persistent acute kidney injury : the RUBY study. Intensive Care Med 46 : 943-953, 2020
19) Bagshaw SM, Al-Khafaji A, Artigas A et al : External validation of urinary C-C motif chemokine ligand 14 (CCL14) for prediction of persistent acute kidney injury. Crit Care 25 : 185, 2021
20) 日本腎臓学会, 日本医学放射線学会, 日本循環器学会 : 腎障害患者におけるヨード造影剤使用に関するガイドライン 2018. 日腎会誌 61 : 933-1081, 2019
21) Miyamoto Y, Iwagami M, Aso S et al : Association between intravenous contrast media exposure and non-recovery from dialysis-requiring septic acute kidney injury : a nationwide observational study. Intensive Care Med 45 : 1570-1579, 2019
22) Timal RJ, Kooiman J, Sijpkens YWJ et al : Effect of no prehydration vs sodium bicarbonate prehydration prior to contrastenhanced computed tomography in the prevention of postcontrast acute kidney injury in adults with chronic kidney disease : the kompas randomized clinical trial. JAMA Intern Med 180 : 533-541, 2020
P.62 掲載の参考文献
1) van Regenmortel N, Hendrickx S, Roelant E et al : 154 compared to 54 mmol per liter of sodium in intravenous maintenance fluid therapy for adult patients undergoing major thoracic surgery (TOPMAST) : a single-center randomized controlled double-blind trial. Intensive Care Med 45 : 1422-1432, 2019
P.63 掲載の参考文献
2) Zhang Z, Mo L, Ho K et al : Association between the use of sodium bicarbonate and mortality in acute kidney injury using marginal structural COx model. Crit Care Med 47 : 1402-1408, 2019
P.64 掲載の参考文献
3) Frontera JA, Valdes E, Huang J et al : Prevalence and impact of hyponatremia in patients with coronavirus disease 2019 in New York City. Crit Care Med 48 : e1211-e1217, 2020
4) Williams V, Jayashree M, Nallasamy K et al : 0.9% saline versus Plasma-Lyte as initial fluid in children with diabetic ketoacidosis (SPinK trial) : a double-blind randomized controlled trial. Crit Care 24 : 1, 2020
P.65 掲載の参考文献
5) Sumarsono A, Wang J, Xie L et al : Prognostic value of hypochloremia in critically ill patients with decompensated cirrhosis. Crit Care Med 48 : e1054-e1061, 2020
P.66 掲載の参考文献
6) Fujii T, Udy AA, Nichol A et al : Incidence and management of metabolic acidosis with sodium bicarbonate in the ICU : an international observational study. Crit Care 25 : 45, 2021
7) Zampieri FG, Machado FR, Biondi RS et al : Effect of intravenous fluid treatment with a balanced solution vs 0.9% saline solution on mortality in critically ill patients : the BaSICS randomized clinical trial. JAMA 326 : 818-829, 2021
P.68 掲載の参考文献
1) Egi M, Ogura H, Yatabe T et al : The Japanese Clinical Practice Guidelines for Management of Sepsis and Septic Shock 2020 (JSSCG 2020). J Intensive Care 9 : 53, 2021
2) Bellomo R, Egi M : What is a NICE-SUGAR for patients in the intensive care unit? Mayo Clin Proc 84 : 400-402, 2009
3) Egi M, Bellomo R, Stachowski E et al : The interaction of chronic and acute glycemia with mortality in critically ill patients with diabetes. Crit Care Med 39 : 105-111, 2021
4) Egi M, Krinsley JS, Maurer P et al : Premorbid glycemic control modifies the interaction between acute hypoglycemia and mortality. Intensive Care Med 42 : 562-571, 2016
P.69 掲載の参考文献
5) Bohe J, Abidi H, Brunot V et al : Individualised versus conventional glucose control in critically-ill patients : the CONTROLING study-a randomized clinical trial. Intensive Care Med 47 : 1271-1283, 2021
6) Egi M, Bellomo R, Stachowski E et al : Hypoglycemia and outcome in critically ill patients. Mayo Clin Proc 85 : 217-224, 2010
7) Wang J, Zhu CK, Yu JQ et al : Hypoglycemia and mortality in sepsis patients : a systematic review and meta-analysis. Heart Lung 50 : 933-940, 2021
8) Horton WB, Barros AJ, Andris RT et al : Pathophysiologic signature of impending ICU hypoglycemia in bedside monitoring and electronic health record data : model development and external validation. Crit Care Med 50 : e221-e230, 2022
P.70 掲載の参考文献
9) Kwan TN, Zwakman-Hessels L, Marhoon N et al : Relative hypoglycemia in diabetic patients with critical illness. Crit Care Med 48 : e233-e240, 2020
10) Egi M, Toda Y, Katayama H et al : Safer glycemic control using isomaltulose-based enteral formula : a pilot randomized crossover trial. J Crit Care 25 : 90-96, 2009
11) Eckert I, Kumbier MCC, Silva FM et al : Association of specialized enteral nutrition with glycemic control and clinical outcomes in critically ill patients : a meta-analysis of randomized controlled trials. Clin Nutr 40 : 3940-3949, 2021
P.71 掲載の参考文献
12) Zeitoun MH, Abdel-Rahim AA, Hasanin MM et al : A prospective randomized trial comparing computerized columnar insulin dosing chart (the Atlanta protocol) versus the joint British diabetes societies for inpatient care protocol in management of hyperglycemia in patients with acute coronary syndrome admitted to cardiac care unit in Alexandria, Egypt. Diabetes Metab Syndr 15 : 711-718, 2021
13) Kitabchi AE, Umpierrez GE, Murphy MB et al : Hyperglycemic crises in adult patients with diabetes : a consensus statement from the American Diabetes Association. Diabetes Care 29 : 2739-2748, 2006
15) Self WH, Semler MW, Wanderer JP et al : Balanced crystalloids versus saline in noncritically ill adults. N Engl J Med 378 : 819-828, 2018
P.72 掲載の参考文献
17) Self WH, Evans CS, Jenkins CA et al : Clinical effects of balanced crystalloids vs saline in adults with diabetic ketoacidosis : a subgroup analysis of cluster randomized clinical trials. JAMA Netw Open 3 : e2024596, 2020
18) Wolfsdorf JI, Glaser N, Agus M et al : ISPAD Clinical Practice Consensus Guidelines 2018 : diabetic ketoacidosis and the hyperglycemic hyperosmolar state. Pediatr Diabetes 19 Suppl 27 : 155-177, 2018
20) Annane D, Renault A, Brun-Buisson C et al : Hydrocortisone plus fludrocortisone for adults with septic shock. N Engl J Med 2018 ; 378 : 809-818, 2018
21) Cohen J, Blumenthal A, Cuellar-Partida G et al : The relationship between adrenocortical candidate gene expression and clinical response to hydrocortisone in patients with septic shock. Intensive Care Med 47 : 974-983, 2021
P.73 掲載の参考文献
22) Hammond NE, Finfer SR, Li Q et al : Health-related quality of life in survivors of septic shock : 6-month follow-up from the ADRENAL trial. Intensive Care Med 46 : 1696-1706, 2020
23) Dichtel LE, Schorr M, Loures de Assis C et al : Plasma free cortisol in states of normal and altered binding globulins : implications for adrenal insufficiency diagnosis. J Clin Endocrinol Metab 104 : 4827-4836, 2019
P.75 掲載の参考文献
1) 日本血栓止血学会 : DIC診断基準 2017年度版
2) Iba T, Umemura Y, Watanabe E et al : Diagnosis of sepsis-induced disseminated intravascular coagulation and coagulopathy. Acute Med Surg 6 : 223, 2019
P.76 掲載の参考文献
3) 日本集中治療医学会 : 日本版敗血症診療ガイドライン 2020 (J-SSCG2020) 正式版 https://www.jsicm.org/pdf/jjsicm28Suppl.pdf (2021年12月30日閲覧)
4) 日本版敗血症診療ガイドライン2020特別委員会COVID-19対策タスクフォース : 日本版敗血症診療ガイドライン 2020 (JSSCG2020) 特別編 COVID-19薬物療法に関するRapid/Living recommendations 第4.1版
5) Short SAP, Gupta S, Brenner SK et al : D-dimer and death in critically ill patients with coronavirus disease 2019. Crit Care Med 49 : e500-511, 2021
6) 射場敏明 : COVID-19凝固異常症抗凝固療法, 線溶・抗線溶療法. Thromb Med 11 : 32-38, 2021
7) Boss K, Kribben A, Tycznski B et al : Pathological findings in rotation thromboelastometry -associated with thromboembolic events in COVID-19 patients. Thromb J 19 : 10, 2021
8) Pavoni V, Gianesello L, Pazzi M et al : Evaluation of coagulation function by rotation thromboelastometry in critically ill patients with severe COVID-19 pneumonia. J Thromb Thrombolysis 50 : 281-286, 2020
9) Correa TD, Cordioli RL, Campos Guerra JC et al : Coagulation profile of COVID-19 patients admitted to the ICU : an exploratory study. PLOS ONE Dec 15 : e0243604, 2020
10) Hranjec T, Estreicher M, Rogers B et al : Integral use of thromboelastography with platelet mapping to guide appropriate treatment, avoid complications, and improve survival of patients with coronavirus disease 2019-related coagulopathy. Crit Care Expl 2 : e0287, 2020
11) Chow JH, Khanna AK, Kethireddy S et al : Aspirin use is associated with decreased mechanical ventilation, intensive care unit admission, and in-hospital mortality in hospitalized patients with coronavirus disease 2019. Anesth Analg 132 : 930, 2021
12) 水谷哲也 : COVID-19凝固異常症SARS-CoV-2の細胞内侵入. Thromb Med 11 : 85, 2021
13) Nicolai L, Leunig A, Brambs S et al : Immunothrombotic dysregulation in COVID-19 pneumonia is associated with respiratory failure and coagulopathy. Circulation 142 : 1179, 2020
P.77 掲載の参考文献
14) Aid M, Busman-Sahay K, Vidal SJ et al : Vascular disease and thrombosis in SARS-CoV-2-infected rhesus macaques. Cell 183 : 1354-1366, 2020
15) Goshua G, Pine AB, Meizlish ML et al : Endotheliopathy in COVID-19-associated coagulopathy : evidence from a single-centre, cross-sectional study. Lanset Haematol 7 : e575-582, 2020
16) Wiersinga WJ, Rhodes A, Cheng AC et al : Pathophysiology, transmission, diagnosis, and treatment of coronavirus disease 2019 (COVID-19) : a review. JAMA 324 : 783-793, 2020
17) Giannis D, Ziogas IA, Gianni P : Coagulation disorders in coronavirus infected patients : COVID-19, SARS-CoV-1, MERS-CoV and lessons from the past. J Clin Virol 127 : 104362, 2020
18) Zhang Y, Xiao M, Zhang S et al : Coagulopathy and antiphospholipid antibodies in patients with Covid-19. N Eng J Med 382 : e38, 2020
19) Wichmann D, Sperhake JP, Lutgehetmann M et al : Autopsy findings and venous thromboembolism in patients with COVID-19 : a prospective cohort study. Ann Interm Med 173 : 268-277, 2020
20) 石倉宏恭, 丸山隼一, 入江悠平他 : 重症新型コロナウイルス感染症 (COVID-19) の凝固線溶系異常の特徴-Case series-. 血栓止血誌 31 : 398-408, 2020
P.78 掲載の参考文献
21) Thachil J, Tang N, Gando S et al : ISTH interim guidance on recognition and management of coagulopathy in COVID-19. J Thromb Haemost 18 : 1023-1026, 2020
P.79 掲載の参考文献
22) 厚生労働省 : 新型コロナウイルス感染症診療の手引き. 第6.1版 https://www.mhlw.go.jp/content/000875189.pdf (2021年12月31日閲覧)
23) Buenen AG, Sinkeldam M, Maas ML et al : Prior use of anticoagulation is associated with a better survival in COVID-19. J Thromb Thrombolysis 52 : 1207-1211, 2021
24) Flam B, Wintzell V, Ludvigsson JF et al : Direct oral anticoagulant use and risk of severe COVID-19. J Intern Med 289 : 411-419, 2021
25) Meizlish ML, Goshua G, Liu Y et al : Intermediate-dose anticoagulation, aspirin, and in-hospital mortality in COVID-19 : a propensity score-matched analysis. Am J Hematol 96 : 471-479, 2021
26) 土井研人 : プロテアーゼ阻害薬. Thromb Med 11 : 207-210, 2021
27) Jang S, Rhee JY : Three cases of treatment with nafamostat in elderly patients with COVID-19 pneumonia who need oxygen therapy. Int J Infect Dis 96 : 500-502, 2020
28) Extracorporeal Life Support Organization : Guideline for Adult Respiratory Failure. http://www.elso.org/Portals/0/ELSO%20Guidelines%20For%20Adult%20Respiratory%20Failure%201_4.pdf (2021年12月31日閲覧)
29) Nakashima R, Nishihara M, Iyonaga T et al : Efficacy of thromboelastography in the management of anticoagulation for venovenous extracorporeal membrane oxygenation in a coronavirus disease 2019 patient : a case report. Medicine (Baltimore) 100 : e26313, 2021
P.80 掲載の参考文献
30) Smolartz A, McCarthy P, Shmookler A et al : Utilization of thromboelastogram and inflammatory markers in the management of hypercoagulable state in patients with COVID-19 requiring ECMO support. Case Rep Crit Care 15 : 8824531, 2021
P.81 掲載の参考文献
2) Hoste EA, Maitland K, Brudney CS et al ; ADQI XII Investigators Group : Four phases of intravenous fluid therapy : a conceptual model. Br J Anaesth 113 : 740-747, 2014
3) 清野雄介 : 敗血症の輸液戦略体液・代謝管理. 37 : 50-56, 2021
4) Meyhoff TS, Moller MH, Hjortrup PB et al : Lower vs higher fluid volumes during initial management of sepsis : a systematic review with meta-analysis and trial sequential analysis. Chest 157 : 1478-1496, 2020
P.82 掲載の参考文献
5) Wang HL, Shao J, Liu WL et al : Initial fluid resuscitation (30 mL/kg) in patients with septic shock : More or less? Am J Emerg Med 50 : 309-315, 2021
6) Khan RA, Khan NA, Bauer SR et al : Association between volume of fluid resuscitation and intubation in high-risk patients with sepsis, heart failure, end-stage renal disease, and cirrhosis. Chest 157 : 286-292, 2020
7) Jagan N, Morrow LE, Walters RW et al : Sepsis, the administration of IV fluids, and respiratory failure : a retrospective analysis-SAIFR study. Chest 159 : 1437-1444, 2021
8) Kaseer HS, Patel R, Tucker C et al : Comparison of fluid resuscitation weight-based dosing strategies in obese patients with severe sepsis. Am J Emerg Med 49 : 268-272, 2021
P.83 掲載の参考文献
9) Rice DM, Ratliff PD, Judd WR et al : Assessing the impact of CKD on outcomes in septic shock patients receiving standard Vs reduced initial fluid volume. Am J Emerg Med 38 : 2147-2150, 2020
10) Rajdev K, Leifer L, Sandhu G et al : Aggressive versus conservative fluid resuscitation in septic hemodialysis patients. Am J Emerg Med 46 : 416-419, 2021
11) Li Y, Li H, Zhang D : Timing of norepinephrine initiation in patients with septic shock : a systematic review and meta-analysis. Crit Care 24 : 488, 2020
P.84 掲載の参考文献
12) Ospina-Tascon GA, Hernandez G, Alvarez I et al : Effects of very early start of norepinephrine in patients with septic shock : a propensity score-based analysis. Crit Care 24 : 52, 2020
13) Orso D, Paoli I, Piani T et al : Accuracy of ultrasonographic measurements of inferior vena cava to determine fluid responsiveness : a systematic review and meta-analysis. J Intensive Care Med 35 : 354-363, 2020
14) Douglas IS, Alapat PM, Corl KA et al : Fluid response evaluation in sepsis hypotension and shock : a randomized clinical trial. Chest 158 : 1431-1445, 2020
P.85 掲載の参考文献
15) Dave C, Shen J, Chaudhuri D et al : Dynamic assessment of fluid responsiveness in surgical ICU patients through stroke volume variation is associated with decreased length of stay and costs : a systematic review and meta-analysis. J Intensive Care Med 35 : 14-23, 2020
16) Janz DR, Casey JD, Semler MW et al ; PrePARE Investigators ; Pragmatic Critical Care Research Group : Effect of a fluid bolus on cardiovascular collapse among critically ill adults undergoing tracheal intubation (PrePARE) : a randomised controlled trial. Lancet Respir Med 7 : 1039-1047, 2019
17) Bissell BD, Laine ME, Thompson Bastin ML et al : Impact of protocolized diuresis for de-resuscitation in the intensive care unit. Crit Care 24 : 70, 2020
18) Vaara ST, Ostermann M, Bitker L et al ; REVERSE-AKI study team : Restrictive fluid management versus usual care in acute kidney injury (REVERSE-AKI) : a pilot randomized controlled feasibility trial. Intensive Care Med 47 : 665-673, 2021
P.86 掲載の参考文献
19) Parke RL, Gilder E, Gillham MJ et al ; Fluids After Bypass Study Investigators : A multicenter, open-label, randomized controlled trial of a conservative fluid management strategy compared with usual care in participants after cardiac surgery : the fluids after bypass study. Crit Care Med 49 : 449-461, 2021
20) Tseng CH, Chen TT, Wu MY et al : Resuscitation fluid types in sepsis, surgical, and trauma patients : a systematic review and sequential network meta-analyses. Crit Care 24 : 693, 2020
21) Zampieri FG, Machado FR, Biondi RS et al : Effect of intravenous fluid treatment with a balanced solution vs 0.9% saline solution on mortality in critically ill patients : the BaSICS randomized clinical trial. JAMA 326 : 1-12, 2021
P.87 掲載の参考文献
22) Barhight MF, Nelson D, Chong G et al : Non-resuscitation fluid in excess of hydration requirements is associated with higher mortality in critically ill children. Pediatr Res 17 : 1-6, 2021
23) Black CG, Thomas NJ, Yehya N : Timing and clinical significance of fluid overload in pediatric acute respiratory distress syndrome. Pediatr Crit Care Med 22 : 795-805, 2021
24) Garrahy A, Dineen R, Hannon AM et al : Continuous versus bolus infusion of hypertonic saline in the treatment of symptomatic hyponatremia caused by SIAD. J Clin Endocrinol Metab 104 : 3595-3602, 2019
25) Baek SH, Jo YH, Ahn S et al : Risk of overcorrection in rapid intermittent bolus vs slow continuous infusion therapies of hypertonic saline for patients with symptomatic hyponatremia : the SALSA randomized clinical trial. JAMA Intern Med 181 : 81-92, 2021
P.88 掲載の参考文献
26) Ramanan M, Attokaran A, Murray L et al : SCOPE-DKA Collaborators and Queensland Critical Care Research Network (QCCRN). Sodium chloride or Plasmalyte-148 evaluation in severe diabetic ketoacidosis (SCOPE-DKA) : a cluster, crossover, randomized, controlled trial. Intensive Care Med 47 : 1248-1257, 2021
P.89 掲載の参考文献
1) Hare GMT, Mazer CD : Anemia : perioperative risk and treatment opportunity. Anesthesiology 135 : 520-530, 2021
2) Turan A, Cohen B, Rivas E et al : Association between postoperative haemoglobin and myocardial injury after noncardiac surgery : a retrospective cohort analysis. Br J Anaeth 126 : 94-101, 2021
P.90 掲載の参考文献
3) Guinn NR, Cooter ML, Weiskopf RB : Lower hemoglobin concentration decreases time to death in severely anemic patients for whom blood transfusion is not an option. J Trauma Acute Care Surg 88 : 803-808, 2020
4) Ducrocq G, Gonzalez-Juanatey JR, Puymirat E et al : Effect of a restrictive vs liberal blood transfusion strategy on major cardiovascular events among patients with acute myocardial infarction and anemia the REALITY randomized clinical trial. JAMA 325 : 552-560, 2021
5) Zeroual N, Blin C, Saour M et al : Restrictive transfusion strategy after cardiac surgery role of central venous oxygen saturation trigger : a randomized controlled trial. Anesthesiology 134 : 370-380, 2021
P.91 掲載の参考文献
6) Roman MA, Abbasciano RG, Pathak S et al : Patient blood management interventions do not lead to important clinical benefits or cost-effectiveness for major surgery : a network meta-analysis. Br J Anaesth 126 : 149-156, 2021
7) Javidroozi M, Hardy JF, Ozawa S : Patient blood management interventions lead to important benefits for major surgery. Comment on Br J Anaesth 2020. Br J Anaesth 126 : e4-e5, 2021
8) Cognasse F, Hally K, Fautex-Daniel S et al : Effects and side effects of platelet transfusion. Haemostaeology 41 : 128-135, 2021
9) Khan F, Singh K, Friedman MT : Artificial blood : The history and current perspectives of blood substitutes. Discoveries 8 : e104, 2020
10) Alayash AI : Mechanisms of toxicity and modulation of hemoglobin-based oxygen carriers. SHOCK 52 : 41-49, 2019
11) Jahr JS, Guinn NR, Lowery DR et al : Blood substitutes and oxygen therapeutics : a review. Anesth Analg 132 : 119-129, 2021
12) Yuan Z, Chen D, Chen X et al : Estimation of the number of blood donors during the COVID-19 incubation period across China and analysis of prevention and control measures for blood transfusion transmission. TRANSFUSION 60 : 1778-1784, 2020
P.92 掲載の参考文献
13) Quaglietta A, Nicolucci A, Posata R et al : Impact of Covid-19 epidemic on the activities of a blood centre, transfusion support for infected patients and clinical outcomes. Transfusion Medicine 31 : 160-166, 2021
14) Delabranche X, Kientz D, Tacquard C et al : Impact of COVID-19 and lockdown regarding blood transfusion. Transfusion 61 : 2327-2335, 2021
15) Velazquez-Kennegy K, Luna A, Sanchez-Tornero A et al : Transfusion support in COVID-19 patients : impact on hospital blood component supply during the outbreak. Transfusion 61 : 361-367, 2021
16) Liu STH, Lin HM, Baine I et al : Convalescent plasma treatment of severe COVID-19 : a propensity score-matched control study. Nature Medicine 26 : 1708-1713, 2020
P.93 掲載の参考文献
17) Stanworth SJ, New HV, Apelseth TO et al : Effects of the COVID-19 pandemic on supply and use of blood for transfusion. Lancet Haematol 7 : e756-e764, 2020
P.94 掲載の参考文献
1) Siegel JD, Rhinehart E, Jackson M et al : 2007 guideline for isolation precautions : preventing transmission of infectious agents in healthcare settings. https://www.cdc.gov/infectioncontrol/guidelines/isolation/index.html (2022年2月15日閲覧)
P.95 掲載の参考文献
2) Moser MR, Bender TR, Margolis HS et al : An outbreak of influenza aboard a commercial airliner. Am J Epidemiol 110 : 1-6, 1979
3) Shen Y, Li C, Dong H : Community outbreak investigation of SARS-CoV-2 transmission among bus riders in eastern China. JAMA Intern Med 180 : 1665-1671, 2020
4) Patel ZM, Fernandez-Miranda J, Hwang PH et al : Precautions for endoscopic transnasal skull base surgery during the COVID-19 pandemic. Neurosurgery 87 : E66-E67, 2020
5) van Doremalen N, Bushmaker T, Morris DH et al : Aerosol and surface stability of SARS-CoV-2 as compared with SARS-CoV-1. N Engl J Med 382 : 1564-1567, 2020
6) Santarpia JL, Rivera DN, Herrera VL et al : Aerosol and surface contamination of SARS-CoV-2 observed in quarantine and isolation care. Sci Rep 10 : 12732, 2020
P.96 掲載の参考文献
7) Brown J, Gregson FKA, Shrimpton A et al : A quantitative evaluation of aerosol generation during tracheal intubation and extubation. Anaesthesia 76 : 174-181, 2021
8) Sah P, Fitzpatrick MC, Zimmer CF et al : Asymptomatic SARS-CoV-2 infection : a systematic review and meta-analysis. Proc Natl Acad Sci USA 118 : e2109229118, 2021
P.97 掲載の参考文献
9) Gu Y, Komiya N, Kamiya H et al : Pandemic (H1N1) 2009 transmission during presymptomatic phase, Japan. Emerg Infect Dis 17 : 1737-1739, 2011
10) Rothe C, Schunk M, Sothmann P et al : Transmission of 2019-nCoV infection from an asymptomatic contact in Germany. N Engl J Med 382 : 970-971, 2020
11) Wei WE, Li Z, Chiew CJ et al : Presymptomatic transmission of SARS-CoV-2 - Singapore, January 23-March 16, 2020. Morb Mortal Wkly Rep 69 : 411-415, 2020
12) He X, Lau EHY, Wu P et al : Temporal dynamics in viral shedding and transmissibility of COVID-19. Nature Med 26 : 672-675, 2020
P.98 掲載の参考文献
13) Anderson DJ, Chen LF, Weber DJ et al : Enhanced terminal room disinfection and acquisition and infection caused by multi-drug-resistant organisms and Clostridium difficile (the Benefits of Enhanced Terminal Room Disinfection study) : a cluster-randomised, multicentre, crossover study. Lancet 389 : 805-814, 2017
14) Marra AR, Schweizer ML, Edmond MB : No-touch disinfection methods to decrease multidrug-resistant organism infections : a systematic review and meta-analysis. Infect Control Hosp Epidemiol 39 : 20-31, 2018
15) Dippenaar R, Smith J : Impact of pulsed xenon ultraviolet disinfection on surface contamination in a hospital facility's ex-pressed human milk feed preparation area. BMC Infect Dis 18 : 91, 2018
16) Villacis JE, Lopez M, Passey D et al : Efficacy of pulsed-xenon ultraviolet light for disinfection of high-touch surfaces in an Ecuadorian hospital. BMC Infect Dis 19 : 575, 2019
17) Ramos CCR, Roque JLA, Sarmiento DB et al : Use of ultraviolet-C in environmental sterilization in hospitals : a systematic review on efficacy and safety. Int J Health Sci 14 : 52-65, 2020
18) Morikane K, Suzuki S, Yoshioka J et al : Clinical and microbiological effect of pulsed xenon ultraviolet disinfection to reduce multidrug-resistant organisms in the intensive care unit in a Japanese hospital : a before-after study. BMC Infect Dis 20 : 82, 2020
19) Kitagawa H, Mori M, Kawano R et al : Combining pulsed xenon ultraviolet disinfection with terminal manual cleaning helps reduce the acquisition rate of methicillin-resistant Staphylococcus aureus. Am J Infect Control 49 : 1048-1051, 2021
P.100 掲載の参考文献
1) Compher C, Bingham AL, McCall M et al : Guidelines for the provision of nutrition support therapy in the adult critically ill patient : The American Society for Parenteral and Enteral Nutrition. JPEN J Parenter Enteral Nutr 46 : 12-41, 2022
2) Reignier J, Boisrame-Helms J, Brisard L et al : Enteral versus parenteral early nutrition in ventilated adults with shock : a randomised, controlled, multicentre, open-label, parallel-group study (NUTRIREA-2). Lancet 391 : 133-143, 2018
P.101 掲載の参考文献
3) Patel JJ, Kozeniecki M, Peppard WJ et al : Phase 3 pilot randomized controlled trial comparing early trophic enteral nutrition with "No Enteral Nutrition" in mechanically ventilated patients with septic shock. JPEN J Parenter Enteral Nutr 44 : 866-873, 2020
4) Piton G, Le Gouge A, Brule N et al : Impact of the route of nutrition on gut mucosa in ventilated adults with shock : an ancillary of the NUTRIREA-2 trial. Intensive Care Med 45 : 948-956, 2019
5) Merker M, Felder M, Gueissaz L et al : Association of baseline inflammation with effectiveness of nutritional support among patients with disease-related malnutrition : a secondary analysis of a randomized clinical trial. JAMA Netw Open 3 : e200663, 2020
6) Schuetz P, Fehr R, Baechli V et al : Individualised nutritional support in medical inpatients at nutritional risk : a randomised clinical trial. Lancet 393 : 2312-2321, 2019
7) McKeever L, Peterson SJ, Cienfuegos S et al : Real-time energy exposure is associated with increased oxidative stress among feeding-tolerant critically ill patients : results from the FEDOX trial. JPEN J Parenter Enteral Nutr 44 : 1484-1491, 2020
8) Floh AA, Herridge J, Fan CS et al : Rapid advancement in enteral nutrition does not affect systemic inflammation and insulin homeostasis following pediatric cardiopulmonary bypass surgery. Pediatr Crit Care Med 21 : e441-e448, 2020
P.102 掲載の参考文献
9) Sundstrom Rehal M, Liebau F, Wernerman J et al : Whole-body protein kinetics in critically ill patients during 50 or 100% energy provision by enteral nutrition : a randomized cross-over study. PLoS One 15 : e0240045, 2020
10) Srinivasan V, Hasbani NR, Mehta NM et al : Heart and lung failure-pediatric insulin titration (HALF-PINT) study investigators. early enteral nutrition is associated with improved clinical outcomes in critically ill children : a secondary analysis of nutrition support in the heart and lung failure-pediatric insulin titration trial. Pediatr Crit Care Med 21 : 213-221, 2020
11) Kim TJ, Park SH, Jeong HB et al : Optimizing nitrogen balance is associated with better outcomes in neurocritically ill patients. Nutrients 12 : 3137, 2020
12) Hartwell JL, Cotton A, Wenos CD et al : Early achievement of enteral nutrition protein goals by intensive care unit day 4 is associated with fewer complications in critically injured adults. Ann Surg 274 : e988-e994, 2021
13) Chinda P, Poomthong P, Toadithep P et al : The implementation of a nutrition protocol in a surgical intensive care unit : a randomized controlled trial at a tertiary care hospital. PLoS One 15 : e0231777, 2020
14) Chapple LS, Summers MJ, Bellomo R et al : Use of a high-protein enteral nutrition formula to increase protein delivery to critically ill patients : a randomized, blinded, parallel-group, feasibility trial. JPEN J Parenter Enteral Nutr 45 : 699-709, 2021
15) Dresen E, Weisbrich C, Fimmers R : Medical high-protein nutrition therapy and loss of muscle mass in adult ICU patients : a randomized controlled trial. Clin Nutr 40 : 1562-1570, 2021
P.103 掲載の参考文献
16) Mousavian SZ, Pasdar Y, Ranjbar G et al : Randomized controlled trial of comparative hypocaloric vs full-energy enteral feeding during the first week of hospitalization in neurosurgical patients at the intensive care unit. JPEN J Parenter Enteral Nutr 44 : 1475-1483, 2020
17) Sun JK, Nie S, Chen YM et al : Effects of permissive hypocaloric vs standard enteral feeding on gastrointestinal function and outcomes in sepsis. World J Gastroenterol 27 : 4900-4912, 2021
18) Casaer MP, Mesotten D, Hermans G et al : Early versus late parenteral nutrition in critically ill adults. N Engl J Med 365 : 506-517, 2011
19) Wang CY, Fu PK, Chao WC et al : Full versus trophic feeds in critically ill adults with high and low nutritional risk scores : a randomized controlled trial. Nutrients 12 : 3518, 2020
20) Charles EJ, Kane WJ, Willcutts KF et al : Hypoenergetic feeding does not improve outcomes in critically ill patients with premorbid obesity : a post hoc analysis of a randomized controlled trial. Nutr Res 74 : 71-77, 2020
21) Looijaard WGPM, Dekker IM, Beishuizen A et al : Early high protein intake and mortality in critically ill ICU patients with low skeletal muscle area and -density. Clin Nutr 39 : 2192-2201, 2020
22) Nakamura K, Nakano H, Naraba H et al : High protein versus medium protein delivery under equal total energy delivery in critical care : a randomized controlled trial. Clin Nutr 40 : 796-803, 2021
P.104 掲載の参考文献
23) de Azevedo JRA, Lima HCM, Frota PHDB et al : High-protein intake and early exercise in adult intensive care patients : a prospective, randomized controlled trial to evaluate the impact on functional outcomes. BMC Anesthesiol 21 : 283, 2021
24) Duan JY, Zheng WH, Zhou H et al : Energy delivery guided by indirect calorimetry in critically ill patients : a systematic review and meta-analysis. Crit Care 25 : 88, 2021
25) Singer P, De Waele E, Sanchez C et al : TICACOS international : a multi-center, randomized, prospective controlled study comparing tight calorie control versus Liberal calorie administration study. Clin Nutr 40 : 380-387, 2021
26) Berger MM, Pantet O, Jacquelin-Ravel N et al : Supplemental parenteral nutrition improves immunity with unchanged carbohydrate and protein metabolism in critically ill patients : the SPN2 randomized tracer study. Clin Nutr 38 : 2408-2416, 2019
27) Gonzalez-Granda A, Seethaler B, Haap M et al : Effect of an intensified individual nutrition therapy on serum metabolites in critically ill patients-a targeted metabolomics analysis of the ONCA study. Clin Nutr ESPEN 43 : 267-275, 2021
P.105 掲載の参考文献
28) McNelly AS, Bear DE, Connolly BA et al : Effect of intermittent or continuous feed on muscle wasting in critical illness : a phase 2 clinical trial. Chest 158 : 183-194, 2020
29) Mahran G, Mahgoup A, Kamel EZ et al : Effect of 2 enteral feeding schedules on intra-abdominal pressure in patients receiving mechanical ventilation : a randomized controlled trial. Crit Care Nurse 39 : 29-35, 2019
30) Ren CJ, Yao B, Tuo M et al : Comparison of sequential feeding and continuous feeding on the blood glucose of critically ill patients : a non-inferiority randomized controlled trial. Chin Med J (Engl) 134 : 1695-1700, 2021
31) Moisey LL, Pikul J, Keller H et al : Adequacy of protein and energy intake in critically ill adults following liberation from mechanical ventilation is dependent on route of nutrition delivery. Nutr Clin Pract 36 : 201-212, 2021
32) Elmokadem EM, El Borolossy RM, Bassiouny AM et al : The efficacy and safety of itopride in feeding intolerance of critically ill patients receiving enteral nutrition : a randomized, double-blind study. BMC Gastroenterol 21 : 126, 2021
33) Peng R, Li H, Yang L et al : The efficacy and safety of prokinetics in critically ill adults receiving gastric feeding tubes : a systematic review and meta-analysis. PLoS One 16 : e0245317, 2021
P.106 掲載の参考文献
1) Disma N, Virag K, Riva T et al : Difficult tracheal intubation in neonates and infants. NEonate and Children audiT of Anaesthesia pRactice IN Europe (NECTARINE) : a prospective European multicentre observational study : Br J Anesth 126 : 1173-1181, 2021
2) Matava CT, Kovatsis PG, Lee JK et al : Pediatric airway management in COVID-19 patients : Consensus Guidelines From the Society for Pediatric Anesthesia's Pediatric Difficult Intubation Collaborative and the Canadian Pediatric Anesthesia Society. Anesth Analg 131 : 61-73, 2020
P.107 掲載の参考文献
3) Rahmani F, Mahmoodpoor A, Salmasi S et al : Safety of healthcare workers during the airway management in adult and pediatric patients with COVID-19. Anesth Pain Med 11 : e112508, 2021
4) Morgan RW, Kienzle M, Sen AI et al : Pediatric resuscitation practices during the coronavirus disease 2019 pandemic. Pediatric Crit Care Med 21 : e651-e660, 2020
5) Berger JT, Maddux AB, Reeder RW et al : Inhaled nitric oxide use in pediatric hypoxemic respiratory failure. Pediatr Crit Care Med 21 : 708-719, 2020
6) Weiss SL, Peters MJ, Alhazzani W et al : Surviving sepsis campaign international guidelines for the management of septic shock and sepsis-associated organ dysfunction in children. Intensive Care Med 46 (Suppl 1) : 10-67, 2020
7) Egi M, Ogura H, Yatabe T et al : The Japanese Clinical Practice Guidelines for Management of Sepsis and Septic Shock 2020 (J-SSCG 2020). Acute Med Surg 8 : e659, 2021
8) Ramanathan K, Yeo N, Alexander P et al : Role of extracorporeal membrane oxygenation in children with sepsis : a systematic review and meta-analysis. Crit Care 24 : 684, 2020
P.108 掲載の参考文献
9) Romaine ST, Potter J, Khanijau A et al : Accuracy of a modified qSOFA score for predicting critical care admission in febrile children. Pediatrics 146 : e20200782, 2020
P.109 掲載の参考文献
10) Bhumbra S, Malin S, Kirkpatrick L et al : Clinical features of critical coronavirus disease 2019 in children. Pediatr Crit Care Med 21 : e948-e953, 2020
11) Gonzalez-Dambrauskas S, Vasquez-Hoyos P, Camporesi A et al : Pediatric critical care and COVID-19. Pediatrics 146 : e20201766, 2020
12) Shekerdemian LS, Mahmood NR, Wolfe KK et al : Characteristics and outcomes of children with coronavirus disease 2019 (COVID-19) infection admitted to US and Canadian pediatric intensive care units. JAMA Pediatr 174 : 868-873, 2020
P.110 掲載の参考文献
13) Sachdeva R, Rice TB, Reisner B et al : The impact of coronavirus disease 2019 pandemic on U.S. and Canadian PICUs. Pediatr Crit Care Med 21 : e643-e650, 2020
14) Feldstein LR, Tenforde MW, Friedman KG et al : Characteristics and outcomes of US children and adolescents with multisystem inflammatory syndrome in children (MISC) compared with severe acute COVID-19. JAMA 325 : 1074-1087, 2021
P.111 掲載の参考文献
15) Son MBF, Murray N, Friedman K et al : Multisystem inflammatory syndrome in children-initial therapy and outcomes. N Engl J Med 385 : 23-34, 2021
16) Ouldali N, Toubiana J, Antona D et al : Association of intravenous immunoglobulins plus methylprednisolone vs immunoglobulins alone with course of fever in multisystem inflammatory syndrome in children. JAMA 325 : 855-864, 2021
P.112 掲載の参考文献
17) Garcia-Salido A, de Carlos Vicente JC, Belda Hofheinz S et al : Severe manifestations of SARS-CoV-2 in children and adolescents : from COVID-19 pneumonia to multisystem inflammatory syndrome : a multicentre study in pediatric intensive care units in Spain. Crit Care 24 : 666, 2020
19) Yates AR, Sutton RM, Reeder RW et al : Survival and cardiopulmonary resuscitation hemodynamics following cardiac arrest in children with surgical compared to medical heart disease. Pediatr Crit Care Med 20 : 126-1136, 2019
II章 集中治療検査・技術
P.116 掲載の参考文献
1) Kim TY, Hwang SO, Jung WJ et al : Early neuro-prognostication with the Patient State Index and suppression ratio in postcardiac arrest patients. J Crit Care 65 : 149-155, 2021
P.117 掲載の参考文献
2) Rossetti AO, Schindler K, Sutter R et al : Continuous vs routine electroencephalogram in critically ill adults with altered consciousness and no recent seizure : a multicenter randomized clinical trial. JAMA Neurol 77 : 1225-1232, 2020
3) Chalak L, Hellstrom-Westas L, Bonifacio S et al : Bedside and laboratory neuromonitoring in neonatal encephalopathy. Semin Fetal Neonatal Med 26 : 101273, 2021
4) Tamura T, Namiki J, Sugawara Y et al : Early outcome prediction with quantitative pupillary response parameters after out-of-hospital cardiac arrest : a multicenter prospective observational study. PLoS One 15 : e0228224, 2020
P.118 掲載の参考文献
5) Perier F, Tuffet S, Maraffi T et al : Electrical impedance tomography to titrate positive end-expiratory pressure in COVID-19 acute respiratory distress syndrome. Crit Care 24 : 678, 2020
6) Puel F, Crognier L, Soule C et al : Assessment of electrical impedance tomography to set optimal positive end-expiratory pressure for veno-venous ECMOtreated severe ARDS patients. J Crit Care 60 : 38-44, 2020
7) Scaramuzzo G, Spadaro S, Dalla Corte F et al : Personalized positive end-expiratory pressure in acute respiratory distress syndrome : comparison between optimal distribution of regional ventilation and positive transpulmonary pressure. Crit Care Med 48 : 1148-1156, 2020
8) Tobin MJ, Laghi F, Jubran A : Why COVID-19 silent hypoxemia is baffling to physicians. Am J Respir Crit Care Med 202 : 356-360, 2020
P.119 掲載の参考文献
9) Nguyen LS, Helias M, Raia L et al : Impact of COVID-19 on the association between pulse oximetry and arterial oxygenation in patients with acute respiratory distress syndrome. Sci Rep 12 : 1462, 2020
10) Zieleskiewicz L, Markarian T, Lopez A et al : Comparative study of lung ultrasound and chest computed tomography scan in the assessment of severity of confirmed COVID-19 pneumonia. Intensive Care Med 46 : 1707-1713, 2020
11) Messmer AS, Zingg C, Muller M et al : Fluid overload and mortality in adult critical care patients-a systematic review and meta-analysis of observational studies. Crit Care Med 48 : 1862-1870, 2020
P.120 掲載の参考文献
12) Chen H, Zhu Z, Zhao C et al : Central venous pressure measurement is associated with improved outcomes in septic patients : an analysis of the MIMIC-III database. Crit Care 24 : 433, 2020
13) Hamzaoui O, Gouezel C, Jozwiak M et al : Increase in central venous pressure during passive leg raising cannot detect preload unresponsiveness. Crit Care Med 48 : e684-e689, 2020
14) Curtis J, Gravenstein N, Giordano C : Endtidal carbon dioxide and ventilation during CPR in relation to the 2020 American Heart Association guidelines for cardiopulmonary resuscitation. J Clin Anesth 75 : 110553, 2021
15) Huang H, Wu C, Shen Q et al : Value of variation of end-tidal carbon dioxide for predicting fluid responsiveness during the passive leg raising test in patients with mechanical ventilation : a systematic review and meta-analysis. Crit Care 26 : 20, 2020
P.121 掲載の参考文献
16) Scully TG, Huang Y, Huang S et al : The effects of static and dynamic measurements using transpulmonary thermodilution devices on fluid therapy in septic shock : a systematic review. Anaesth Intensive Care 48 : 11-24, 2020
17) Arntfield R, Lau V, Landry Y et al : Impact of critical care transesophageal echocardiography in medical-surgical ICU patients : characteristics and results from 274 consecutive examinations. J Intensive Care Med 35 : 896-902, 2020
18) Bagate F, Rouze A, Zerimech F et al : Transesophageal echocardiography-associated tracheal microaspiration and ventilator-associated pneumonia in intubated critically ill patients : a multicenter prospective observational study. Crit Care 24 : 679, 2020
19) Mongkolpun W, Orbegozo D, Cordeiro CPR et al : Alterations in skin blood flow at the fingertip are related to mortality in patients with circulatory shock. Crit Care Med 48 : 443-450, 2020
P.122 掲載の参考文献
20) Cavalcante Dos Santos E, Orbegozo D, Mongkolpun W et al : Systematic review and meta-analysis of effects of transfusion on hemodynamic and oxygenation variables. Crit Care Med 48 : 241-248, 2020
21) Garzotto F, Comoretto RI, Ostermann M et al : Preventing infectious diseases in intensive care unit by medical devices remote control : lessons from COVID-19. J Crit Care 61 : 119-124, 2021.
22) Fusaro MV, Becker C, Scurlock C : Evaluating tele-ICU implementation -based on observed and predicted ICU mortality : a systematic review and meta-analysis. Crit Care Med 47 : 501-507, 2019
23) Escobar GJ, Liu VX, Schuler A et al : Automated identification of adults at risk for in-hospital clinical deterioration. N Engl J Med 383 : 1951-1960, 2020
P.123 掲載の参考文献
1) The Hypothermia after Cardiac Arrest Study Group : Mild therapeutic hypothermia to improve the neurologic outcome after cardiac arrest. N Engl J Med 346 : 549-556, 2002
3) Nielsen N, Wetterslev J, Cronberg T et al : Targeted temperature management at 33 degrees C versus 36 degrees C after cardiac arrest. N Engl J Med 369 : 2197-2206, 2013
P.124 掲載の参考文献
4) Dankiewicz J, Cronberg T, Lilja G et al : Hypothermia versus normothermia after out-of-hospital cardiac arrest. N Engl J Med 384 : 2283-2294, 2021
5) Bray JE, Stub D, Bloom JE et al : Changing target temperature from 33℃ to 36℃ in the ICU management of out-of-hospital cardiac arrest : a before and after study. Resuscitation 113 : 39-43, 2017
6) Garfield B, Abdoolraheem MY, Dixon A et al : Temporal changes in targeted temperature management for out-of-hospital cardiac arrest-examining the effect of the targeted temperature management trial : a retrospective cohort study. Ther Hypothermia Temp Manag 11 : 230-237, 2021
7) Nolan JP, Orzechowska I, Harrison DA et al : Changes in temperature management and outcome after out-of-hospital cardiac arrest in United Kingdom intensive care units following publication of the targeted temperature management trial. Resuscitation 162 : 304-311, 2021
P.125 掲載の参考文献
8) Taccone FS, Picetti E, Vincent JL : High quality targeted temperature management (TTM) after cardiac arrest. Crit Care 24 : 6, 2020
9) Nordberg P, Taccone FS, Truhlar A et al : Effect of trans-nasal evaporative intraarrest cooling on functional neurologic outcome in out-of-hospital cardiac arrest : the PRINCESS randomized clinical Trial. JAMA 321 : 1677-1685, 2019
10) Awad A, Taccone FS, Jonsson M et al : Time to intra-arrest therapeutic hypothermia in out-of-hospital cardiac arrest patients and its association with neurologic outcome : a propensity matched sub-analysis of the PRINCESS trial. Intensive Care Med 46 : 1361-1370, 2020
11) Liao X, Zhou Z, Zhou M et al : Effects of endovascular and surface cooling on resuscitation in patients with cardiac arrest and a comparison of effectiveness, stability, and safety : a systematic review and meta-analysis. Crit Care 24 : 27, 2020
P.126 掲載の参考文献
12) Hifumi T, Inoue A, Kokubu N et al : Association between rewarming duration and neurological outcome in out-of-hospital cardiac arrest patients receiving therapeutic hypothermia. Resuscitation 146 : 170-177, 2020
13) Francois B, Cariou A, Clere-Jehl R et al : Prevention of early ventilator-associated pneumonia after cardiac arrest. N Engl J Med 381 : 1831-1842, 2019
P.127 掲載の参考文献
15) Callaway CW, Coppler PJ, Faro J et al : Association of initial illness severity and outcomes after cardiac arrest with targeted temperature management at 36℃ or 33℃. JAMA Netw Open 3 : e208215, 2020
P.128 掲載の参考文献
16) Nishikimi M, Ogura T, Nishida K et al : Outcome related to level of targeted temperature management in postcardiac arrest syndrome of low, moderate, and high severities : a Nationwide Multicenter Prospective Registry. Crit Care Med 49 : e741-e750, 2021
P.129 掲載の参考文献
17) Andrews PJ, Sinclair HL, Rodriguez A et al : Therapeutic hypothermia to reduce intracranial pressure after traumatic brain injury : the Eurotherm3235 RCT. Health Technol Assess 22 : 1-134, 2018
18) Hui J, Feng J, Tu Y et al : Safety and efficacy of long-term mild hypothermia for severe traumatic brain injury with refractory intracranial hypertension (LTH-1) : a multicenter randomized controlled trial. EClinicalMedicine 32 : 100732, 2021
19) Kim SJ, Thom SR, Kim H et al : Effects of adjunctive therapeutic hypothermia combined with hyperbaric oxygen therapy in acute severe carbon monoxide poisoning. Crit Care Med 48 : e706-e714, 2020
P.130 掲載の参考文献
1) Ahmad I, Smith AF : Principles for guidelines and guidelines for principles of universal airway management. Anaesthesia 75 : 1570-1571, 2020
2) Chrimes N, Higgs A, Law JA et al : Project for Universal Management of Airways-part 1 : concept and methods. Anaesthesia 75 : 1671-1682, 2020
P.131 掲載の参考文献
3) Peng PWH, Ho PL, Hota SS : Outbreak of a new coronavirus : what anaesthetists should know. Br J Anaesth 124 : 497-501, 2020
4) Yao W, Wang T, Jiang B et al : Emergency tracheal intubation in 202 patients with COVID-19 in Wuhan, China : lessons learnt and international expert recommendations. Br J Anaesth 125 : e28-37, 2020
5) Brewster DJ, Chrimes N, Do TB et al : Consensus statement : Safe Airway Society principles of airway management and tracheal intubation specific to the COVID-19 adult patient group. Med J Aust 212 : 472-481, 2020
6) Cook TM, El-Boghdadly K, McGuire B et al : Consensus guidelines for managing the airway in patients with COVID-19 : guidelines from the Difficult Airway Society, the Association of Anaesthetists the Intensive Care Society, the Faculty of Intensive Care Medicine and the Royal College of Anaesthetists. Anaesthesia 75 : 785-99, 2020
7) Malik JS, Jenner C, Ward PA : Maximising application of the aerosol box in protecting healthcare workers during the COVID-19 pandemic. Anaesthesia 75 : 974-975, 2020
8) Saito T, Asai T : Aerosol containment device for airway management of patients with COVID-19 : a narrative review. J Anesth 35 : 384-389, 2021
9) Dullemond K, Renschler C, Trojanowski J et al : Success and complications of endotracheal intubation in critical care settings under COVID-19 protocols. Can J Emerg Med 23 : 512-517, 2021
10) Frank RC, Mendez SR, Stevenson EK et al : Obesity and the risk of intubation or death in patients with coronavirus disease 2019. Crit Care Med 48 : e1097-1101, 2020
P.132 掲載の参考文献
11) Angel LF, Amoroso NE, Rafeq S et al : Percutaneous dilational tracheostomy for coronavirus disease 2019 patients requiring mechanical ventilation. Crit Care Med 49 : 1058-1067, 2021
12) Agarwal A, Basmaji J, Muttalib F et al : High-flow nasal cannula for acute hypoxemic respiratory failure in patients with COVID-19 : systematic reviews of effectiveness and its risks of aerosolization, dispersion, and infection transmission. Can J Anaesth 67 : 1217-1248, 2020
13) Chandel A, Patolia S, Brown AW et al : High-flow nasal cannula therapy in COVID-19 : using the ROX index to predict success. Respir Care 66 : 909-919, 2021
14) Hernandez-Romieu AC, Adelman MW, Hockstein MA et al : Timing of intubation and mortality among critically ill coronavirus disease 2019 patients : a single-center cohort study. Crit Care Med 48 : e1045-1053, 2020
P.133 掲載の参考文献
15) Casey JD, Janz DR, Russell DW et al : Bag-mask ventilation during tracheal intubation of critically ill adults. N Engl J Med 380 : 811-821, 2019
16) Daigle CH, Fiadjoe JE, Laverriere EK et al : Difficult bag-mask ventilation in critically ill children is independently associated with adverse events. Crit Care Med 48 : e744-752, 2020
17) Conway JA, Kharayat P, Sanders RC Jr et al : Ketamine use for tracheal intubation in critically ill children is associated with a lower occurrence of adverse hemodynamic events. Crit Care Med 48 : e489-497, 2020
18) Russotto V, Myatra SN, Laffey JG et al : Intubation practices and adverse periintubation events in critically ill patients from 29 countries. JAMA 325 : 1164-1172, 2021
19) Dey S, Pradhan D, Saikia P et al : Intubation in the Intensive Care Unit : C-MAC video laryngoscope versus Macintosh laryngoscope. Med Intensiva (Engl Ed) 44 : 135-141, 2020
P.134 掲載の参考文献
20) Amalric M, Larcher R, Brunot V et al : Impact of videolaryngoscopy expertise on first-attempt intubation success in critically ill patients. Crit Care Med 48 : e889-896, 2020
21) Krisciunas GP, Langmore SE, Gomez-Taborda S et al : The association between endotracheal tube size and aspiration (during flexible endoscopic evaluation of swallowing) in acute respiratory failure survivors. Crit Care Med 48 : 1604-1611, 2020
22) Emeriaud G, Napolitano N, Polikoff L et al : Impact of failure of noninvasive ventilation on the safety of pediatric tracheal intubation. Crit Care Med 48 : 1503-1512, 2020
23) Chaudhuri D, Granton D, Wang DX et al : Moderate certainty evidence suggests the use of high-flow nasal cannula does not decrease hypoxia when compared with conventional oxygen therapy in the peri-intubation period : Results of a systematic review and meta-analysis. Crit Care Med 48 : 571-578, 2020
P.135 掲載の参考文献
24) Thille AW, Muller G, Gacouin A et al : Effect of postextubation high-flow nasal oxygen with noninvasive ventilation vs high-flow nasal oxygen alone on reintubation among patients at high risk of extubation failure : a randomized clinical trial. JAMA 322 : 1465-1475, 2019
25) Guihard B, Chollet-Xemard C, Lakhnati P et al : Effect of Rocuronium vs succinylcholine on endotracheal intubation success rate among patients undergoing out-of-hospital rapid sequence intubation : a randomized clinical trial. JAMA 322 : 2303-2312, 2019
26) Okubo M, Komukai S, Izawa J et al : Prehospital advanced airway management for paediatric patients with out-of-hospital cardiac arrest : a nationwide cohort study. Resuscitation 145 : 175-184, 2019
27) Kreutziger J, Hornung S, Harrer C et al : Comparing the McGrath Mac video laryngoscope and direct laryngoscopy for prehospital emergency intubation in air rescue patients : a multicenter, randomized, controlled trial. Crit Care Med 47 : 1362-1370, 2019
P.136 掲載の参考文献
1) Gattinoni L, Marini JJ : Isn't it time to abandon ARDS? the COVID-19 lesson. Crit Care (London, England) 25 : 326-326, 2021
3) Egi M, Ogura H, Yatabe T et al : The Japanese Clinical Practice Guidelines for Management of Sepsis and Septic Shock 2020 (JSSCG 2020). J Intensive Care 9 : 53, 2021
P.137 掲載の参考文献
5) Protti A, Andreis DT, Milesi M et al : Lung anatomy, energy load, and ventilator-induced lung injury. Intensive Care Med Exp 3 : 34, 2015
6) Zhang Z, Zheng B, Liu N et al : Mechanical power normalized to predicted body weight as a predictor of mortality in patients with acute respiratory distress syndrome. Intensive Care Med 45 : 856-864, 2019
7) Parhar KKS, Zjadewicz K, Soo A et al : Epidemiology, mechanical power, and 3-year outcomes in acute respiratory distress syndrome patients using standardized screening. an observational cohort study. Ann Am Thorac Soc 16 : 1263-1272, 2019
8) Pereira Romano ML, Maia IS, Laranjeira LN et al : Driving pressure-limited strategy for patients with acute respiratory distress syndrome. a pilot randomized clinical trial. Ann Am Thorac Soc 17 : 596-604, 2020
P.138 掲載の参考文献
9) Writing Group for the Alveolar Recruitment for Acute Respiratory Distress Syndrome Trial (ART) Investigators : Effect of lung recruitment and titrated positive end-expiratory pressure (PEEP) vs low PEEP on mortality in patients with acute respiratory distress syndrome : a randomized clinical trial. JAMA 318 : 1335-1345, 2017
10) Zampieri FG, Costa EL, Iwashyna TJ et al : Heterogeneous effects of alveolar recruitment in acute respiratory distress syndrome : a machine learning reanalysis of the Alveolar Recruitment for Acute Respiratory Distress Syndrome Trial. Br J Anaesth 123 : 88-95, 2019
11) Hodgson CL, Cooper DJ, Arabi Y et al : Maximal Recruitment Open Lung Ventilation in Acute Respiratory Distress Syndrome (PHARLAP). a phase II, multicenter randomized controlled clinical trial. Am J Respir Crit Care Med 200 : 1363-1372, 2019
12) Chen L, Del Sorbo L, Grieco DL et al : Potential for lung recruitment estimated by the recruitment-to-inflation ratio in acute respiratory distress syndrome. a clinical trial. Am J Respir Crit Care Med 201 : 178-187, 2020
P.139 掲載の参考文献
13) Writing Committee and Steering Committee for the RELAx Collaborative Group : Effect of a lower vs higher positive end-ex-piratory pressure strategy on ventilator-free days in ICU patients without ARDS : a randomized clinical trial. JAMA 324 : 2509-2520, 2020
14) Sud S, Friedrich JO, Adhikari NKJ et al : Comparative effectiveness of protective ventilation strategies for moderate and severe acute respiratory distress syndrome. a network meta-analysis. Am J Respir Crit Care Med 203 : 1366-1377, 2021
P.140 掲載の参考文献
15) Kacmarek RM, Villar J, Parrilla D et al : Neurally adjusted ventilatory assist in acute respiratory failure : a randomized controlled trial. Intensive Care Med 46 : 2327-2337, 2020
P.141 掲載の参考文献
18) National Heart, Lung, and Blood Institute PETAL Clinical Trials Network : Early neuromuscular blockade in the acute respiratory distress syndrome. N Engl J Med 380 : 1997-2008, 2019
19) Torbic H, Krishnan S, Harnegie MP et al : Neuromuscular blocking agents for ARDS : a systematic review and meta-analysis. Respir Care 66 : 120-128, 2021
P.142 掲載の参考文献
20) Zhang H, Penninger JM, Li Y et al : Angiotensin-converting enzyme 2 (ACE2) as a SARS-CoV-2 receptor : molecular mechanisms and potential therapeutic target. Intensive Care Med 46 : 586-590, 2020
21) Melms JC, Biermann J, Huang H et al : A molecular single-cell lung atlas of lethal COVID-19. Nature 595 : 114-119, 2021
23) Fan E, Beitler JR, Brochard L et al : COVID-19-associated acute respiratory distress syndrome : is a different approach to management warranted? Lancet Respir Med 8 : 816-821, 2020
P.144 掲載の参考文献
1) Dellweg D, Kerl J, Gena AW et al : Exhalation spreading during nasal high-flow therapy at different flow rates. Crit Care Med 49 : e693-e700, 2021
2) Leonard S, Atwood CW Jr, Walsh BK et al : Preliminary findings on control of dispersion of aerosols and droplets during high-velocity nasal insufflation therapy using a simple surgical mask : implications for the high-flow nasal cannula. Chest 158 : 1046-1049, 2020
3) Faraone A, Beltrame C, Crociani A et al : Effectiveness and safety of noninvasive positive pressure ventilation in the treatment of COVID-19-associated acute hypoxemic respiratory failure : a single center, non-ICU setting experience. Intern Emerg Med 16 : 1183-1190, 2021
4) Duan J, Chen B, Liu X et al : Use of high-flow nasal cannula and noninvasive ventilation in patients with COVID-19 : a multicenter observational study. Am J Emerg Med. 2021 Aug ; 46 : 276-281.
5) Ospina-Tascon, Calderon-Tapia LE, Garcia AF et al : Effect of high-flow oxygen therapy vs conventional oxygen therapy on invasive mechanical ventilation and clinical recovery in patients with severe COVID-19 : a randomized clinical trial. JAMA 326 : 2161-2171, 2021
6) Teng XB, Shen Y, Han MF et al : The value of high-flow nasal cannula oxygen therapy in treating novel coronavirus pneumonia. Eur J Clin Invest, 2021 Mar ; 51 (3) : e13435.
7) Hu M, Zhou Q, Zheng R et al : Application of high-flow nasal cannula in hypoxemic patients with COVID-19 : a retrospective cohort study. BMC Pulm Med 20 : 324, 2020
P.145 掲載の参考文献
8) Mamo D, Zangrillo A, Cabrini L et al : Noninvasive ventilation after thoracoabdominal aortic surgery : a pilot randomized controlled trial. J Cardiothorac Vasc Anesth 33 : 1639-1645, 2019
9) Ampatzidou F, Boutou AK, Karagounis L et al : Noninvasive ventilation to treat respiratory failure after cardiac surgery : predictors of application and outcome. Respir Care 64 : 1123-1131, 2019
P.146 掲載の参考文献
10) Granton D, Chaudhuri D, Wang D et al : High-flow nasal cannula compared with conventional oxygen therapy or noninvasive ventilation immediately postextubation : a systematic review and meta-analysis. Crit Care Med 48 : e1129-e1136, 2020
11) Wang Y, Huang D, Ni Y et al : High-flow nasal cannula vs conventional oxygen therapy for postcardiothoracic surgery. Respir Care 65 : 1730-1737, 2020
12) Lu Z, Chang W, Meng S et al : The effect of high-flow nasal oxygen therapy on postoperative pulmonary complications and hospital length of stay in postoperative patients : a systematic review and meta-analysis. J Intensive Care Med 35 : 1129-1140, 2020
P.147 掲載の参考文献
14) Vaschetto R, Pecere A, Perkins GD et al : Effects of early extubation followed by noninvasive ventilation versus standard extubation on the duration of invasive mechanical ventilation in hypoxemic non-hypercapnic patients : a systematic review and individual patient data meta-analysis of randomized controlled trials. Crit Care 25 : 189, 2021
15) Shan M, Pang X, Wang W et al : Noninvasive ventilation as a weaning strategy in subjects with acute hypoxemic respiratory failure. Respir Care 65 : 1574-1584, 2020
16) Andino R, Vega G, Pacheco SK et al : High-flow nasal oxygen reduces endotracheal intubation : a randomized clinical trial. Ther Adv Respir Dis 14 : 1753466620956459, 2020
17) Ruangsomboon O, Limsuwat C, Praphruetkit N et al : Nasal high-flow oxygen versus conventional oxygen therapy for acute severe asthma patients : a pilot randomized controlled trial. Acad Emerg Med 28 : 530-541, 2021
19) Qaseem A, Etxeandia-Ikobaltzeta I, Fitterman N et al : Appropriate use of high-flow nasal oxygen in hospitalized patients for initial or postextubation management of acute respiratory failure : a clinical guideline from the american college of physicians. Ann Intern Med 174 : 977-984, 2021
P.148 掲載の参考文献
20) Goncalves G, Saeed H, Abdelrahim ME et al : Non-invasive ventilation in patients with an altered level of consciousness. a clinical review and practical insights. Adv Respir Med 88 : 233-244, 2020
21) Comellini V, Pacilli AMG, Nava S : Benefits of non-invasive ventilation in acute hypercapnic respiratory failure. Respirology 24 : 308-317, 2019
22) Hill NS, Spoletini G, Schumaker G et al : Noninvasive ventilatory support for acute hypercapnic respiratory failure. Respir Care 64 : 647-657, 2019
P.149 掲載の参考文献
23) Coudroy R, Hoppe MA, Robert R et al : Influence of noninvasive ventilation protocol on intubation rates in subjects with de novo respiratory failure. Respir Care 65 : 525-534, 2020
24) Frat JP, Joly F, Thille AW : Noninvasive ventilation versus oxygen therapy in patients with acute respiratory failure. Curr Opin Anaesthesiol 32 : 150-155, 2019
25) Innocenti F, Giordano L, Gualtieri S et al : Prediction of mortality with the use of noninvasive ventilation for acute respiratory failure. Respir Care 65 : 1847-1856, 2020
26) Vivier E, Haudebourg AF, Le Corvoisier P et al : Diagnostic accuracy of diaphragm ultrasound in detecting and characterizing patient-ventilator asynchronies during noninvasive ventilation. Anesthesiology 132 : 1494-1502, 2020
P.150 掲載の参考文献
27) Sheehy RD, Duce B, Edwards TP et al : Double-triggering during noninvasive ventilation in a simulated lung model. Respir Care 65 : 1333-1338, 2020
28) Harnisch LO, Olgemoeller U, Mann J et al : Noninvasive neurally adjusted ventilator assist ventilation in the postoperative period produces better patient-ventilator synchrony but not comfort. Pulm Med 2020 : 4705042, 2020
29) Oppersma E, Doorduin J, Roesthuis LH et al : Patient-ventilator interaction during noninvasive ventilation in subjects with exacerbation of COPD : effect of support level and ventilator mode. Respir Care 65 : 1315-1322, 2020
30) Prasad KT, Gandra RR, Dhooria S et al : Comparing noninvasive ventilation delivered using neurally-adjusted ventilatory assist or pressure support in acute respiratory failure. Respir Care 66 : 213-220, 2021
31) Shang S, Wang Y : Comparison of outcomes of high-flow nasal cannula and noninvasive positive-pressure ventilation in patients with hypoxemia and various APACHE II scores after extubation. Ther Adv Respir Dis 15 : 17534666211004235, 2021
P.151 掲載の参考文献
32) Zayed Y, Barbarawi M, Kheiri B et al : Initial noninvasive oxygenation strategies in subjects with de novo acute hypoxemic respiratory failure. Respir Care 64 : 1433-1444, 2019
33) Ferreyro BL, Angriman F, Munshi L et al : Association of noninvasive oxygenation strategies with all-cause mortality in adults with acute hypoxemic respiratory failure : a systematic review and meta-analysis. JAMA 324 : 57-67, 2020
P.152 掲載の参考文献
1) Hallstrom A, Rea TD, Sayre MR et al : Manual chest compression vs use of an automated chest compression device during resuscitation following out-of-hospital cardiac arrest : a randomized trial. JAMA 295 : 2620-2628, 2006
2) Wik L, Olsen JA, Persse D et al : Manual vs. integrated automatic load-distributing band CPR with equal survival after out of hospital cardiac arrest. the randomized CIRC trial. Resuscitation 85 : 741-748, 2014
P.153 掲載の参考文献
3) Perkins GD, Lall R, Quinn T et al : Mechanical versus manual chest compression for out-of-hospital cardiac arrest (PARAMEDIC) : a pragmatic, cluster randomised controlled trial. Lancet 385 : 947-955, 2015
4) Ebell MH, Vellinga A, Masterson S et al : Meta-analysis of the accuracy of termination of resuscitation rules for out-ofhospital cardiac arrest. Emerg Med J 36 : 479-484, 2019
5) Ahrens T, Schallom L, Bettorf K et al : End-tidal carbon dioxide measurements as a prognostic indicator of outcome in cardiac arrest. Am J Crit Care 10 : 391-398, 2001
6) Levine RL, Wayne MA, Miller CC : Endtidal carbon dioxide and outcome of out-of-hospital cardiac arrest. N Engl J Med 337 : 301-306, 1997
7) Wayne MA, Levine RL, Miller CC : Use of end-tidal carbon dioxide to predict outcome in prehospital cardiac arrest. Ann Emerg Med 25 : 762-767, 1995
8) Akinci E, Ramadan H, Yuzbasioglu Y et al : Comparison of end-tidal carbon dioxide levels with cardiopulmonary resuscitation success presented to emergency department with cardiopulmonary arrest. Pak J Med Sci 30 : 16-21, 2014
9) Holmberg MJ, Issa MS, Moskowitz A et al : Vasopressors during adult cardiac arrest : a systematic review and meta-analysis. Resuscitation 139 : 106-121, 2019
10) Brown CG, Martin DR, Pepe PE et al : A comparison of standard-dose and high-dose epinephrine in cardiac arrest outside the hospital. The Multicenter High-Dose Epinephrine Study Group. N Engl J Med 327 : 1051-1055, 1992
11) Choux C, Gueugniaud PY, Barbieux A et al : Standard doses versus repeated high doses of epinephrine in cardiac arrest outside the hospital. Resuscitation 29 : 3-9, 1995
12) Gueugniaud PY, Mols P, Goldstein P et al : A comparison of repeated high doses and repeated standard doses of epinephrine for cardiac arrest outside the hospital. European Epinephrine Study Group. N Engl J Med 339 : 1595-1601, 1998
P.154 掲載の参考文献
13) Lindner KH, Ahnefeld FW, Prengel AW : Comparison of standard and high-dose adrenaline in the resuscitation of asystole and electromechanical dissociation. Acta Anaesthesiol Scand 35 : 253-256, 1991
14) Lipman J, Wilson W, Kobilski S et al : High-dose adrenaline in adult in-hospital asystolic cardiopulmonary resuscitation : a double-blind randomised trial. Anaesth Intensive Care 21 : 192-196, 1993
15) Sherman BW, Munger MA, Foulke GE et al : High-dose versus standard-dose epinephrine treatment of cardiac arrest after failure of standard therapy. Pharmacotherapy 17 : 242-247, 1997
16) Stiell IG, Hebert PC, Weitzman BN et al : High-dose epinephrine in adult cardiac arrest. N Engl J Med 327 : 1045-1050, 1992
17) Callaham M, Madsen CD, Barton CW et al : A randomized clinical trial of high-dose epinephrine and norepinephrine vs standard-dose epinephrine in prehospital cardiac arrest. JAMA 268 : 2667-2672, 1992
18) Granfeldt A, Avis SR, Lind PC et al : Intravenous vs. intraosseous administration of drugs during cardiac arrest : a systematic review. Resuscitation 149 : 150-157, 2020
19) Kim JH, Kim MJ, You JS et al : Multimodal approach for neurologic prognostication of out-of-hospital cardiac arrest patients undergoing targeted temperature management. Resuscitation 134 : 33-40, 2019
20) Lee KS, Lee SE, Choi JY et al : Useful computed tomography score for estimation of early neurologic outcome in postcardiac arrest patients with therapeutic hypothermia. Circ J 81 : 1628-1635, 2017
21) Kim SH, Choi SP, Park KN et al : Early brain computed tomography findings are -associated with outcome in patients treated with therapeutic hypothermia after out-of-hospital cardiac arrest. Scand J Trauma 21 : 57, 2013
22) Lee BK, Jeung KW, Lee HY et al : Combining brain computed tomography and serum neuron specific enolase improves the prognostic performance compared to either alone in comatose cardiac arrest survivors treated with therapeutic hypothermia. Resuscitation 84 : 1387-1392, 2013
23) Scarpino M, Lolli F, Lanzo G et al : Neurophysiological and neuroradiological test for early poor outcome (Cerebral Performance Categories 3-5) prediction after cardiac arrest : prospective multicentre prognostication data. Data Brief 27 : 104755, 2019
P.155 掲載の参考文献
24) Ryoo SM, Jeon SB, Sohn CH et al : Predicting outcome with diffusion-weighted imaging in cardiac arrest patients receiving hypothermia therapy : multicenter retrospective cohort study. Crit Care Med 43 : 2370-2377, 2015
25) Jeon CH, Park JS, Lee JH et al : Comparison of brain computed tomography and diffusion-weighted magnetic resonance imaging to predict early neurologic outcome before target temperature management comatose cardiac arrest survivors. Resuscitation 118 : 21-26, 2017
26) Greer DM, Scripko PD, Wu O et al : Hippocampal magnetic resonance imaging abnormalities in cardiac arrest are associated with poor outcome. J Stroke Cerebrovasc Dis 22 : 899-905, 2013
27) Jang J, Oh SH, Nam Y et al : Prognostic value of phase information of 2D T2*-weighted gradient echo brain imaging in cardiac arrest survivors : a preliminary study. Resuscitation 140 : 142-149, 219
28) Choi SP, Park KN, Wee JH et al : Can somatosensory and visual evoked potentials predict neurological outcome during targeted temperature management in post cardiac arrest patients? Resuscitation 119 : 70-75, 2017
29) Dhakal LP, Sen A, Stanko CM et al : Early absent pupillary light reflexes after cardiac arrest in patients treated with therapeutic hypothermia. Ther Hypothermia Temp Manag 6 : 116-121, 2016
30) Oddo M, Sandroni C, Citerio G et al : Quantitative versus standard pupillary light reflex for early prognostication in comatose cardiac arrest patients : an international prospective multicenter double-blinded study. Intensive Care Med 44 : 2102-2111, 2018
31) Fatuzzo D, Beuchat I, Alvarez V et al : Does continuous EEG influence prognosis in patients after cardiac arrest? Resuscitation 132 : 29-32, 2018
32) Dragancea I, Horn J, Kuiper M et al : Neurological prognostication after cardiac arrest and targeted temperature management 33℃ versus 36℃ : results from a randomised controlled clinical trial. Resuscitation 93 : 164-170, 2015
33) Leao RN, Avila P, Cavaco R et al : Therapeutic hypothermia after cardiac arrest : outcome predictors. Rev Bras Ter Intensiva 27 : 322-332, 2015
P.156 掲載の参考文献
34) Ruijter BJ, Tjepkema-Cloostermans MC, Tromp SC et al : Early electroencephalography for outcome prediction of postanoxic coma : a prospective cohort study. Ann Neurol 86 : 203-214, 2019
35) Grippo A, Carrai R, Scarpino M et al : Neurophysiological prediction of neurological good and poor outcome in post-anoxic coma. Acta Neurol Scand 135 : 641-648, 2017
36) De Santis P, Lamanna I, Mavroudakis N et al : The potential role of auditory evoked potentials to assess prognosis in comatose survivors from cardiac arrest. Resuscitation 120 : 119-124, 2017
37) Kim SW, Oh JS, Park J et al : Short-latency positive peak following N20 somatosensory evoked potential is superior to N20 in predicting neurologic outcome after out-of-hospital cardiac arrest. Crit Care Med 46 : e545-e551, 2018
38) Scarpino M, Carrai R, Lolli F et al : Neurophysiology for predicting good and poor neurological outcome at 12 and 72 h afte cardiac arrest : the ProNeCA multicentre prospective study. Resuscitation 147 : 95-103, 2020
39) Maciel CB, Morawo AO, Tsao CY et al : SSEP in therapeutic hypothermia era. J Clin Neurophysiol 34 : 469-475, 2017
40) Soar J, Berg KM, Andersen LW et al : Adult Advanced Life Support : 2020 International Consensus on Cardiopulmonary Resuscitation and Emergency Cardiovascular Care Science with Treatment Recommendations. Resuscitation 156 : A80-A119, 2020
41) Panchal AR, Berg KM, Hirsch KG et al : 2019 American Heart Association focused update on advanced cardiovascular life support : use of advanced airways, vasopressors, and extracorporeal cardiopulmonary resuscitation during cardiac arrest : an update to the American Heart Association guidelines for cardiopulmonary resuscitation and emergency cardiovascular care. Circulation 140 : e881-e894, 2019
42) Holmberg MJ, Geri G, Wiberg S et al : Extracorporeal cardiopulmonary resuscitation for cardiac arrest : a systematic review. Resuscitation 131 : 91-100, 2018
43) Blumenstein J, Leick J, Liebetrau C et al : Extracorporeal life support in cardiovascular patients with observed refractory inhospital cardiac arrest is associated with favourable short and long-term outcomes : a propensity-matched analysis. Eur Heart J Acute Cardiovasc Care 5 : 13-22, 2016
P.157 掲載の参考文献
44) Chen YS, Lin JW, Yu HY et al : Cardiopulmonary resuscitation with assisted extracorporeal life-support versus conventional cardiopulmonary resuscitation in adults with in-hospital cardiac arrest : an observational study and propensity analysis. Lancet 372 : 554-561, 2008
45) Lin JW, Wang MJ, Yu HY et al : Comparing the survival between extracorporeal rescue and conventional resuscitation in adult in-hospital cardiac arrests : propensity analysis of three-year data. Resuscitation 81 : 796-803, 2010
46) D'Arrigo S, Cacciola S, Dennis M et al : Predictors of favourable outcome after inhospital cardiac arrest treated with extracorporeal cardiopulmonary resuscitation : a systematic review and meta-analysis. Resuscitation 121 : 62-70, 2017
47) Abrams D, MacLaren G, Lorusso R et al : Extracorporeal cardiopulmonary resuscitation in adults : evidence and implications. Intensive Care Med 48 : 1-15, 2022
48) Downing J, Al Falasi R, Cardona S et al : How effective is extracorporeal cardiopulmonary resuscitation (ECPR) for out-of-hospital cardiac arrest? a systematic review and meta-analysis. Am J Emerg Med 51 : 127-138, 2022
49) Yannopoulos D, Bartos J, Raveendran G et al : Advanced reperfusion strategies for patients with out-of-hospital cardiac arrest and refractory ventricular fibrillation (ARREST) : a phase 2, single centre, open-label, randomised controlled trial. Lancet 396 (10265) : 1807-1816, 2020
P.158 掲載の参考文献
1) O'Grady NP, Alexander M, Burns LA et al : Guidelines for the prevention of intravascular catheter-related infections. Clin Infect Dis 52 : e162-93, 2011
P.159 掲載の参考文献
2) Timsit JF, Baleine J, Bernard L et al : Expert consensus-based clinical practice guidelines management of intravascular catheters in the intensive care unit. Ann Intensive Care 10 : 118, 2020
3) Maki DG, Ringer M, Alvarado CJ : Prospective randomised trial of povidoneiodine, alcohol, and chlorhexidine for prevention of infection associated with central venous and arterial catheters. Lancet 338 : 339-343, 1991
4) Yasuda H, Sanui M, Abe T et al ; for Japanese Society of Education for Physicians and Trainees in Intensive Care (JSEPTIC) Clinical Trial Group : Comparison of the efficacy of three topical antiseptic solutions for the prevention of catheter colonization : a multicenter randomized controlled study. Crit Care 21 : 320, 2017
5) Lai NM, Lai NA, O'Riordan E et al : Skin antisepsis for reducing central venous catheter-related infections. Cochrane Database Syst Rev 7 : CD010140, 2016
6) Mermel LA : Sequential use of povidone-iodine and chlorhexidine for cutaneous antisepsis : a systematic review. Infect Control Hosp Epidemiol 41 : 98-101, 2020
7) Masuyama T, Yasuda H, Sanui M et al : Effect of skin antiseptic solutions on the incidence of catheter-related bloodstream infection : a systematic review and network meta-analysis. J Hosp Infect 110 : 156-164, 2021
P.160 掲載の参考文献
8) Guenezan J, Marjanovic N, Drugeon B et al ; CLEAN-3 trial investigators : Chlorhexidine plus alcohol versus povidone iodine plus alcohol, combined or not with innovative devices, for prevention of short-term peripheral venous catheter infection and failure (CLEAN 3 study) : an investigator-initiated, open-label, single centre, randomised-controlled, two-by-two factorial trial. Lancet Infect Dis 21 : 1038-1048, 2021
9) Mimoz O, Lucet JC, Kerforne T et al ; CLEAN trial investigators : Skin antisepsis with chlorhexidine-alcohol versus povidone iodine-alcohol, with and without skin scrubbing, for prevention of intravascularcatheter-related infection (CLEAN) : an open-label, multicentre, randomised, controlled, two-by-two factorial trial. Lancet 386 : 2069-2077, 2015
10) Boisson M, Corbi P, Kerforne T et al : Multicentre, open-label, randomised, controlled clinical trial comparing 2% chlorhexidine-70% isopropanol and 5% povidone iodine-69% ethanol for skin antisepsis in reducing surgical-site infection after cardiac surgery : the CLEAN 2 study protocol. BMJ Open 9 : e026929, 2019
11) Yasuda H, Kashiura M, Kishihara Y et al : Efficacy and safety of 1.5% aqueous olanexidine gluconate antiseptic solution compared to 1% alcoholic chlorhexidine for the prevention of intravenous catheter-related infections (Apollo study) : a protocol for a randomised controlled trial BMJ Open Dec 2021, 11 : e053925, 2021
P.161 掲載の参考文献
12) Gorski LA, Hadaway L, Hagle ME et al : Infusion therapy standards of practice, 8th Edition. J Infus Nurs 44 (1S Suppl 1) : S1-S224, 2021
13) Prachanpanich N, Morakul S, Kiatmongkolkul N : Effectiveness of securing central venous catheters with topical tissue adhesive in patients undergoing cardiac surgery : a randomized controlled pilot study. BMC Anesthesiol 21 : 70, 2021
14) Bahl A, Gibson SM, Jankowski D et al : Short peripheral intravenous catheter securement with cyanoacrylate glue compared to conventional dressing : a randomized controlled trial. J Vasc Access 11 : 11297298211024037, 2021
P.162 掲載の参考文献
15) Marsh N, Webster J, Ullman AJ et al : Peripheral intravenous catheter non-infectious complications in adults : a systematic review and meta-analysis. J Adv Nurs 76 : 3346-3362, 2020
P.163 掲載の参考文献
16) Yasuda H, Yamamoto R, Hayashi Y et al ; AMOR-VENUS study group : Occurrence and incidence rate of peripheral intravascular catheter-related phlebitis and complications in critically ill patients : a prospective cohort study (AMOR-VENUS study). J Intensive Care 9 : 3, 2021
17) Blanco-Mavillard I, de Pedro-Gomez JE, Rodriguez-Calero MA et al : Multimodal intervention for preventing peripheral intravenous catheter failure in adults (PREBACP) : a multicentre, cluster-randomised, controlled trial. Lancet Haematol 8 : e637-e647, 2021
P.164 掲載の参考文献
18) Rickard CM, Marsh NM, Larsen EN et al : Effect of infusion set replacement intervals on catheter-related bloodstream infections (RSVP) : a randomised, controlled, equivalence (central venous access device) -non-inferiority (peripheral arterial catheter) trial. Lancet 397 : 1447-1458, 2021
P.166 掲載の参考文献
1) 2021年度循環器疾患診療実態調査報告書 : JROAD ; the Japanese Registry Of All cardiac and vascular Diseases. 日本循環器病学会 https://www.j-circ.or.jp/jittai_chosa/media/jittai_chosa2020web.pdf (2022年1月15日閲覧)
P.167 掲載の参考文献
2) 日本循環器学会/日本心不全学会合同ガイドライン : 急性・慢性心不全診療ガイドライン (2017年改訂版). Guidelines for Diagnosis and Treatment of Acute and Chronic Heart Failure (JCS 2017/JHFS 2017)
3) 日本循環器学会/日本心臓血管外科学会/日本胸部外科学会/日本血管外科学会合同ガイドライン : 2021年改訂版 重症心不全に対する植込型補助人工心臓治療ガイドライン. JCS/JSCVS/JATS/JSVS 2021 Guideline on Implantable Left Ventricular Assist Device for Patients with Advanced Heart Failure
4) Fuernau G, Ledwoch J, Desch S et al : Impact of timing of intraaortic balloon counterpulsation on mortality in cardiogenic shock-a subanalysis of the IABPSCHOCK II trial. Eur Heart J Acute Cardiovasc Care 10 : 54-61, 2021
5) Bhimaraj A, Agrawal T, Duran A et al : Percutaneous left axillary artery placement of intra-aortic balloon pump in advanced heart failure patients. JACC Heart Fail 8 : 313-323, 2020
P.168 掲載の参考文献
6) Tsangaris A, Alexy T, Kalta R et al : Overview of veno-arterial extracorporeal membrane oxygenation (VA-ECMO) support for the management of cardiogenic shock. Front Cardiovasc Med 8 : 686558, 2021
7) Ostadal P, Pokyta R, Kruger A et al : Extracorporeal membrane oxygenation in the therapy of cardiogenic shock (ECMOCS) : rationale and design of the multicenter randomized trial. Eur J Heart Fail 19 : 124-127, 2017
8) Kowalewski M, Zielinski K, Brodie D et al : Venoarterial extracorporeal membrane oxygenation for postcardiotomy shock-analysis of the Extracorporeal Life Support Organization Registry. Crit Care Med 49 : 1107-1117, 2021
P.169 掲載の参考文献
9) Hutin A, Abu-Habsa M, Burns B et al : Early ECPR for out-of-hospital cardiac arrest : best practice in 2018. Resuscitation 130 : 44-48, 2018
10) Lunz D, Calbro L, Belliato M et al : Extracorporeal membrane oxygenation for refractory cardiac arrest : a retrospective multicenter study. Intensive Care Med 46 : 973-982, 2020
11) Hifumi T, Inoue A, Takiguchi T et al : Variability of extracorporeal cardiopulmonary resuscitation practice in patients with out-of-hospital cardiac arrest from the emergency department to intensive care unit in Japan. Acute Medi Surg 8 : e647, 2021
12) Richardson ASC, Tonna JE, Nanjayya V et al : Extracorporeal cardiopulmonary resuscitation in adults. interim guideline consensus statement from the Extracorporeal Life Support Organization. ASAIO J 67 : 221-228, 2021
P.170 掲載の参考文献
13) Nakamura M, Imamura T, Ueno H et al : Current indication and practical management of percutaneous left ventricular assist device support therapy in Japan. J Cardiol 75 : 228-232, 2020
14) Schrage B, Becher PM, Bernhardt A et al : Left ventricular unloading is associated with lower mortality in patients with cardiogenic shock treated with venoarterial extracorporeal membrane oxygenation : results from an international, multicenter cohort study. Circulation 142 : 2095-2106, 2020
15) Schrage B, Ibrahim K, Loehn T et al : Impella support for acute myocardial infarction complicated by cardiogenic shock. Circulation 139 : 1249-1258, 2019
16) Karami M, Eriksen E, Ouweneel DM et al : Long-term 5-year outcome of the randomized IMPRESS in severe shock trial : percutaneous mechanical circulatory support vs. intra-aortic balloon pump in cardiogenic shock after acute myocardial infarction. Eur Heart J Acute Cardiovasc Care 6 : 1009-1015, 2021
P.171 掲載の参考文献
17) Chatzis G, Markus B, Luesebrink U et al : Early Impella support in postcardiac arrest cardiogenic shock complicating acute myocardial infarction improves short- and long-term survival. Crit Care Med 49 : 943-955, 2021
18) Haurand JM, Haberkorn S, Haschemi J et al : Outcome of patients with nonischaemic cardiogenic shock supported by percutaneous left ventricular assist device. ESC Heart Fail 8 : 3594-3602, 2021
P.172 掲載の参考文献
20) Peek GJ, Mugford M, Tiruvoipati R et al : Efficacy and economic assessment of conventional ventilatory support versus extracorporeal membrane oxygenation for severe adult respiratory failure (CESAR) : a multicentre randomised controlled trial. Lancet 374 : 17-23, 2009
21) Combes A, Hajage D, Capellier G et al : Extracorporeal membrane oxygenation for severe acute respiratory distress syndrome. N Eng J Med 378 : 1965-1975, 2018
22) Combes A, Peek GJ, Hajage D et al : ECMO for severe ARDS : systemic review and individual patient data meta-analysis. Intensive Care Med 46 : 2048-2057, 2020
23) Nelson-McMillan K, Vricella LA, Stewart FD et al : Recovery from total acute lung failure after 20 months of extracorporeal life support. ASAIO J 66 : e11-e14, 2020
P.173 掲載の参考文献
24) Jenelle B, Velia AM, Christine S et al : Extracorporeal membrane oxygenation for COVID-19 : updated 2021 guidelines from the extracorporeal life support organization. ASAIO J 67 : 485-495, 2021
25) Barbaro R, MacLaren G, Boonstra P et al : Extracorporeal membrane oxygenation support in COVID-19 : an international cohort study of the Extracorporeal Life Support Organization registry. Lancet 396 : 1071-1078, 2020
26) Barbaro R, MacLaren G, Boonstra P et al : Extracorporeal membrane oxygenation support for COVID-19 : evolving outcomes from the international Extracorporeal Life Support Organization registry. Lancet 398 : 1230-1238, 2021
27) Ohsumi A, Takamatsu J, Yuasa I et al : Living-donor lung transplantation for post-COVID-19 respiratory failure. Ann Thorac Surg S0003-4975 (21) 01840-3, 2021
28) Cypel M, Keshavjee S : When to consider lung transplantation for COVID-19? Lancet Respir Med 8 : 944-946, 2020
P.175 掲載の参考文献
1) Johri AM, Galen B, Kirkpatrick JN et al : ASE statement on point-of-care ultrasound during the 2019 novel coronavirus pandemic. J Am Soc Echocardiogr 33 : 670-673, 2020
2) Diaz-Gomez JL, Mayo PH, Koenig SJ et al : Point-of-care ultrasonography. N Engl J Med 385 : 1593-1602, 2021
3) Atkinson P, Bowra J, Milne J et al : International Federation for Emergency Medicine Consensus Statement : Sonography in hypotension and cardiac (SHoC) : an international consensus on the use of point of care ultrasound for undifferentiated hypotension and during cardiac arrest. CJEM 19 : 459-470, 2017
4) Dudek M, Szarpak L, Peacock FW et al : Diagnostic performance of point-of-use ultrasound of resuscitation outcomes : a systematic review and meta-analysis of 3265 patients. Cardiol J, 2021 [online ahead of print]
P.176 掲載の参考文献
5) 日本蘇生協議会監 : JRC蘇生ガイドライン 2020. 医学書院, 東京, 2021
6) Soar J, Berg KM, Andersen LW et al : Adult Advanced Life Support : 2020 International consensus on cardiopulmonary resuscitation and emergency cardiovascular care science with treatment recommendations. Resuscitation 156 : 80-119, 2020
7) Zanobetti M, Scorpiniti M, Gigli C et al : Point-of-care ultrasonography for evaluation of Acute Dyspnea in the ED. Chest 151 : 1295-1301, 2017
8) Kameda T, Kimura A : Basic point-of-care ultrasound framework -based on the airway, breathing and circulation approach for the initial management of shock and dyspnea. Acute Med Surg 7 : e481, 2020
10) Galie N, Humbert M, Vachiery JL et al : 2015 ESC/ERS Guidelines for the diagnosis and treatment of pulmonary hypertension. Eur Heart J 37 : 67-119, 2016
11) Venkateshvaran A, Seidova N, Tureli HO et al : Accuracy of echocardiographic estimates of pulmonaryarterypressures in pulmonary hypertension : insights from the KARUM hemodynamic database. Int J Cardiovasc Imaging 37 : 2637-2645, 2021
P.177 掲載の参考文献
12) Lang RM, Badano LP, Avi VM et al : Recommendations for cardiac chamber quantification by echocardiography in adults : an update from the American society of echocardiography and the European association of cardiovascular imaging. Eur Heart J Cardiovasc Imaging 16 : 233-270, 2015
13) Lanspa MJ, Burk RE, Wilson EL et al : Echocardiogram-guided resuscitation versus early goal-directed therapy in the treatment of septic shock : a randomized, controlled, feasibility trial. J Intensive Care 6 : 50, 2018
P.178 掲載の参考文献
14) 江木盛時, 小倉裕司, 矢田部智昭他 : 日本敗血症診療ガイドライン 2020. 日集中医誌 28, 2020
15) Feng M, McSparron JI, Kien DT et al : Transthoracic echocardiography and mortality in sepsis : analysis of the MIMIC-III database. Intensive Care Med 44 : 884-892, 2018
16) Vallabhajosyula S, Shankar A, Vojjini R et al : Impact of right ventricular dysfunction on short-term and long-term mortality in sepsis a meta-analysis of 1373 patients. Chest 159 : 2254-2263, 2021
17) Lanspa MJ, Cirulis MM, Wiley BM et al : Right ventricular dysfunction in early sepsis and septic shock. Chest 159 : 1055-1063, 2021
P.179 掲載の参考文献
18) Sanfilippo F, Di Falco D, Noto A et al : Association of weaning failure from mechanical ventilation with transthoracic echocardiography parameters : a systematic review and meta-analysis. Br J Anaesth 126 : 319-330, 2021
19) Beaubien-Souligny W, Rola P, Haycock K et al : Quantifying systemic congestion with Point-Of-Care ultrasound : development of the venous excess ultrasound grading system. Ultrasound J 12 : 16, 2020
P.180 掲載の参考文献
20) Ren B, Yan F, Deng Z et al : Extremely high incidence of lower extremity deep venous thrombosis in 48 patients with severe COVID-19 in Wuhan. Circulation 142 : 181-183, 2020
21) Hussain A, Via G, Melniker L et al : Multiorgan point-of-care ultrasound for COVID-19 (PoCUS4COVID) : international expert consensus. Crit Care 24 : 702, 2020
22) Kameda T, Mizuma Y, Taniguchi H et al : Pointofcare lung ultrasound for the assessment of pneumonia : a narrative review in the COVID19 era. J Med Ultrason 48 : 31-43, 2021
23) Peyrony O, Marbeuf-Gueye C, Truong V et al : Accuracy of emergency department clinical fndings for diagnosis of coronavirus disease 2019. Ann Emerg Med 76 : 405-412, 2020
24) Kusunose K, Abe T, Haga A et al : A deep learning approach for assessment of regional wall motion abnormality from echo-cardiographic images. JACC Cardiovasc Imaging 13 (2 Pt 1) : 374-381, 2020
P.182 掲載の参考文献
1) Cribier A, Eltchaninoff H, Bash A et al : Percutaneous transcatheter implantation of an aortic valve prosthesis for calcific aortic stenosis : first human case description. Circulation 106 : 3006-3008, 2002
P.183 掲載の参考文献
2) Mack MJ, Leon MB, Thourani VH et al : Transcatheter aortic-valve replacement with a balloon-expandable valve in lowrisk patients. N Engl J Med 380 : 1695-1705, 2019
3) Popma JJ, Deeb GM, Yakubov SJ et al : Transcatheter aortic-valve replacement with a self-expanding valve in low-risk patients. N Engl J Med 380 : 1706-1715, 2019
4) Izumi C, Eishi K, Ashihara K et al : JCS/JSCS/JATS/JSVS 2020 guidelines on the management of valvular heart disease. Circ J 84 : 2037-2119, 2020
5) Committee for Scientific Affairs TJAfTS, Shimizu H, Endo S et al : Thoracic and cardiovascular surgery in Japan in 2016 : annual report by The Japanese Association for Thoracic Surgery. Gen Thorac Cardiovasc Surg 67 : 377-411, 2019
6) Handa N, Kumamaru H, Torikai K et al : Learning curve for transcatheter aortic valve implantation under a controlled introduction system-initial analysis of a Japanese nationwide registry-. Circulation Journal 82 : 1951-1958, 2018
7) Yamamoto M, Watanabe Y, Tada N et al : Transcatheter aortic valve replacement outcomes in Japan : Optimized CathEter vAlvular iNtervention (OCEAN) Japanese multicenter registry. Cardiovasc Revasc Med 20 : 843-851, 2019
P.184 掲載の参考文献
8) Shimura T, Yamamoto M, Kano S et al : Impact of the clinical frailty scale on outcomes after transcatheter aortic valve replacement. Circulation 135 : 2013-2024, 2017
9) Yanagisawa R, Tanaka M, Yashima F et al : Frequency and consequences of cognitive impairmentin patients underwent transcatheter aortic valve implantation. Am J Cardiol 122 : 844-850, 2018
10) Otto CM, Nishimura RA, Bonow RO et al : 2020 ACC/AHA Guideline for the management of patients with valvular heart disease : executive summary : a report of the American College of Cardiology/American Heart Association Joint Committee on Clinical Practice Guidelines. Circulation 143 : e35-e71, 2021
11) Vahanian A, Beyersdorf F, Praz F et al : 2021 ESC/EACTS Guidelines for the management of valvular heart disease. Eur Heart J 43 : 561-632, 2022
12) Yoon SH, Bleiziffer S, De Backer O et al : Outcomes in transcatheter aortic valve replacement for bicuspid versus tricuspid aortic valve stenosis. J Am Coll Cardiol 69 : 2579-2589, 2017
13) Deutsch MA, Erlebach M, Burri M et al : Beyond the five-year horizon : long-term outcome of high-risk and inoperable patients undergoing TAVR with firstgeneration devices. EuroIntervention 14 : 41-49, 2018
14) Sathananthan J, Lauck S, Polderman J et al : Ten year follow-up of high-risk patients treated during the early experience with transcatheter aortic valve replacement. Catheter Cardiovasc Interv 97 : E431-E437, 2021
15) Jorgensen TH, Thyregod HGH, Ihlemann N et al : Eight-year outcomes for patients with aortic valve stenosis at low surgical risk randomized to transcatheter vs. surgical aortic valve replacement. Eur Heart J 42 : 2912-2919, 2021
16) Landes U, Webb JG, De Backer O et al : Repeat transcatheter aortic valve replacement for transcatheter prosthesis dysfunction. J Am Coll Cardiol 75 : 1882-1893, 2020
P.185 掲載の参考文献
17) Makkar RR, Fontana G, Jilaihawi H et al : Possible subclinical leaflet thrombosis in bioprosthetic aortic valves. N Engl J Med 373 : 2015-2024, 2015
18) Yanagisawa R, Tanaka M, Yashima F et al : Early and late leaflet thrombosis after transcatheter aortic valve replacement. Circ Cardiovasc Interv 12 : e007349, 2019
19) Brouwer J, Nijenhuis VJ, Delewi R et al : Aspirin with or without clopidogrel after transcatheter aortic-valve implantation. N Engl J Med 383 : 1447-1457, 2020
20) Nijenhuis VJ, Brouwer J, Delewi R et al : Anticoagulation with or without clopidogrel after transcatheter aortic-valve implantation. N Engl J Med 382 : 1696-1707, 2020
21) Kawashima H, Watanabe Y, Hioki H et al : Direct oral anticoagulants versus vitamin K antagonists in patients with atrial fibrillation after TAVR. JACC Cardiovasc Interv 13 : 2587-2597, 2020
22) Van Mieghem NM, Unverdorben M, Hengstenberg C et al : Edoxaban versus vitamin K antagonist for atrial fibrillation after TAVR. N Engl J Med 385 : 2150-2160, 2021
23) Mentias A, Desai MY, Saad M et al : Management of aortic stenosis in patients with end-stage renal disease on hemodialysis. Circ Cardiovasc Interv 13 : e009252, 2020
P.186 掲載の参考文献
24) Tabata M, Kumamaru H, Ono A et al : The association of in-hospital transcatheter aortic valve replacement availability on outcomes of surgical aortic valve replacement in elderly patients. Circ J 84 : 1599-1604, 2020
25) Stone GW, Lindenfeld J, Abraham WT et al : Transcatheter mitral-valve repair in patients with heart failure. N Engl J Med 379 : 2307-2318, 2018
P.187 掲載の参考文献
26) Obadia JF, Messika-Zeitoun D, Leurent G et al : Percutaneous repair or medical treatment for secondary mitral regurgitation. N Engl J Med 379 : 2297-2306, 2018
27) Maisano F, Franzen O, Baldus S et al : Percutaneous mitral valve interventions in the real world : early and 1-year results from the ACCESS-EU, a prospective, multicenter, nonrandomized post-approval study of the MitraClip therapy in Europe. J Am Coll Cardiol 62 : 1052-1061, 2013
28) Auricchio A, Schillinger W, Meyer S et al : Correction of mitral regurgitation in nonresponders to cardiac resynchronization therapy by MitraClip improves symptoms and promotes reverse remodeling. J Am Coll Cardiol 58 : 2183-2189, 2011
P.188 掲載の参考文献
29) Hayashida K, Yasuda S, Matsumoto T et al : AVJ-514 trial- baseline characteristics and 30-day outcomes following MitraClip(R) treatment in a Japanese Cohort. Circ J 81 : 1116-1122, 2017
P.189 掲載の参考文献
1) Chang R, Kerby JD, Kalkwarf KJ et al : Earlier time to hemostasis is associated with decreased mortality and rate of complications : results from the pragmatic randomized optimal platelet and plasma ratio trial. J Trauma Acute Care Surg 87 : 342-349, 2019
P.190 掲載の参考文献
2) Chehab M, Afaneh A, Bible L et al : Angioembolization in intra-abdominal solid organ injury : does delay in angioembolization affect outcomes? J Trauma Acute Care Surg 89 : 723-729, 2020
3) Mouawad NJ, Paulisin J, Hofmeister S et al : Blunt thoracic aortic injury-concepts and management. J Cardiothorac Surg 15 : 62, 2020
4) Pang D, Hildebrand D, Bachoo P : Thoracic endovascular repair (TEVAR) versus open surgery for blunt traumatic thoracic aortic injury. Cochrane Database Syst Rev 2 : CD006642, 2019
5) Cheng YT, Cheng CT, Wang SY et al : Long-term outcomes of endovascular and open repair for traumatic thoracic aortic injury. JAMA Network Open 2 : e187861, 2019
6) Padia SA, Ingraham CR, Moriarty JM et al : Society of Interventional Radiology Position Statement on Endovascular Intervention for Trauma. J Vasc Interv Radiol 31 : 363-369, 2020
7) Alarhayem AQ, Rasmussen TE, Farivar B et al : Timing of repair of blunt thoracic aortic injuries in the thoracic endovascular aortic repair era. J Vasc Surg 73 : 896-902, 2021
P.191 掲載の参考文献
8) Saqib Y : A systematic review of the safety and efficacy of non-operative management in patients with high grade liver injury. Surgeon 18 : 165-177, 2020
9) 日本IVR学会, 日本外傷学会編 : 肝外傷に対するIVRのガイドライン 2016, 2016
10) Coccolini F, Coimbra R, Ordonez C et al : Liver trauma : WSES 2020 guidelines. World J Emerg Surg 15 : 24, 2020
11) Virdis F, Reccia I, Di Saverio S et al : Clinical outcomes of primary arterial embolization in severe hepatic trauma : a systematic review. Diagn Interv Imaging 100 : 65-75, 2019
12) Tamura S, Maruhashi T, Kashimi F et al : Transcatheter arterial embolization for severe blunt liver injury in hemodynamically unstable patients : a 15-year retrospective study. Scand J Trauma Resusc Emerg Med 29 : 66, 2021
P.192 掲載の参考文献
13) Schneider AB, Gallaher J, Raff L et al : Splenic preservation after isolated splenic blunt trauma : the angioembolization paradox. Surgery 170 : 628-633, 2021
14) Brahmbhatt AN, Ghobryal B, Wang P et al : Evaluation of splenic artery embolization technique for blunt trauma. J Emerg Trauma Shock 14 : 148-152, 2021
15) Arvieux C, Frandon J, Tidadini F et al : Effect of prophylactic embolization on patients with blunt trauma at high risk of splenectomy : a randomized clinical trial. JAMA Surg 155 : 1102-1111, 2020
P.193 掲載の参考文献
16) Coccolini F, Moore EE, Kluger Y et al : Kidney and uro-trauma : WSES-AAST guidelines. World J Emerg Surg 14 : 54, 2019
17) Smith TA, Eastaway A, Hartt D et al : Endovascular embolization in renal trauma : a narrative review. Ann Transl Med 9 : 1198, 2021
18) Colaco M, Navarrete RA, MacDonald SM et al : Nationwide procedural trends for renal trauma management. Ann Surg 269 : 367-369, 2019
19) Wijffels DJ, Verbeek DO, Ponsen KJ et al : Imaging and endovascular treatment of bleeding pelvic fractures : review article. Cardiovasc Intervent Radiol 42 : 10-18, 2019
20) 日本IVR 学会編 : 骨盤骨折に対するIVR施行医のためのガイドライン 2017. 2017
21) Chou CH, Wu YT, Fu CY et al : Hemostasis as soon as possible? The role of the time to angioembolization in the management of pelvic fracture. World J Emerg Surg 14 : 28, 2019
P.194 掲載の参考文献
22) Maruhashi T, Kashimi F, Kotoh R et al : Novel transcatheter arterial embolization method for hemodynamically unstable pelvic fractures to prevent complications of gluteal necrosis. Eur J Trauma Emerg Surg 46 : 1129-1136, 2020
23) JA-HERS : The hybrid emergency room system : a novel trauma evaluation and care system created in Japan. Acute Med Surg 6 : 247-251, 2019
24) Umemura Y, Watanabe A, Kinoshita T et al : Hybrid emergency room shows maximum effect on trauma resuscitation when used in patients with higher severity. J Trauma Acute Care Surg 90 : 232-239, 2021
25) Tarasconi A, Baiocchi GL, Pattonieri V et al : Transcatheter arterial embolization versus surgery for refractory non-variceal upper gastrointestinal bleeding : a meta-analysis. World J Emerg Surg 14 : 3, 2019
P.195 掲載の参考文献
26) 日本消化器病学会編 : 消化性潰瘍診療ガイドライン 2020 (改訂第3版). 南江堂, 東京, 2020
27) Chevallier O, Comby PO, Guillen K et al : Efficacy, safety and outcomes of transcatheter arterial embolization with N-butyl cyanoacrylate glue for non-variceal gastrointestinal bleeding : a systematic review and meta-analysis. Diagn Interv Imaging 102 : 479-487, 2021
28) Obara H, Kentaro M, Inoue M et al : Current management strategies for visceral artery aneurysms : an overview. Surg Today 50 : 38-49, 2020
29) Chaer RA, Abularrage CJ, Coleman DM et al : The Society for Vascular Surgery clinical practice guidelines on the management of visceral aneurysms. J Vasc Surg 72 : 3S-39S, 2020
30) Barrionuevo P, Malas MB, Nejim B et al : A systematic review and meta-analysis of the management of visceral artery aneurysms. J Vasc Surg 72 : 40S-45S, 2020
P.196 掲載の参考文献
1) Zarbock A, Kellum JA, Schmidt C et al : Effect of early vs delayed initiation of renal replacement therapy on mortality in critically ill patients with acute kidney injury : the ELAIN randomized clinical trial. JAMA 315 : 2190-2199, 2016
2) Gaudry S, Hajage D, Schortgen F et al : Initiation strategies for renal-replacement therapy in the intensive care unit. N Eng J Med 375 : 122-133, 2016
3) Barbar SD, Clere-Jehl R, Bourredjem A et al : Timing of renal-replacement therapy in patients with acute kidney injury and sepsis. N Eng J Med 379 : 1431-1442, 2018
4) Gaudry S, Hajage D, Benichou N et al : Delayed versus early initiation of renal replacement therapy for severe acute kidney injury : a systematic review and individual patient data meta-analysis of randomized clinical trials. Lancet 395 : 1506-1515, 2020
P.197 掲載の参考文献
5) Bagshaw SM, Wald R, Adhikari NKJ et al : Timing of Initiation of renal-replacement therapy in acute kidney injury. N Eng J Med 383 : 240-251, 2020
6) Gaudry S, Hajage D, Lefevre LM et al : Comparison of two delayed strategies for renal replacement therapy initiation for severe acute kidney injury (AKIKI 2) : a multicentre, open-label, randomized, controlled trial. Lancet 397 : 1293-1300, 2021
P.198 掲載の参考文献
7) Pan HC, Chen YY, Tsai IJ et al : Accelerated versus standard initiation of renal replacement therapy for critically ill patients with acute kidney injury : a systematic review and meta-analysis of RCT studies. Crit Care 25 : 5, 2021
9) Cruz DN, Antonelli M, Fumagalli R et al : Early use of polymyxin B hemoperfusion in abdominal septic shock : the EUPHAS randomized controlled trial. JAMA 301 : 2445-2452, 2009
10) Payen DM, Guilhot J, Launey Y et al : Early use of polymyxin B hemoperfusion in patients with septic shock due to peritonitis : a multicenter randomized control trial. Intensive Care Med 41 : 975-984, 2015
11) Dellinger RP, Bagshaw SM, Antonelli M et al : Effect of targeted polymyxin B hemoperfusion on 28-day mortality in patients with septic shock and elevated endotoxin level : the EUPHRATES randomized clinical trial. JAMA 320 : 1455-1463, 2018
12) Klein DJ, Foster D, Walker PM et al : Polymyxin B hemoperfusion in endotoxemic septic shock patients without extreme endotoxemia : a post hoc analysis of the EUPHRATES trial. Intensive Care Med 44 : 2205-2212, 2018
13) Nakata H, Yamakawa K, Kabata D et al : Identifying septic shock populations benefitting from polymyxin B hemoperfusion : a prospective cohort study incorporating a restricted cubic spline regression model. Shock 54 : 667-674, 2020
14) Fujimori K, Tarasawa K, Fushimi K : Effectiveness of polymyxin B hemoperfusion for sepsis depends on the baseline SOFA score : a nationwide observational study. Ann Intensive Care 11 : 141 (1-9), 2021
15) Lee WY, Kim HJ, Kim EY et al : Impact of polymyxin B hemoperfusion therapy on high endotoxin activity level patients after successful infection source control : a prospective cohort study. Sci Rep 11 : 24132, 2021
P.199 掲載の参考文献
16) Li X, Liu C, Mao Z et al : Effectiveness of polymyxin B-immobilized hemoperfusion against sepsis and septic shock : a systematic review and meta-analysis. J Crit Care 63 : 187-195, 2021
17) Kobashi S, Maruhashi T, Nakamura T et al : The 28-day survival of two cytokineadsorbing hemofilters for continuous renal replacement therapy : a single-center retrospective comparative study. Acute Med Surg 6 : 60-67, 2019
18) Hayashi K, Sasabuchi Y, Matsui H et al : Clinical effect of the acrylonitrile-co-methallyl sulfonate surface-treated membrane as a cytokine adsorption therapy for sepsis due to acute panperitonitis : a retrospective cohort study. Blood Purif 49 : 364-371, 2020
19) Broman ME, Hansson F, Vincent JL et al : Endotoxin and cytokine reducing properties of the oXiris membrane in patients with septic shock : a randomized crossover double-blind study. PLoS One 14 : e0220444, 2019
20) Hawchar F, Laszlo I, Oveges N et al : Extracorporeal cytokine adsorption in septic shock : a proof of concept randomized controlled pilot study. J Crit Care 49 : 172-178, 2019
21) Schadler D, Pausch C, Heise D et al : The effect of a novel extracorporeal cytokine hemoadsorption device on IL-6 elinination in septic patients : a randomized controlled trial. PLoS One 12 : e0187015, 2017
22) Friesecke S, Trager K, Schittek GA et al : International registry on the use of the Cytosorb(R) adsorber in ICU patients : study protocol and preliminary results. Med Klin Intensivmed Notfmed 114 : 699-707, 2019
P.200 掲載の参考文献
23) Schultz P, Schwier E, Eickmeyer C et al : High-dose Cytosorb hemoadsorption is associated with improved survival in patients with septic shock : a retrospective cohort study. J Crit Care 64 : 184-192, 2021
24) Scharf C, Schroeder I, Paam M et al : Can the cytokine adsorber CytoSorb(R) help to mitigate cytokine storm and reduce mortality in critically ill patients? a propensity score matching analysis. Ann Intensive Care 11 : 115, 2021
25) Shao M, Li XM, Liu F et al : Acute kidney injury is associated with severe infection and fatality in patients with COVID-19 : a systematic review and meta-analysis of 40 studies and 24,527 patients. Pharmacol Res 161 : 105-107, 2020
26) Kamran SM, Mirza ZE, Naseem A et al : Therapeutic plasma exchange for coronavirus disease-2019 triggered cytokine release syndrome : a retrospective propensity matched control study. PLoS One 16 : e0244853, 2021
27) Faqihi F, Alharthy A, Abdulaziz S et al : Therapeutic plasma exchange in patients with life-threatening COVID-19 : a randomized controlled clinical trial. Int J Antimicrob Agents 57 : 106334, 2021
28) De Rosa S, Cutuli SL, Ferrer R et al : Polymyxin B hemoperfusion in coronavirus disease 2019 patients with endotoxic shock : case series from EUPHAS2 registry. Artif Organs 45 : 187-194, 2021
29) Supady A, Weber E, Rieder M et al : Cytokine adsorption in patients with severe COVID-19 pneumonia requiring extracorporeal membrane oxygenation (CYCOV) : a single centre, open-label, randomized controlled trial. Lancet Respir Med 9 : 755-762, 2021
P.202 掲載の参考文献
1) Mizobe T, Sessler DI : Temperature monitoring (Chapter 26). Civetta, Taylor, & Kirby's Critical Care, 5th Edition. Edited by Gabrielli A, Layon AJ, Yu M. Lippincott Williams & Wilkins, Philadelphia, pp285-301, 2018
2) Sessler DI : Perioperative Temperature Monitoring. Anesthesiology 134 : 111-118, 2021
3) Zhang Z, Xu M, Wu D et al : Postoperative myocardial injury in middle-aged and elderly patients following curative resection of esophageal cancer with aggressive or standard body temperature management : a randomized controlled trial. Anesth Analg 129 : 352-359, 2019
4) Nam K, Jo WY, Kwon SM et al : Association between postoperative body temperature and all-cause mortality after off-pump coronary artery bypass graft surgery : a retrospective observational study. Anesth Analg 130 : 1381-1388, 2020
P.203 掲載の参考文献
5) Morton S, Kua J, Mullington CJ : Epidural analgesia, intrapartum hyperthermia, and neonatala brain injury : a systematic review and meta-analysis. Br J Anaesth 126 : 500-515, 2021
6) Chen WA, Liu CC, Mnisi Z et al : Warming strategies for preventing hypothermia and shivering during cesarean section : a systematic review with network meta-analysis of randomized clinical trials. Int J Surg 71 : 21-28, 2019
P.204 掲載の参考文献
7) Loeliger RC, Maushart CI, Gashi G et al : Relation of diet-induced thermogenesis to brown adipose tissue activity in healthy men. Am J Physiol Endocrinol Metab 320 : E93-101, 2021
8) Hamamoto H, Yamamoto M, Masubuchi S et al : The impact of preoperative carbohydrate loading on intraoperative body temperature : a randomized controlled clinical trial. Surg Endosc 32 : 4393-4401, 2018
P.205 掲載の参考文献
9) Yang C, Cheng Y, Liu S et al : Effect of preoperative oral carbohydrate loading on body temperature during combined spinal-epidural anesthesia for elective cesarean delivery. Anesth Analg 133 : 731-738, 2021
10) Grayson KE, Bailey M, Balachandran M et al : The effect of early sedation with dexmedetomidine on body temperature in critically ill patients. Crit Care Med 49 : 1118-1128, 2021
P.206 掲載の参考文献
11) Culver A, Coiffard B, Antonini F et al : Circadian disruption of core temperature in trauma patients : a single-center retrospective observational study. J Intensive Care 8 : 4, 2020
12) Coiffard B, Diallo AB, Culver A et al : Exacerbation of circadian rhythms of core body temperature and sepsis in trauma patients. J Crit Care 60 : 23-26, 2020
13) Davidson S, Villarroel M, Harford M et al : Day-to-day progression of vital-sign circadian rhythms in the intensive care unit. Crit Care 25 : 156, 2021
14) Kushimoto S, Abe T, Ogura H et al : Impact of body temperature abnormalities on the implementation of sepsis bundles and outcomes in patients with severe sepsis : a retrospective sub-group analysis of the focused outcome research on emergency care for acute respiratory distress syndrome, sepsis and trauma study. Crit Care Med 47 : 691-699, 2019
P.207 掲載の参考文献
15) Shimazui T, Nakada T, Walley KR et al : Significance of body temperature in elderly patients with sepsis. Crit Care 24 : 387, 2020
P.208 掲載の参考文献
1) Altmann ES, Crossingham I, Wilson S et al : Intra-pleural fibrinolytic therapy versus placebo, or a different fibrinolytic agent, in the treatment of adult parapneumonic effusions and empyema. Cochrane Database Syst Rev 2019 : CD002312, 2019
P.209 掲載の参考文献
2) Aldaghlawi F, Kurman JS, Lilly JA et al : A systematic review of digital vs analog drainage for air leak after surgical resection or spontaneous pneumothorax. Chest 157 : 1346-1353, 2020
3) Ruigrok D, Kunst PWA, Blacha MMJ et al : Digital versus analogue chest drainage system in patients with primary spontaneous pneumothorax : a randomized controlled trial. BMC Pulm Med 20 : 136, 2020
4) Barozzi L, Biagio LS, Meneguzzi M et al : Novel, digital, chest drainage system in cardiac surgery. J Card Surg 35 : 1492-1497, 2020
5) Mowery NT, Gunter OL, Collier BR et al : Practice management guidelines for management of hemothorax and occult pneumothorax. J Trauma 70 : 510-518, 2011
P.210 掲載の参考文献
6) Gilbert RW, Fontebasso AM, Park L et al : The management of occult hemothorax in adults with thoracic trauma : a systematic review and meta-analysis. J Trauma Acute Care Surg 89 : 1225-1232, 2020
7) Patel NJ, Dultz L, Ladhani HA et al : Management of simple and retained hemothorax : a practice management guideline from the Eastern Association for the Surgery of Trauma : Hemothorax Management Guideline. Am J Surg 221 : 873-884, 2021
8) Zhang JT, Dong S, Chu XP et al : Randomized trial of an improved drainage strategy versus routine chest tube after lung wedge resection. Ann Thorac Surg 109 : 1040-1046, 2020
9) Bachichi TG, Leao LEV, Perfeito JAJ et al : Traditional chest drainage versus drainage by thoracotomy : a prospective randomized study. Einstein (Sao Paulo) 18 : eAO4409, 2020
10) Lentz RJ, Shojaee S, Grosu HB et al : The impact of gravity vs suction-driven therapeutic thoracentesis on pressure-related complications : the GRAVITAS multicenter randomized controlled trial. Chest 157 : 702-711, 2020
11) Tan J, Chen H, He J et al : Needle aspiration versus closed thoracostomy in the treatment of spontaneous pneumothorax : a meta-analysis. Lung 198 : 333-344, 2020
P.211 掲載の参考文献
12) Clements TW, Sirois M, Parry N et al : OPTICC : a multicentre trial of occult pneumothoraces subjected to mechanical ventilation : the final report. Am J Surg 221 : 1252-1258, 2021
13) Anweier N, Apaer S, Zeng Q et al : Is routine abdominal drainage necessary for patients undergoing elective hepatectomy? a protocol for systematic review and meta-analysis. Medicine (Baltimore) 100 : e24689, 2021
14) Weindelmayer J, Mengardo V, Veltri A et al : Should we still use prophylactic drain in gastrectomy for cancer? a systematic review and meta-analysis. Eur J Surg Oncol 46 : 1396-1403, 2020
P.212 掲載の参考文献
15) Lyu Y, Cheng Y, Wang B et al : Peritoneal drainage or no drainage after pancreaticoduodenectomy and/or distal pancreatectomy : a meta-analysis and systematic review. Surg Endosc 34 : 4991-5005, 2020
16) Sinnaeve PR, Adriaenssens T : A contemporary look at pericardiocentesis. Trends Cardiovasc Med 29 : 375-383, 2019
17) Flint N, Siegel RJ : Echo-guided pericardiocentesis : when and how should it be performed? Curr Cardiol Rep 22 : 71, 2020
18) Luis SA, Kane GC, Luis CR et al : Overview of optimal techniques for pericardiocentesis in contemporary practice. Curr Cardiol Rep 22 : 60, 2020
19) Coppadoro A, Bellani G, Foti G : Nonpharmacological interventions to prevent ventilator-associated pneumonia : a literature review. Respir Care 64 : 1586-1595, 2019
20) Pozuelo-Carrascosa DP, Herraiz-Adillo A, Alvarez-Bueno C et al : Subglottic secretion drainage for preventing ventilator-associated pneumonia : an overview of systematic reviews and an updated meta-analysis. Eur Respir Rev 29 : 190107, 2020
P.213 掲載の参考文献
21) Elbatanouny AM, Ragheb AM, Abdelbary AM et al : Percutaneous nephrostomy versus JJ ureteric stent as the initial drainage method in kidney stone patients presenting with acute kidney injury : a prospective randomized study. Int J Urol 27 : 916-921, 2020
22) Surya M, Bhoil R, Sharma YP : Study of ultrasound-guided needle aspiration and catheter drainage in the management of liver abscesses. J Ultrasound 23 : 553-562, 2020
P.214 掲載の参考文献
23) Muthu S, Ramakrishnan E, Natarajan KK et al : Risk-benefit analysis of wound drain usage in spine surgery : a systematic review and meta-analysis with evidence summary. Eur Spine J 29 : 2111-2128, 2020
P.215 掲載の参考文献
1) Swayngim R, Preslaski C, Burlew CC et al : Comparison of clinical outcomes using activated partial thromboplastin time versus antifactor-Xa for monitoring therapeutic unfractionated heparin : a systematic review and meta-analysis. Thromb Res 208 : 18-25, 2021
2) Wu T, Xia X, Chen W et al : The effect of anti-Xa monitoring on the safety and efficacy of low-molecular-weight heparin anticoagulation therapy : a systematic review and meta-analysis. J Clin Pharm Ther 45 : 602-608, 2020
P.216 掲載の参考文献
3) Willems A, Roeleveld PP, Labarinas S et al : Anti-Xa versus time-guided anticoagulation strategies in extracorporeal membrane oxygenation : a systematic review and meta-analysis. Perfusion 36 : 501-512, 2021
4) Tauseef A, Zafar M, Arshad W et al : Role of immature platelet fraction (IPF) in sepsis patients : a systematic review. J Family Med Prim Care 10 : 2148-2152, 2021
5) Sugiyama M, Kinoshita N, Ide S et al : Serum CCL17 level becomes a predictive marker to distinguish between mild/moderate and severe/critical disease in patients with COVID-19. Gene 766 : 145145, 2021
6) Levine MN, Hirsh J, Gent M et al : A randomized trial comparing activated thromboplastin time with heparin assay in patients with acute venous thromboembolism requiring large daily doses of heparin. Arch Intern Med 154 : 49-56, 1994
P.217 掲載の参考文献
7) Salim R, Nachum Z, Gavish I et al : Adjusting enoxaparin dosage according to anti-FXa levels and pregnancy outcome in thrombophilic women. a randomised controlled trial. Thromb Haemost 116 : 687-695, 2016
8) Alhenc-Gelas M, Jestin-Le Guernic C, Vitoux JF et al : Adjusted versus fixed doses of the low-molecular-weight heparin fragmin in the treatment of deep vein thrombosis. Fragmin-Study Group. Thromb Haemost 71 : 698-702, 1994
P.219 掲載の参考文献
9) Kienast J, Schmitz G : Flow cytometric analysis of thiazole orange uptake by platelets : a diagnostic aid in the evaluation of thrombocytopenic disorders. Blood 75 : 116-121, 1990
10) De Blasi RA, Cardelli P, Costante A et al : Immature platelet fraction in predicting sepsis in critically ill patients. Intensive Care Med 39 : 636-643, 2013
11) Buoro S, Manenti B, Seghezzi M et al : Innovative haematological parameters for early diagnosis of sepsis in adult patients admitted in intensive care unit. J Clin Pathol 71 : 330-335, 2018
12) Enz Hubert RM, Rodrigues MV, Andreguetto BD et al : Association of the immature platelet fraction with sepsis diagnosis and severity. Sci Rep 5 : 8019, 2015.
P.220 掲載の参考文献
P.221 掲載の参考文献
1) Biomarkers Definitions Working Group : Biomarkers and surrogate endpoints : preferred definitions and conceptual frame-work. Clin Pharmacol Ther 69 : 89-95, 2001
2) Evans L, Rhodes A, Alhazzani W et al : Surviving sepsis campaign : international guidelines for management of sepsis and septic shock 2021. Intensive Care Med 47 : 1181-1247, 2021
3) Almuhayawi MS, Wong AYW, Kynning M et al : Identification of microorganisms directly from blood culture bottles with polymicrobial growth : comparison of Film Array and direct MALDI-TOF MS. APMIS 129 : 178-185, 2021
4) Angelis G, Grossi A, Menchinelli G et al : Rapid molecular tests for detection of antimicrobial resistance determinants in Gram-negative organisms from positive blood cultures : a systematic review and meta-analysis. Clin Microbiol Infect 26 : 271-280, 2020
P.222 掲載の参考文献
5) Papafilippou L, Claxton A, Dark P et al : Nanotools for sepsis diagnosis and treatment. Adv Healthc Mater 10 : e2001378, 2021
6) Paudel R, Dogra P, Montgomery-Yates A et al : Procalcitonin : a promising tool or just another overhyped test? Int J Med Sci 17 : 332-337, 2020
7) Liying Lai, Yijie Lai, Hao Wang et al : Diagnostic accuracy of procalcitonin compared to C-reactive protein and interleukin 6 in recognizing gram-negative blood-stream infection : a meta-analytic study. Dis Markers 2020 : 4873074, 2020
P.223 掲載の参考文献
9) Yamamoto T, Nishimura N, Kaga S et al : Diagnostic accuracy of presepsin for sepsis by the new Sepsis-3 definitions. Am J Emerg Med 37 : 1936-1941, 2019
10) Doerflinger M, Reljic B, Menassa J et al : Circulating BiP/Grp78 is a novel prognostic marker for sepsis-mediated immune cell death. FEBS J 288 : 1809-1821, 2021
11) Bime C, Casanova N, Oita RC et al : Development of a biomarker mortality risk model in acute respiratory distress syndrome. Crit Care 23 : 410, 2019
P.224 掲載の参考文献
12) Goodwin AJ, Li P, Halushka PV et al : Circulating miRNA 887 is differentially expressed in ARDS and modulates endothelial function. Am J Physiol Lung Cell Mol Physiol 318 : L1261-L1269, 2020
13) Chen W, Liu L, Yang J et al : MicroRNA-146b correlates with decreased acute respiratory distress syndrome risk, reduced disease severity, and lower 28-day mortality in sepsis patients. J Clin Lab Anal 34 : 1-9, 2020
14) Wang Q, Feng Q, Zhang Y et al : Decreased microRNA 103 and microRNA 107 predict increased risks of acute respiratory distress syndrome and 28-day mortality in sepsis patients. Medicine (Baltimore) 99 : e20729, 2020
15) Liao SY, Casanova NG, Bime C et al : Identification of early and intermediate biomarkers for ARDS mortality by multiomic approaches. Sci Rep 11 : 1-12, 2021
16) Jackson Chornenki NL, Dwivedi DJ, Kwong AC et al : Identification of hemostatic markers that define the pre-DIC state : a multi-center observational study. J Thromb Haemost 18 : 2524-2531, 2020
18) Catenacci V, Sheikh F, Patel K et al : The prognostic utility of protein C as a biomarker for adult sepsis : a systematic review and meta-analysis. Crit Care 26 : 21, 2022
P.225 掲載の参考文献
19) Takayama W, Endo A, Morishita K et al : Dielectric blood coagulometry for the early detection of sepsis-induced disseminated intravascular coagulation : a prospective observational study. Crit Care Med (IF : 7.6 ; Q1) 50 : e31-e39, 2022
20) Deshayes S, Aouba A, Grateau G et al : Infections and AA amyloidosis : an overview. Int J Clin Pract 75 : e13966, 2021
21) Sack GH Jr : Serum amyloid A (SAA) proteins. Subcell Biochem 94 : 421-436, 2020
22) Abouelasrar Salama S, Gouwy M, Van Damme J et al : The turning away of serum amyloid A biological activities and receptor usage. Immunology 163 : 115-127, 2021
23) Akbari H, Tabrizi R, Lankarani KB et al : The role of cytokine profile and lymphocyte subsets in the severity of coronavirus disease 2019 (COVID-19) : a systematic review and meta-analysis. Life Sci 258 : 118167, 2020
P.226 掲載の参考文献
24) Zhou J, Lu Y, Wang S et al : Association between serum amyloid A levels and coronary heart disease : a systematic review and meta-analysis of 26 studies. Inflamm Res 69 : 331-345, 2020
25) Zeng F, Huang Y, Guo Y et al : Association of inflammatory markers with the severity of COVID-19 : a meta-analysis. Int J Infect Dis 96 : 467-474, 2020
26) Kappert K, Jahic A, Tauber R : Assessment of serum ferritin as a biomarker in COVID-19 : bystander or participant? Insights by comparison with other infectious and non-infectious diseases. Biomarkers 25 : 616-625, 2020
27) Zhou F, Yu T, Du R et al : Clinical course and risk factors for mortality of adult inpatients with COVID-19 in Wuhan, China : a retrospective cohort study. Lancet 395 : 1054-1062, 2020
28) Wang F, Hou H, Luo Y et al : The laboratory tests and host immunity of COVID-19 patients with different severity of illness. JCI Insight 5 (10), 2020
29) Chen G, Wu D, Guo W et al : Clinical and immunological features of severe and moderate coronavirus disease 2019. J Clin Invest 130 : 2620-2629, 2020
30) Guo W, Li M, Dong Y et al : Diabetes is a risk factor for the progression and prognosis of COVID-19. Diabetes Metab Res Rev 36 : 1-9, 2020
III章 特有の病態と治療
P.228 掲載の参考文献
1) Fehr AR, Perlman S : Corona viruses : an overview of their replication and pathogenesis. Methods Mol Biol 1282 : 1-23, 2015
2) Bourgonje AR, Abdulle AE, Timens W et al : Angiotensin-converting enzyme 2 (ACE2), SARS-CoV-2 and the pathophysiology of coronavirus disease 2019 (COVID-19). J Pathol 251 : 228-248, 2020
3) Han H, Ma Q, Li C et al : Profiling serum cytokines in COVID-19 patients reveals IL-6 and IL-10 are disease severity predictors. Emerg Microbes Infect 9 : 1123-1130, 2020
4) Gupta A, Madhavan MV, Sehgal K et al : Extrapulmonary manifestations of COVID-19. Nat Med 26 : 1017-1032, 2020
P.229 掲載の参考文献
5) Yang Y, Shen C, Li J et al : Plasma IP-10 and MCP-3 levels are highly associated with disease severity and predict the progression of COVID-19. J Allergy Clin Immunol 146 : 119-127.e4, 2020
6) 厚生労働省 : 新型コロナウイルス感染症COVID-19診療の手引き 第1版 https://ajhc.or.jp/siryo/20200317-covid19.pdf (2022年1月13日閲覧)
7) 厚生労働省 : 新型コロナウイルス感染症COVID-19診療の手引き 第6.0版 https://www.mhlw.go.jp/content/000851077.pdf (2022年1月13日閲覧)
8) Weinreich DM, Sivapalasingam S, Norton T et al : REGEN-COV antibody combination and outcomes in outpatients with Covid-19. N Engl J Med 385 : e81, 2021
9) Weinreich DM, Sivapalasingam S, Norton T et al : REGN-COV2, a Neutralizing antibody cocktail, in outpatients with Covid-19. N Engl J Med 384 : 238-235, 2021
10) Lo MK, Jordan R, Arvey A et al : GS-5734 and its parent nucleoside analog. inhibit Filo-, Pneumo-, and Paramyxoviruses. Sci Rep 7 : 43395, 2017
P.230 掲載の参考文献
11) Beigel JH, Tomashek KM, Dodd LE et al : Remdesivir for the treatment of Covid-19-final report. N Engl J Med 383 : 1813-1826, 2020
12) Spinner CD, Gottlieb RL, Criner GJ et al : Effect of remdesivir vs standard care on clinical status at 11 days in patients with moderate COVID-19 : a randomized clinical trial. JAMA 324 : 1048-1057, 2020
13) WHO Solidarity Trial Consortium ; Pan H, Peto R, Ana-Maria Henao-Restrepo et al : Repurposed antiviral drugs for Covid-19-Interim WHO Solidarity Trial Results. N Engl J Med 384 : 497-511, 2021
14) Yamakawa K, Yamamoto R, Ishimaru G et al : Septic Shock 2020 (J-SSCG 2020), the COVID-19 Task Force : Japanese Rapid/Living recommendations on drug management for COVID-19. Acute Med Surg 8 : e664, 2021 [online ahead of print]
15) Jayk Bernal A, Gomes da Silva MM, Musungaie DB et al : Molnupiravir for oral treatment of Covid-19 in nonhospitalized patients. N Engl J Med 16 : NEJMoa2116044, 2021
P.231 掲載の参考文献
16) Pfizer Receives U.S. FDA Emergency Use Authorization for Novel COVID-19 Oral Antiviral Treatment https://www.pfizer.com/news/press-release/press-release-detail/pfizer-receivesus-fda-emergency-use-authorization-novel (2022年1月13日閲覧)
17) Horby P, Lim WS, Emberson JR et al : Dexamethasone in hospitalized patients with Covid-19. N Engl J Med 384 : 693-704, 2021
18) Tomazini BM, Maia IS, Cavalcanti AB et al : Effect of dexamethasone on days alive and ventilator-free in patients with moderate or severe acute respiratory distress syndrome and COVID-19 : the CoDEX randomized clinical trial. JAMA 324 : 1307-1316, 2020
19) Kalil AC, Patterson TF, Mehta AK et al : Baricitinib plus remdesivir for hospitalized adults with Covid-19. N Engl J Med 384 : 795-807, 2021
20) Marconi VC, Ramanan AV, de Bono S et al : Efficacy and safety of baricitinib for the treatment of hospitalised adults with COVID-19 (COV-BARRIER) : a randomized, double-blind, parallel-group, placebo-controlled phase 3 trial. Lancet Respir Med 9 : 1407-1418, 2021
P.232 掲載の参考文献
21) Guerin C, Reignier J, Richard JC et al : Prone positioning in severe acute respiratory distress syndrome. N Engl J Med 368 : 2159-2168, 2013
22) Coppo A, Bellani G, Winterton D et al : Feasibility and physiological effects of prone positioning in non-intubated patients with acute respiratory failure due to COVID-19 (PRON-COVID) : a prospective cohort study. Lancet Respir Med 8 : 765-774, 2020
23) Badulak J, Antonini MV, Stead CM et al : Extracorporeal membrane oxygenation for COVID-19 : updated 2021 Guidelines from the Extracorporeal Life Support Organization. ASAIO J 67 : 485-495, 2021
24) Giani M, Martucci G, Madotto F et al : Prone positioning during venovenous extracorporeal membrane oxygenation in acute respiratory distress syndrome. a multicenter cohort study and propensity-matched analysis. Ann Am Thorac Soc 18 : 495-501, 2021
P.233 掲載の参考文献
25) Grasselli G, Tonetti T, Protti A et al : Pathophysiology of COVID-19-associated acute respiratory distress syndrome : a multicentre prospective observational study. Lancet Respir Med 8 : 1201-1208, 2020
26) Archer SL, Sharp WW, Weir EK : Differentiating COVID-19 pneumonia from acute respiratory distress syndrome and high altitude pulmonary edema : therapeutic implications. Circulation 142 : 101-104, 2020
29) NIH : Coronavirus Disease 2019 (COVID-19) Treatment Guidelines https://www.covid19treatmentguidelines.nih.gov/ (2022年1月13日閲覧)
30) Chen N, Zhou M, Dong X et al : Epidemiological and clinical characteristics of 99 cases of 2019 novel coronavirus pneumonia in Wuhan, China : a descriptive study. Lancet 395 : 507-513, 2020
31) NPO法人日本ECMOnet : COVID-19重症患者状況の集計 http://crisis.ecmonet.jp/ (2022年1月13日閲覧)
32) Extracorporeal Life Support Organization COVID-19 Interim Guidelines https://www.elso.org/Portals/0/Files/pdf/guidelines%20elso%20covid%20for%20web_Final.pdf (2022年1月13日閲覧)
34) Badulak J, Antonini MV, Stead CM et al : Extracorporeal membrane oxygenation for COVID-19 : updated 2021 Guidelines from the Extracorporeal Life Support Organization. ASAIO J 67 : 485-495, 2021
P.234 掲載の参考文献
35) Schmidt M, Pham T, Arcadipane A et al : Mechanical ventilation management during extracorporeal membrane oxygenation for acute respiratory distress syndrome. an international multicenter prospective cohort. Am J Respir Crit Care Med 200 : 1002-1012, 2019
P.235 掲載の参考文献
P.236 掲載の参考文献
3) ICU-ROX Investigators and the Australian and New Zealand Intensive Care Society Clinical Trials Group ; Mackle D, Bellomo R et al : Conservative oxygen therapy during mechanical ventilation in the ICU. N Engl J Med 382 : 989-998, 2020
4) Schjorring OL, Klitgaard TL, Perner A et al : Lower or higher oxygenation targets for acute hypoxemic respiratory failure. N Engl J Med 384 : 1301-1311, 2021
6) Rozencwajg S, Guihot A, Franchineau G et al : Ultra-protective ventilation reduces biotrauma in patients on venovenous extracorporeal membrane oxygenation for severe acute respiratory distress syndrome. Crit Care Med 47 : 1505-1512, 2019
7) McNamee JJ, Gillies MA, Barrett NA et al : Effect of lower tidal volume ventilation facilitated by extracorporeal carbon dioxide removal vs standard care ventilation on 90-day mortality in patients with acute hypoxemic respiratory failure : the REST randomized clinical trial. JAMA 326 : 1013-1023, 2021
8) Bellani G, Grassi A, Sosio S et al : Driving pressure is associated with outcome during assisted ventilation in acute respiratory distress syndrome. Anesthesiology 131 : 594-604, 2019
P.237 掲載の参考文献
9) Yehya N, Hodgson CL, Amato MBP et al : Response to ventilator adjustments for predicting acute respiratory distress syndrome mortality. driving pressure versus oxygenation. Ann Am Thorac Soc 18 : 857-864, 2021
10) Coppola S, Caccioppola A, Froio S et al : Effect of mechanical power on intensive care mortality in ARDS patients. Crit Care 24 : 246, 2020
11) Chiu L-C, Lin S-W, Chuang L-P et al : Mechanical power during extracorporeal membrane oxygenation and hospital mortality in patients with acute respiratory distress syndrome. Crit Care 25 : 13, 2021
12) Pensier J, de Jong A, Hajjej Z et al : Effect of lung recruitment maneuver on oxygenation, physiological parameters and mortality in acute respiratory distress syndrome patients : a systematic review and meta-analysis. Intensive Care Med 45 : 1691-1702, 2019
13) Turbil E, Terzi N, Cour M et al : Positive end-expiratory pressure-induced recruited lung volume measured by volume-pressure curves in acute respiratory distress syndrome : a physiologic systematic review and meta-analysis. Intensive Care Med 46 : 2212-2225, 2020
14) Beitler JR, Sarge T, Banner-Goodspeed VM et al : Effect of titrating positive endexpiratory pressure (PEEP) with an esophageal pressure-guided strategy vs an empirical high PEEP-Fio2 strategy on death and days free from mechanical ventilation among patients with acute respiratory distress syndrome : a randomized clinical trial. JAMA 321 : 846-857, 2019
15) Wang R, Sun B, Li X et al : Mechanical ventilation strategy guided by transpulmonary pressure in severe acute respiratory distress syndrome treated with venovenous extracorporeal membrane oxygenation. Crit Care Med 48 : 1280-1288, 2020
P.238 掲載の参考文献
16) Pelosi P, Ball L, Barbas CSV et al : Personalized mechanical ventilation in acute respiratory distress syndrome. Crit Care 25 : 250, 2021
17) Constantin J-M, Jabaudon M, Lefrant J-Y et al : Personalised mechanical ventilation tailored to lung morphology versus low positive end-expiratory pressure for patients with acute respiratory distress syndrome in France (the LIVE study) : a multicentre, single-blind, randomised controlled trial. Lancet Respir Med 7 : 870-880, 2019
18) He H, Chi Y, Yang Y et al : Early individualized positive end-expiratory pressure guided by electrical impedance tomography in acute respiratory distress syndrome : a randomized controlled clinical trial. Crit Care 25 : 230, 2021
19) Parhar KKS, Stelfox HT, Fiest KM et al : Standardized management for hypoxemic respiratory failure and ARDS : systematic review and meta-analysis. Chest 158 : 2358-2369, 2020
P.239 掲載の参考文献
21) National Heart, Lung, and Blood Institute PETAL Clinical Trials Network ; Moss M, Huang DT et al : Early neuromuscular blockade in the acute respiratory distress syndrome. N Engl J Med 380 : 1997-2008, 2019
23) Peter JV, John P, Graham PL et al : Corticosteroids in the prevention and treatment of acute respiratory distress syndrome (ARDS) in adults : meta-analysis. BMJ 336 : 1006-1009, 2008
24) Villar J, Ferrando C, Martinez D et al : Dexamethasone treatment for the acute respiratory distress syndrome : a multicentre, randomised controlled trial. Lancet Respir Med 8 : 267-276, 2020
25) Sud S, Friedrich JO, Adhikari NKJ et al : Comparative effectiveness of protective ventilation strategies for moderate and severe acute respiratory distress syndrome. a network meta-analysis. Am J Respir Crit Care Med 203 : 1366-1377, 2021
26) Guervilly C, Prud'homme E, Pauly V et al : Prone positioning and extracorporeal membrane oxygenation for severe acute respiratory distress syndrome : time for a randomized trial? Intensive Care Med 45 : 1040-1042, 2019
27) Rilinger J, Zotzmann V, Bemtgen X et al : Prone positioning in severe ARDS requiring extracorporeal membrane oxygenation. Crit Care 24 : 397, 2020
P.240 掲載の参考文献
28) Poon WH, Ramanathan K, Ling RR et al : Prone positioning during venovenous extracorporeal membrane oxygenation for acute respiratory distress syndrome : a systematic review and meta-analysis. Crit Care 25 : 292, 2021
29) Combes A, Peek GJ, Hajage D et al : ECMO for severe ARDS : systematic review and individual patient data meta-analysis. Intensive Care Med 46 : 2048-2057, 2020
30) Combes A, Schmidt M, Hodgson CL et al : Extracorporeal life support for adults with acute respiratory distress syndrome. Intensive Care Med 46 : 2464-2476, 2020
P.241 掲載の参考文献
1) Zilberberg MD, Nathanson BH, Puzniak LA et al : Descriptive epidemiology and outcomes of nonventilated hospitalacquired, ventilated hospital-acquired, and ventilator-associated bacterial pneumonia in the United States, 2012-2019. Crit Care Med, 2021 [online ahead of print]
2) Kalil AC, Metersky ML, Klompas M et al : Management of adults with hospitalacquired and ventilator-associated pneumonia : 2016 Clinical Practice Guidelines by the Infectious Diseases Society of America and the American Thoracic Society. Clin Infect Dis 63 : e61-e111, 2016
P.242 掲載の参考文献
3) Torres A, Niederman MS, Chastre J et al : International ERS/ESICM/ESCMID/ALAT guidelines for the management of hospital-acquired pneumonia and ventilator-associated pneumonia : Guidelines for the management of hospital-acquired pneumonia (HAP)/ventilator-associated pneumonia (VAP) of the European Respiratory Society (ERS), European Society of Intensive Care Medicine (ESICM), European Society of Clinical Microbiology and Infectious Diseases (ESCMID) and Asociacion Latinoamericana del Torax (ALAT). Eur Respir J 50 : 1700582, 2017
4) 日本呼吸器学会成人肺炎診療ガイドライン2017作成委員会 : 成人肺炎診療ガイドライン 2017
5) Kelly DN, Martin-Loeches I : Comparing current US and European guidelines for nosocomial pneumonia. Curr Opin Pulm Med 25 : 263-270, 2019
7) Fernando SM, Tran A, Cheng W et al : Diagnosis of ventilator-associated pneumonia in critically ill adult patients-a systematic review and meta-analysis. Intensive Care Med 46 : 1170-1179, 2020
P.243 掲載の参考文献
8) Zhou J, Song J, Gong S et al : Lung ultrasound combined with procalcitonin for a diagnosis of ventilator-associated pneumonia. Respir Care 64 : 519-527, 2019
9) Pradhan S, Shrestha PS, Shrestha GS et al : Clinical impact of lung ultrasound monitoring for diagnosis of ventilator associated pneumonia : a diagnostic randomized controlled trial. J Crit Care 58 : 65-71, 2020
10) Frondelius T, Atkova I, Miettunen J et al : Diagnostic and prognostic prediction models in ventilator-associated pneumonia : systematic review and meta-analysis of prediction modelling studies. J Crit Care 67 : 44-56, 2021
11) Dominedo C, Ceccato A, Torres A : Ventilator-associated pneumonia : new principles guiding empiric antibiotic therapy. Curr Opin Infect Dis 33 : 182-188, 2020
P.244 掲載の参考文献
12) Cisneros JM, Rosso-Fernandez CM, Roca-Oporto C et al : Colistin versus meropenem in the empirical treatment of ventilator-associated pneumonia (Magic Bullet study) : an investigator-driven, open-label, randomized, noninferiority controlled trial. Crit Care 23 : 383, 2019
13) Wunderink RG, Matsunaga Y, Ariyasu M et al : Cefiderocol versus high-dose, extended-infusion meropenem for the treatment of Gram-negative nosocomial pneumonia (APEKS-NP) : a randomised, double-blind, phase 3, non-inferiority trial. Lancet Infect Dis 21 : 213-225, 2021
14) Zaragoza R, Vidal-Cortes P, Aguilar G et al : Update of the treatment of nosocomial pneumonia in the ICU. Crit Care 24 : 383, 2020
15) Rouby JJ, Sole-Lleonart C, Rello J ; European Investigators Network for Nebulized Antibiotics in Ventilator-associated Pneumonia : Ventilator-associated pneumonia caused by multidrug-resistant Gram-negative bacteria : understanding nebulization of aminoglycosides and colistin. Intensive Care Med 46 : 766-770, 2020
16) Tang R, Luo R, Wu B et al : Effectiveness and safety of adjunctive inhaled antibiotics for ventilator-associated pneumonia : a systematic review and meta-analysis of randomized controlled trials. J Crit Care 65 : 133-139, 202
P.245 掲載の参考文献
17) De Bus L, Depuydt P, Steen J et al : Antimicrobial de-escalation in the critically ill patient and assessment of clinical cure : the DIANA study. Intensive Care Med 46 : 1404-1417, 2020
18) Cowley MC, Ritchie DJ, Hampton N et al : Outcomes -associated with de-escalating therapy for methicillin-resistant staphylococcus aureus in culture-negative nosocomial pneumonia. Chest 155 : 53-59, 2019
19) Francois B, Cariou A, Clere-Jehl R et al : Prevention of early ventilator-associated pneumonia after cardiac arrest. N Engl J Med 381 : 1831-1842, 2019
20) Zhao T, Wu X, Zhang Q et al : Oral hygiene care for critically ill patients to prevent ventilator-associated pneumonia. Cochrane Database Syst Rev 12 : CD008367, 2020
P.246 掲載の参考文献
21) Virk HS, Wiersinga WJ : Current place of probiotics for VAP. Crit Care 23 : 46, 2019
22) Batra P, Soni KD, Mathur P : Efficacy of probiotics in the prevention of VAP in critically ill ICU patients : an updated systematic review and meta-analysis of randomized control trials. J Intensive Care 8 : 81, 2020
23) Johnstone J, Meade M, Lauzier F et al : Effect of probiotics on incident ventilator-associated pneumonia in critically ill patients : a randomized clinical trial. JAMA 326 : 1024-1033, 2021
24) Rouze A, Martin-Loeches I, Povoa P et al : Relationship between SARS-CoV-2 infection and the incidence of ventilator-associated lower respiratory tract infections : a European multicenter cohort study. Intensive Care Med 47 : 188-198, 2021
25) Blonz G, Kouatchet A, Chudeau N et al : Epidemiology and microbiology of ventilator-associated pneumonia in COVID-19 patients : a multicenter retrospective study in 188 patients in an un-inundated French region. Crit Care 25 : 72, 2021
26) Luyt C-E, Sahnoun T, Gautier M et al : Ventilator-associated pneumonia in patients with SARS-CoV-2-associated acute respiratory distress syndrome requiring ECMO : a retrospective cohort study. Ann Intensive Care 10 : 158, 2020
P.247 掲載の参考文献
1) Kuo K, Palmer L : Pathophysiology of hemorrhagic shock. J Vet Emerg Crit Care (San Antonio) 32 : 22-31, 2022
2) Moore EE, Moore HB, Kornblith LZ et al : Trauma-induced coagulopathy. Nat Rev Dis Primers 7 : 30, 2021
P.248 掲載の参考文献
3) Li SR, Guyette F, Brown J et al : Early prehospital tranexamic acid following injury is associated with a 30-day survival benefit : a secondary analysis of a randomized clinical trial. Ann Surg 274 : 419-426, 2021
4) Roberts I, Shakur-Still H, Aeron-Thomas A et al : Tranexamic acid to reduce head injury death in people with traumatic brain injury : the CRASH-3 international RCT. Health Technol Assess 25 : 1-76, 2021
5) Sentilhes L, Senat MV, Le Lous et al : Tranexamic acid for the prevention of blood loss after cesarean delivery. N Engl J Med 384 : 1623-1634, 2021
6) Ribeiro-Junior MAF, Costa CTK, de Souza Augusto S et al : The role of direct peritoneal resuscitation in the treatment of hemorrhagic shock after trauma and in emergency acute care surgery : a systematic review. Eur J Trauma Emerg Surg, 2021 [online ahead of print]
7) Gasior M, Desperak P, Dudek D et al : Multivessel intervention in myocardial infarction with cardiogenic shock : CUL-PRIT-SHOCK trial outcomes in the PLACS registry. J Clin Med 10 : 1832, 2021
P.249 掲載の参考文献
8) Bhatt DL, Lopes RD, Harrington RA : Diagnosis and treatment of acute coronary syndromes : a review. JAMA 327 : 662-675, 2022
9) Miyashita S, Banlengchit R, Marbach JA et al : Left ventricular unloading before percutaneous coronary intervention is associated with improved survival in patients with acute myocardial infarction complicated by cardiogenic shock : a systematic review and meta-analysis. Cardiovasc Revasc Med 10 : S1553-8389 (21) 00717-X, 2021
10) Meani P, Lorusso R, Pappalardo F : ECPella : Concept, physiology and clinical applications. J Cardiothorac Vasc Anesth 36 : 557-566, 2022
11) Belohlavek J, Smalcova J, Rob D et al : Effect of intra-arrest transport, extracorporeal cardiopulmonary resuscitation, and immediate invasive assessment and treatment on functional neurologic outcome in refractory out-of-hospital cardiac arrest : a randomized clinical trial. JAMA 327 : 737-747, 2022
12) Saad M, Kennedy KF, Imran H et al : Association between COVID-19 diagnosis and in-hospital mortality in patients hospitalized with ST-segment elevation myocardial infarction. JAMA 326 : 1940-1952, 2021
P.250 掲載の参考文献
13) Sun LY, Jones PM, Wijeysundera DN et al : Association between handover of anesthesiology care and 1-year mortality among adults undergoing cardiac surgery. JAMA Netw Open 5 : e2148161, 2022
14) Di Vece D, Silverio A, Bellino M et al : Dynamic left intraventricular obstruction phenotype in Takotsubo syndrome. J Clin Med 10 : 3235, 2021
15) Abozenah M, Kadado AJ, Aljamal A et al : Concurring hypertrophic cardiomyopathy and takotsubo cardiomyopathy : assessment and management. Heart Lung 50 : 546-557, 2021
16) Alerhand S, Sundaram T, Gottlieb M : What are the echocardiographic findings of acute right ventricular strain that suggest pulmonary embolism? Anaesth Crit Care Pain Med 40 : 100852, 2021
P.251 掲載の参考文献
17) Takazawa T, Yamaura K, Hara T et al : Practical guidelines for the response to perioperative anaphylaxis. J Anesth 35 : 778-793, 2021
18) Simionescu AA, Danciu BM, Stanescu AMA : Severe anaphylaxis in pregnancy : a systematic review of clinical presentation to determine outcomes. J Pers Med 11 : 1060, 2021
19) Vallabhajosyula S, Shankar A, Vojjini R et al : Impact of right ventricular dysfunction on short-term and long-term mortality in sepsis : a meta-analysis of 1,373 patients. Chest 159 : 2254-2263, 2021
20) Piotti A, Novelli D, Meessen JMTA et al : Endothelial damage in septic shock patients as evidenced by circulating syndecan-1, sphingosine-1-phosphate and soluble VE-cadherin : a substudy of ALBIOS. Crit Care 25 : 113, 2021
21) Saoraya J, Wongsamita L, Srisawat N et al : Plasma syndecan-1 is associated with fluid requirements and clinical outcomes in emergency department patients with sepsis. Am J Emerg Med 42 : 83-89, 2021
22) Hatanaka K, Ito T, Madokoro Y et al : Circulating syndecan-1 as a predictor of persistent thrombocytopenia and lethal outcome : a population study of patients with suspected sepsis requiring intensive care. Front Cardiovasc Med 8 : 730553, 2021
23) Hahn RG, Zdolsek M, Zdolsek J : Plasma concentrations of syndecan-1 are dependent on kidney function. Acta Anaesthesiol Scand 65 : 809-815, 2021
P.252 掲載の参考文献
24) Piva E, Zuin J, Pelloso M et al : Monocyte distribution width (MDW) parameter as a sepsis indicator in intensive care units. Clin Chem Lab Med 59 : 1307-1314, 2021
25) Hausfater P, Robert Boter N, Morales Indiano C et al : Monocyte distribution width (MDW) performance as an early sepsis indicator in the emergency department : comparison with CRP and procalcitonin in a multicenter international European prospective study. Crit Care 25 : 227, 2021
26) Eisinger GJ, Osman W, Prather ER et al : Inflammasome activation in an in vitro sepsis model recapitulates increased monocyte distribution width seen in patients with sepsis. Crit Care Explor 4 : e0631, 2022
27) Lv SJ, Zhang GH, Xia JM et al : Early use of high-dose vitamin C is beneficial in treatment of sepsis. Ir J Med Sci 190 : 1183-1188, 2021
28) May CN, Bellomo R, Lankadeva YR : Therapeutic potential of megadose vitamin C to reverse organ dysfunction in sepsis and COVID-19. Br J Pharmacol 178 : 3864-3868, 2021
P.253 掲載の参考文献
29) Fujii T, Salanti G, Belletti A et al : Effect of adjunctive vitamin C, glucocorticoids, and vitamin B1 on longer-term mortality in adults with sepsis or septic shock : a systematic review and a component network meta-analysis. Intensive Care Med 48 : 16-24, 2022
30) Scholz SS, Borgstedt R, Ebeling N et al : Mortality in septic patients treated with vitamin C : a systematic meta-analysis. Crit Care 25 : 17, 2021
P.254 掲載の参考文献
1) Piroth Z, Boxma-de Klerk BM, Omerovic E et al : The natural history of nonculprit lesions in STEMI : an FFR substudy of the compare-acute trial. JACC Cardiovasc Interv 13 : 954-961, 2020
2) Sheth T, Pinilla-Echeverri N, Moreno R et al : Nonculprit lesion severity and outcome of revascularization in patients with STEMI and multivessel coronary disease. J Am Coll Cardiol 76 : 1277-1286, 2020
P.255 掲載の参考文献
3) Puymirat E, Cayla G, Simon T et al : Multivessel PCI guided by FFR or angiography for myocardial infarction. N Engl J Med 385 : 297-308, 2021
4) Denormandie P, Simon T, Cayla G et al : Compared outcomes of ST-Elevation myocardial infarction patients with multivessel disease treated with primary percutaneous coronary intervention and preserved fractional flow reserve of non-culprit lesions treated conservatively and of those with low fractional flow reserve managed invasively : insights from the FLOWER MI trial. Circ Cardiovasc Interv 14 : e011314, 2021
5) Cerrato E, Mejia-Renteria H, Dehbi HM et al : Revascularization deferral of nonculprit stenoses on the basis of fractional flow reserve : 1-year outcomes of 8,579 patients. JACC Cardiovasc Interv 13 : 1894-1903, 2020
6) Montone RA, Niccoli G, Crea F et al : Management of non-culprit coronary plaques in patients with acute coronary syndrome. Eur Heart J 41 : 3579-3586, 2020
7) Banning AP, Serruys P, De Maria GL et al : Five-year outcomes after state-of-theart percutaneous coronary revascularization in patients with de novo three-vessel disease : final results of the SYNTAX II study. Eur Heart J, 2021
8) Fearon WF, Zimmermann FM, De Bruyne B et al : Fractional flow reserve-guided PCI as compared with coronary bypass surgery. N Engl J Med, 2021 [online ahead of print]
P.256 掲載の参考文献
9) Farooq V, van Klaveren D, Steyerberg EW et al : Anatomical and clinical characteristics to guide decision making between coronary artery bypass surgery and percutaneous coronary intervention for individual patients : development and validation of SYNTAX score II. Lancet 381 : 639-650, 2013
10) Takahashi K, Serruys PW, Fuster V et al : Redevelopment and validation of the SYNTAX score II to individualise decision making between percutaneous and surgical revascularisation in patients with complex coronary artery disease : secondary analysis of the multicentre randomised controlled SYNTAXES trial with external cohort validation. Lancet 396 : 1399-1412, 2020
11) Hara H, Takahashi K, van Klaveren D et al : Sex differences in all-cause mortality in the decade following complex coronary revascularization. J Am Coll Cardiol 76 : 889-899, 2020
12) Kawashima H, Serruys PW, Ono M et al : Impact of optimal medical therapy on 10-year mortality after coronary revascularization. J Am Coll Cardiol 78 : 27-38, 2021
13) Madhavan MV, Howard JP, Naqvi A et al : Long-term follow-up after ultrathin vs. conventional 2nd-generation drug-eluting stents : a systematic review and meta-analysis of randomized controlled trials. Eur Heart J 42 : 2643-2654, 2021
14) Romaguera R, Salinas P, Gomez-Lara J et al : Amphilimus- versus zotarolimuseluting stents in patients with diabetes mellitus and coronary artery disease (SUGAR trial). Eur Heart J hab395, 2021 [online ahead of print]
P.257 掲載の参考文献
15) Jeger RV, Farah A, Ohlow M-A et al : Long-term efficacy and safety of drugcoated balloons versus drug-eluting stents for small coronary artery disease (BASKET-SMALL 2) : 3-year follow-up of a randomised, non-inferiority trial. Lancet 396 : 1504-1510, 2020
16) Giacoppo D, Alfonso F, Xu B et al : Paclitaxel-coated balloon angioplasty vs. drug-eluting stenting for the treatment of coronary in-stent restenosis : a comprehensive, collaborative, individual patient data meta-analysis of 10 randomized clinical trials (DAEDALUS study). Eur Heart J 41 : 3715-3728, 2020
17) Hildick-Smith D, Egred M, Banning A et al : The European bifurcation club left main coronary stent study : a randomized comparison of stepwise provisional vs. systematic dual stenting strategies (EBC MAIN). Eur Heart J 42 : 3829-3839, 2021
18) Jaffer FA, Mehilli J, Escaned J : Left main coronary disease at the bifurcation : should the pendulum swing back towards the provisional stenting approach? Eur Heart J 42 : 3840-3843, 2021
19) Ybarra LF, Rinfret S, Brilakis ES et al : Definitions and clinical trial design principles for coronary artery chronic total occlusion therapies CTO-arc consensus recommendations. Circulation 143 : 479-500, 2021
20) Wu EB, Brilakis ES, Mashayekhi K et al : Global chronic total occlusion crossing algorithm : JACC state-of-the-art review. J Am Coll Cardiol 78 : 840-853, 2021
P.258 掲載の参考文献
21) Beohar N, Kaltenbach LA, Wojdyla D et al : Trends in usage and clinical outcomes of coronary atherectomy : a report from the national cardiovascular data registry CathPCI registry. Circ Cardiovasc Interv 13 : e008239, 2020
22) Kinnaird T, Gallagher S, Sharp A et al : Operator volumes and in-hospital outcomes : an analysis of 7,740 rotational atherectomy procedures from the BCIS national database. JACC Cardiovasc Interv 14 : 1423-1430, 2021
23) Collison D, Didagelos M, Aetesam-ur-Rahman M et al : Post-stenting fractional flow reserve vs coronary angiography for optimization of percutaneous coronary intervention (TARGET-FFR). Eur Heart J 42 : 4656-4668, 2021
24) Hong S-J, Mintz GS, Ahn C-M et al : Effect of intravascular ultrasound-guided drugeluting stent implantation : 5-year follow-up of the IVUS-XPL randomized trial. JACC Cardiovasc Interv 13 : 62-71, 2020
25) Xu B, Tu S, Song L et al : Angiographic quantitative flow ratio- guided coronary intervention (FAVOR III China) : a multicentre, randomised, sham-controlled trial. Lancet 398 : 2149-2159, 2021
P.259 掲載の参考文献
26) Shishikura D, Kataoka Y, Di Giovanni G et al : Progression of ultrasound plaque attenuation and low echogenicity associates with major adverse cardiovascular events. Eur Heart J 41 : 2965-2973, 2020
27) Stone GW, Maehara A, Ali ZA et al : Percutaneous coronary intervention for vulnerable coronary atherosclerotic plaque. J Am Coll Cardiol 76 : 2289-2301, 2020
28) Kamran H, Jneid H, Kayani WT et al : Oral antiplatelet therapy after acute coronary syndrome : a review. JAMA 325 : 1545-1555, 2021
29) Mayer K, Bongiovanni D, Karschin V et al : Ticagrelor or prasugrel for platelet inhibition in acute coronary syndrome patients : the ISAR-REACT 5 Trial. J Am Coll Cardiol 76 : 2569-2571, 2020
30) O'Donoghue ML, Murphy SA, Sabatine MS et al : The safety and efficacy of aspirin discontinuation on a background of a P2Y12 inhibitor in patients after percutaneous coronary intervention : a systematic review and meta-analysis. Circulation 142 : 538-545, 2020
P.261 掲載の参考文献
1) 2021年日本循環器学会/日本心不全学会合同ガイドラインフォーカスアップデート版 急性・慢性心不全診療. https://www.j-circ.or.jp/cms/wp-content/uploads/2021/03/JCS2021_Tsutsui.pdf (2022年3月30日閲覧)
2) McDonagh TA, Metra M, Adamo M et al : 2021 ESC Guidelines for the diagnosis and treatment of acute and chronic heart failure. Eur Heart J 42 : 3599-3726, 2021
3) Bozkurt B, Coats AJS, Tsutsui H et al : Universal definition and classification of heart failure : a report of the Heart Failure Society of America, Heart Failure Association of the European Society of Cardiology, Japanese Heart Failure Society and Writing Committee of the Universal Definition of Heart Failure Endorsed by Canadian Heart Failure Society, Heart Failure Association of India, the Cardiac Society of Australia and New Zealand, and the Chinese Heart Failure Association. J Cardiac Fail 27 : 387-413, 2021
4) Pieske B, Tschope C, de Boer RA et al : How o diagnose heart failure with preserved ejection fraction : the HFA-PEFF diagnostic algorithm : a consensus recommendation from the Heart Failure Association (HFA) of the European Society of Cardiology (ESC). Eur J Heart Fail 22 : 391-412, 2020
5) Boorsma EM, Ter Maaten JM, Damman K et al : Congestion in heart failure : a contemporary look at physiology, diagnosis and treatment. Nat Rev Cardiol 17 : 641-655, 2020
P.262 掲載の参考文献
6) Nunez J, Llacer P, Garcia-Blas S et al : CA125-guided diuretic treatment versus usual care in patients with acute heart failure and renal dysfunction. Am J Med 133 : 370-380, 2020
7) de la Espriella R, Nunez E, Llacer P et al : Early urinary sodium trajectory and risk of adverse outcomes in acute heart failure and renal dysfunction. Rev Esp Cardiol 74 : 616-623, 2021
10) Abdin A, Anker SD, Butler J, et al : 'Time is prognosis' in heart failure : time-to-treatment initiation as a modifiable risk factor. ESC Heart Fail 8 : 4444-4453, 2021
11) Pang PS, Russell FM, Ehrman R et al : Department management of acute heart failure (BLUSHED-AHF) : a randomized controlled pilot trial. J Am Coll Cardiol 9 : 638-648, 2021
263
P.264 掲載の参考文献
13) DeVore AD, Braunwald E, Morrow DA et al : Initiation of angiotensin-neprilysin inhibition after acute decompensated heart failure secondary analysis of the openlabel extension of the PIONEER-HF trial. JAMA Cardiol 5 : 202-207, 2020
14) Bhatt DL, Szarek M, Steg PG et al : Sotagliflozin in patients with diabetes and recent worsening heart failure. N Engl J Med 384 : 117-128, 2020
15) Damman K, Beusekamp JC, Boorsma EM et al : Randomized, double-blind, placebo-controlled, multicentre pilot study on the effects of empagliflozin on clinical outcomes in patients with acute decompensated heart failure (EMPA-RESPONSEAHF). Eur J Heart Fail 22 : 713-722, 2020
P.265 掲載の参考文献
16) Mentz RJ, DeVore AD, Tasissa G et al : PredischaRge initiation of Ivabradine in the ManagEment of heart failure : results of the PRIME-HF Trial. Am Heart J 223 : 98-105, 2020
17) Armstrong PW, Pieske B, Anstrom KJ et al : Vericiguat in patients with heart failure and reduced ejection fraction. N Engl J Med 382 : 1883-1893, 2020
18) Cox ZL, Hung R, Lenihan DJ et al : Diuretic strategies for loop diuretic resistance in acute heart failure. J Am Coll Cardiol 8 : 157-168, 2020
P.266 掲載の参考文献
19) Ponikowski P, Kirwan B-A, Anker SD et al : Ferric carboxymaltose for iron deficiency at discharge after acute heart failure : a multicentre, double-blind, randomised, controlled trial. Lancet 396 : 1895-1904, 2020
20) Kitzman DW, Whellan DJ, Duncan P et al : Physical rehabilitation for older patients hospitalized for heart failure. N Engl J Med 385 : 203-216, 2021
P.267 掲載の参考文献
1) 2019 AHA/ACC/HRS Focused update of the 2014 AHA/ACC/HRS Guideline for the management of patients with atrial fibrillation. Circulation 140 : e125-151, 2019
2) Hindricks G, Potpara T, Dagres N et al : 2020 ESC Guidelines for the diagnosis and management of atrial fibrillation developed in collaboration with the European Association for Cardio-Thoracic Surgery (EACTS). Eur Heart J 42 : 373-498, 2020
P.268 掲載の参考文献
3) 小野克重, 岩崎雄樹, 清水 渉他 : 2020年改訂版不整脈薬物治療ガイドライン. 日本循環器学会/日本不整脈心電学会合同ガイドライン 2020 https://www.j-circ.or.jp/cms/wp-content/uploads/2020/01/JCS2020_Ono.pdf (2022年2月14日閲覧)
5) Yasuda S, Kaikita K, Akao M et al : Antithrombotic therapy for atrial fibrillation with stable coronary disease. N Engl J Med 381 : 1103-1113, 2019
6) Okumura K, Akao M, Yoshida T et al : Low-dose edoxaban in very elderly patients with atrial fibrillation. N Engl J Med 383 : 1735-1745, 2020
P.269 掲載の参考文献
7) 栗田隆志, 野上昭彦他 : 不整脈非薬物治療ガイドライン (2018年改訂版). 日本循環器学会/日本不整脈心電学会合同ガイドライン 2019 https://www.j-circ.or.jp/cms/wp-content/uploads/2018/07/JCS2018_kurita_nogami.pdf (2022年2月14日閲覧)
8) Packer DL, Mark DB, Robb RA et al ; CABANA Investigators : Effect of catheter ablation vs antiarrhythmic drug therapy on mortality, stroke, bleeding, and cardiac arrest among patients with atrial fibrillation : the CABANA randomized clinical trial. JAMA 321 : 1261-1274, 2019
9) Turagam MK, Garg J, Whang W et al : Catheter ablation of atrial fibrillation in patients with heart failure : a meta-analysis of randomized controlled trials. Ann Intern Med 170 : 41-50, 2019
10) 栗田隆志, 野上昭彦他 : 2021年JCS/JHRSガイドライン フォーカスアップデート版 不整脈非薬物治療. 日本循環器学会/日本不整脈心電学会合同ガイドライン 2021 https://www.j-circ.or.jp/cms/wp-content/uploads/2021/03/JCS2021_Kurita_Nogami.pdf (2022年2月14日閲覧)
P.270 掲載の参考文献
11) Kirchhof P, Camm AJ, Goette A et al ; EAST-AFNET 4 Trial Investigators : Early rhythm-control therapy in patients with atrial fibrillation. N Engl J Med 383 : 1305-1316, 2020
12) Marrouche NF, Brachmann J, Andresen D et al ; CASTLE-AF Investigators : Catheter ablation for atrial fibrillation with heart failure. N Engl J Med 378 : 417-427, 2018
13) Sohns C, Zintl K, Zhao Y et al : Impact of left ventricular function and heart failure symptoms on outcomes post ablation of atrial fibrillation in heart failure : CASTLE-AF trial. Circ Arrhythm Electrophysiol 13 : e008461, 2020
P.271 掲載の参考文献
14) Nogami A, Harada T, Sekiguchi Y et al ; ABRIDGE-J (Ablation Perioperative Dabigatran in Use Envisioning in Japan) Investigators : Safety and efficacy of minimally interrupted dabigatran vs uninterrupted warfarin therapy in adults undergoing atrial fibrillation catheter ablation : a randomized clinical trial. JAMA Netw Open 2 : e191994, 2019
15) Kimata A, Nogami A, Yamasaki H et al : Optimal interruption time of dabigatran oral administration to ablation (OA time) in patients with atrial fibrillation : integrated analysis of 2 randomized controlled clinical trials. J Cardiol S0914-5087 (20) 30414-7, 2021
16) Nakamura K, Naito S, Sasaki T et al : Uninterrupted vs. interrupted periprocedural direct oral anticoagulants for catheter ablation of atrial fibrillation : a prospective randomized single-centre study on postablation thrombo-embolic and haemorrhagic events. Europace 21 : 259-267, 2019
17) Aonuma K, Yamasaki H, Nakamura M et al : Percutaneous WATCHMAN left atrial appendage closure for Japanese patients with nonvalvular atrial fibrillation at increased risk of thromboembolism-first results from the SALUTE trial. Circ J 82 : 2946-2953, 2018
18) Aonuma K, Yamasaki H, Nakamura M et al : Efficacy and safety of left atrial appendage closure with WATCHMAN in Japanese nonvalvular atrial fibrillation patients-final 2-year follow-up outcome data from the SALUTE trial. Circ J 84 : 1237-1243, 2020
P.272 掲載の参考文献
19) Osmancik P, Herman D, Neuzil P et al ; PRAGUE-17 Trial Investigators : Left atrial appendage closure versus direct oral anticoagulants in high-risk patients with atrial fibrillation. J Am Coll Cardiol 75 : 3122-3135, 2020
P.273 掲載の参考文献
1) Evans L, Rhodes A, Alhazzani W et al : Surviving sepsis campaign : international guidelines for management of sepsis and septic shock 2021. Intensive Care Med 47 : 1181-1247, 2021
2) Kumar A, Roberts D, Wood KE et al : Duration of hypotension before initiation of effective antimicrobial therapy is the critical determinant of survival in human septic shock. Crit Care Med 34 : 1589-1596, 2006
3) Ferrer R, Martin-Loeches I, Phillips G et al : Empiric antibiotic treatment reduces mortality in severe sepsis and septic shock from the first hour : results from a guideline-based performance improvement program. Crit Care Med 42 : 1749-1755, 2014
P.274 掲載の参考文献
4) Bloos F, Ruddel H, Thomas-Ruddel D et al : Effect of a multifaceted educational intervention for anti-infectious measures on sepsis mortality : a cluster randomized trial. Intensive Care Med 43 : 1602-1612, 2017
5) Alam N, Oskam E, Stassen PM et al : Prehospital antibiotics in the ambulance for sepsis : a multicentre, open label, randomised trial. Lancet Respir Med 6 : 40-50, 2018
P.275 掲載の参考文献
6) Bartoletti M, Giannella M, Lewis RE et al : Extended infusion of β-lactams for bloodstream infection in patients with liver cirrhosis : an observational multicenter study. Clin Infect Dis 69 : 1731-1739, 2019
7) Zembles TN, Schortemeyer R, Kuhn EM et al : Extended infusion of beta-lactams is associated with improved outcomes in pediatric patients. J Pediatr Pharmacol Ther 26 : 187-193, 2021
P.276 掲載の参考文献
8) Kumar A, Ellis P, Arabi Y et al : Initiation of inappropriate antimicrobial therapy results in a fivefold reduction of survival in human septic shock. Chest 136 : 1237-1248, 2009
9) Rybak MJ, Le J, Lodise TP et al : Therapeutic monitoring of vancomycin for serious methicillin-resistant Staphylococcus aureus infections : a revised consensus guideline and review by the American Society of Health-System Pharmacists, the Infectious Diseases Society of America, the Pediatric Infectious Diseases Society, and the Society of Infectious Diseases Pharmacists. Clin Infect Dis 71 : 1361-1364, 2020
10) Neely MN, Kato L, Youn G et al : Prospective trial on the use of trough concentration versus area under the curve to determine therapeutic vancomycin dosing. Antimicrob Agents Chemother 62 : e02042-17, 2018
11) Oda K, Jono H, Nosaka K et al : Reduced nephrotoxicity with vancomycin therapeutic drug monitoring guided by area under the concentration-time curve against a trough 15-20 μg/mL concentration. Int J Antimicrob Agents 56 : 106109, 2020
P.277 掲載の参考文献
12) Daikos GL, Tsaousi S, Tzouvelekis LS et al : Carbapenemase-producing Klebsiella pneumoniae bloodstream infections : lowering mortality by antibiotic combination schemes and the role of carbapenems. Antimicrob Agents Chemother 58 : 2322-2328, 2014
13) Infectious Diseases Society of America : Guidance on the treatment of antimicrobial resistant gram-negative infections. IDSA, 2020.9.8 https://www.idsociety.org/practice-guideline/amr-guidance/ (2022年1月8日閲覧)
14) Tamma PD, Aitken SL, Bonomo RA et al : Infectious Diseases Society of America Guidance on the Treatment of Extended-Spectrum beta-lactamase Producing Enterobacterales (ESBL-E), Carbapenem-Resistant Enterobacterales (CRE), and Pseudomonas aeruginosa with Difficult-to-Treat Resistance (DTR-P. aeruginosa). Clin Infect Dis 72 : e169-e183, 2021
15) Kohno S, Bando H, Yoneyama F et al : The safety and efficacy of relebactam/imipenem/cilastatin in Japanese patients with complicated intra-abdominal infection or complicated urinary tract infection : a multicenter, open-label, noncomparative phase 3 study. J Infect Chemother 27 : 262-270, 2021
P.278 掲載の参考文献
16) Suzuki H, Hitomi S, Yaguchi Y et al : Prospective intervention study with a microarray-based, multiplexed, automated molecular diagnosis instrument (Verigene system) for the rapid diagnosis of bloodstream infections, and its impact on the clinical outcomes. J Infect Chemother 21 : 849-856, 2015
P.279 掲載の参考文献
1) Singer M, Deutschman CS, Seymour CW et al : The third international consensus definitions for sepsis and septic shock (Sepsis-3). JAMA 315 : 801-810, 2016
P.280 掲載の参考文献
3) Egi M, Ogura H, Yatabe T et al : The Japanese clinical practice guidelines for management of sepsis and septic shock 2020 (J-SSCG 2020). J Intensive Care 9 : 53, 2021
4) Seymour CW, Liu VX, Iwashyna TJ et al : Assessment of clinical criteria for sepsis : for the third international consensus Definitions for sepsis and septic shock (Sepsis-3). JAMA 315 : 762-774, 2016
5) 松田直之 : 敗血症の診断と治療. "集中治療医学レビュー 2020-'21" 大塚将秀, 佐藤直樹, 松田直之編. pp 205-211, 総合医学社, 東京, 2020
6) Evans L, Rhodes A, Alhazzani W et al : Surviving sepsis campaign : international guidelines for management of sepsis and septic shock 2021. Intensive Care Med 47 : 1181-1247, 2021
7) Usman OA, Usman AA, Ward MA : Comparison of SIRS, qSOFA, and NEWS for the early identification of sepsis in the emergency department. Am J Emerg Med 37 : 1490-1497, 2019
8) Jones M : NEWSDIG. The national early warning score development and implementation group. Clin Med (Lond) 12 : 501-503, 2012
9) National Early Warning Score (NEWS) 2 https://www.rcplondon.ac.uk/projects/outputs/national-early-warning-scorenews-2 (2022年3月30日閲覧)
10) Sabir L, Ramlakhan S, Goodacre S : Comparison of qSOFA and Hospital Early Warning Scores for prognosis in suspected sepsis in emergency department patients : a systematic review. Emerg Med J 39 : 284-294, 2022
11) Alencar J, Marina Gomez Gomez L, Cortez AL et al : Performance of NEWS, qSOFA, and SIRS scores for assessing mortality, early bacterial infection, and admission to ICU in COVID-19 patients in the emergency department. Front Med (Lausanne) 9 : 779516, 2022
P.281 掲載の参考文献
12) Kaukonen KM, Bailey M, Pilcher D et al : Systemic inflammatory response syndrome criteria in defining severe sepsis. N Engl J Med 372 : 1629-1638, 2015
13) Oduncu AF, Kiyan GS, Yalcinli S : Comparison of qSOFA, SIRS, and NEWS scoring systems for diagnosis, mortality, and morbidity of sepsis in emergency department. Am J Emerg Med 48 : 54-59, 2021
14) Ruangsomboon O, Boonmee P, Limsuwat C et al : The utility of the rapid emergency medicine score (REMS) compared with SIRS, qSOFA and NEWS for Predicting in-hospital Mortality among Patients with suspicion of Sepsis in an emergency department. BMC Emerg Med 21 : 2, 2021
15) Azijli K, Minderhoud T, Mohammadi P et al : A prospective, observational study of the performance of MEWS, NEWS, SIRS and qSOFA for early risk stratification for adverse outcomes in patients with suspected infections at the emergency department. Acute Med 20 : 116-124, 2021
16) Latten GHP, Polak J, Merry AHH et al : Frequency of alterations in qSOFA, SIRS, MEWS and NEWS scores during the emergency department stay in infectious patients : a prospective study. Int J Emerg Med 14 : 69, 2021
P.282 掲載の参考文献
17) Wattanasit P, Khwannimit B : Comparison the accuracy of early warning scores with qSOFA and SIRS for predicting sepsis in the emergency department. Am J Emerg Med 46 : 284-288, 2021
18) Clar J, Oltra MR, Benavent R et al : Prognostic value of diagnostic scales in community-acquired sepsis mortality at an emergency service. Prognosis in community-adquired sepsis. BMC Emerg Med 21 : 161, 2021
19) Pairattanakorn P, Angkasekwinai N, Sirijatuphat R et al : Diagnostic and prognostic utility compared among different sepsis scoring systems in adult patients with sepsis in Thailand : a prospective cohort study. Open Forum Infect Dis 8 : ofaa573, 2020
20) Lind ML, Mooney SJ, Carone M et al : Development and validation of a machine learning model to estimate bacterial sepsis among immunocompromised recipients of stem cell transplant. JAMA Netw Open 4 : e214514, 2021
21) Bedoya AD, Futoma J, Clement ME et al : Machine larning for early detection of sepsis : an internal and temporal validation study. JAMIA Open 3 : 252-260, 2020
22) David S, Bode C, Putensen C et al : Adjuvant therapeutic plasma exchange in septic shock. Intensive Care Med 47 : 352-354, 2021
23) Weng J, Chen M, Fang D et al : Therapeutic plasma exchange protects patients with sepsis-associated disseminated intravascular coagulation by improving endothelial function. Clin Appl Thromb Hemost 27 : 10760296211053313, 2021
24) Taylor FB Jr, Toh CH, Hoots WK et al : Towards definition, clinical and laboratory criteria, and a scoring system for disseminated intravascular coagulation. Thromb Haemost 86 : 1327-1330, 2001
25) Matsuda N, Teramae H, Yamamoto S et al : Increased death receptor pathway of apoptotic signaling in septic mouse aorta : effect of systemic delivery of FADD siRNA. Am J Physiol Heart Circ Physiol 298 : H92-101, 2010
26) Villalba N, Baby S, Yuan SY : The endothelial glycocalyx as a double-edged sword in microvascular homeostasis and pathogenesis. Front Cell Dev Biol 9 : 711003, 2021
27) Stahl K, Hillebrand UC, Kiyan Y et al : Effects of therapeutic plasma exchange on the endothelial glycocalyx in septic shock. Intensive Care Med Exp 9 : 57, 2021
P.283 掲載の参考文献
28) Stahl K, Bikker R, Seeliger B et al : Effect of therapeutic plasma exchange on immunoglobulin deficiency in early and severe septic shock. J Intensive Care Med 36 : 1491-1497, 2021
29) Kakihana Y, Nishida O, Taniguchi T et al : Efficacy and safety of landiolol, an ultra-short-acting β1-selective antagonist, for treatment of sepsis-related tachyarrhythmia (J-Land 3S) : a multicentre, open-label, randomised controlled trial. Lancet Respir Med 8 : 863-872, 2020
30) Matsuda N, Nishida O, Taniguchi T et al : Impact of patient characteristics on the efficacy and safety of landiolol in patients with sepsis-related tachyarrhythmia : subanalysis of the J-Land 3S randomised controlled study. EClinicalMedicine 28 : 100571, 2020
31) Hawn JM, Bauer SR, Yerke J et al : Effect of phenylephrine push before continuous infusion norepinephrine in patients with septic shock. Chest 159 : 1875-1883, 2021
32) Patel VV, Sullivan JB, Cavanaugh J : Analysis of mortality in patients treated with phenylephrine in septic shock. J Pharm Pract 8971900211000218, 2021
P.284 掲載の参考文献
34) Jain G, Singh DK : Comparison of phenylephrine and norepinephrine in the management of dopamine-resistant septic shock. Indian J Crit Care Med 14 : 29-34, 2010
35) Chen C, Pang L, Wang Y et al : Combination era, using combined vasopressors showed benefits in treating septic shock patients : a network meta-analysis of randomized controlled trials. Ann Transl Med 7 : 535, 2019
36) Brown RA, Dixon J, Farmer JB et al : Dopexamine : a novel agonist at peripheral dopamine receptors and beta 2-adrenoceptors. Br J Pharmacol 85 : 599-608, 1985
37) Bangash MN, Abbott TEF, Patel NSA et al : The effect of β2-Adrenoceptor agonists on leucocyte-endothelial adhesion in a rodent model of laparotomy and endotoxemia. Front Immunol 11 : 1001, 2020
38) Ito T, Kakuuchi M, Maruyama I : Endotheliopathy in septic conditions : mechanistic insight into intravascular coagulation. Crit Care 25 : 95, 2021
39) Hattori Y, Hattori K, Machida T, Matsuda N : Vascular endotheliitis associated with infections : its pathogenetic role and therapeutic implication. Biochem Pharmacol 197 : 114909, 2022
40) Clere-Jehl R, Merdji H, Kassem M et al : A translational investigation of IFN-α and STAT1 signaling in endothelial cells during septic shock provides therapeutic perspectives. Am J Respir Cell Mol Biol 65 : 167-175, 2021
41) Chaudhary H, Ramaswamy S, Qaiser Y et al : Lemierre's syndrome with severe thrombocytopenia without disseminated intravascular coagulation : a case report and literature review. Am J Med Case Rep 9 : 158-162, 2021
P.285 掲載の参考文献
42) Irie Y, Hoshino K, Kawano Y et al : Relationship between serum zinc level and sepsis-induced coagulopathy. Int J Hematol 115 : 87-95, 2022
43) Prasad AS, Bao B : Molecular mechanisms of zinc as a pro-antioxidant mediator : clinical therapeutic implications. antioxidants (Basel) 8 : 164, 2019
44) Wendisch D, Dietrich O, Mari T et al : SARS-CoV-2 infection triggers profibrotic macrophage responses and lung fibrosis. Cell 184 : 6243-6261, 2021
45) Cheng P, Li S, Chen H : Macrophages in lung injury, repair, and fibrosis. Cells 10 : 436, 2021
46) Anderko RR, Gomez H, Canna SW et al : Sepsis with liver dysfunction and coagulopathy predicts an inflammatory pattern of macrophage activation. Intensive Care Med Exp 10 : 6, 2022
47) Imaeda T, Nakada TA, Takahashi N et al : Trends in the incidence and outcome of sepsis using data from a Japanese nationwide medical claims database-the Japan Sepsis Alliance (JaSA) study group. Crit Care 25 : 338, 2021
48) 総務省報道資料 : 統計からみた我が国の高齢者. 令和3年9月19日 https://www.stat.go.jp/data/topics/pdf/topics129.pdf (2022年3月30日閲覧)
49) Takahashi K, Umemura Y, Yamakawa K et al : Age is associated with the efficacy of anticoagulant therapies against sepsis-induced disseminated intravascular coagulation. Clin Appl Thromb Hemost 27 : 10760296211033030, 2021
P.287 掲載の参考文献
1) Evans L, Rhodes A, Alhazzani W et al : Surviving Sepsis Campaign : International Guidelines for Management of Sepsis and Septic Shock. Crit Care Med 49 : e1063-e1143, 2021
2) Egi M, Ogura H, Yatabe T et al : The Japanese Clinical Practice Guidelines for Management of Sepsis and Septic Shock 2020 (J-SSCG 2020). Acute Med Surg 8 : e659, 2021
P.288 掲載の参考文献
3) Iba T, Watanabe E, Umemura Y et al : Sepsis-associated disseminated intravascular coagulation and its differential diagnoses. J Intensive Care Med 7, 2019
4) Vincent J-L, Francois B, Zabolotskikh I et al : Effect of a recombinant human soluble thrombomodulin on mortality in patients with sepsis-associated coagulopathy : the SCARLET randomized clinical trial. JAMA 321 : 1993-2002, 2019
5) van der Poll T : Recombinant human soluble thrombomodulin in patients with sepsis-associated coagulopathy : another negative sepsis trial? JAMA 321 : 1978-1980, 2019
P.289 掲載の参考文献
6) Francois B, Fiancette M, Helms J et al : Efficacy and safety of human soluble thrombomodulin (ART-123) for treatment of patients in France with sepsis-associated coagulopathy : post hoc analysis of SCARLET. Ann Intensive Care 11 : 53, 2021
7) Levi M, Vincent J-L, Tanaka K et al : Effect of a recombinant human soluble thrombomodulin on baseline coagulation biomarker levels and mortality outcome in patients with sepsis-associated coagulopathy. Crit Care Med 48 : 1140-1147, 2020
8) Matsubara T, Yamakawa K, Umemura Y et al : Significance of plasma fibrinogen level and antithrombin activity in sepsis : a multicenter cohort study using a cubic spline model. Thromb Res 181 : 17-23, 2019
P.290 掲載の参考文献
9) Okamoto H, Muraki I, Okada H et al : Recombinant antithrombin attenuates acute respiratory distress syndrome in experimental endotoxemia. Am J Pathol 191 : 1526-1536, 2021
10) Yamakawa K, Gando S, Ogura H et al : Identifying sepsis populations benefitting from anticoagulant therapy : a prospective cohort study incorporating a restricted cubic spline regression Model. Thromb Haemost 119 : 1740-1751, 2019
11) Valeriani E, Squizzato A, Gallo A et al : Efficacy and safety of recombinant human soluble thrombomodulin in patients with sepsis-associated coagulopathy : a systematic review and meta-analysis. J Thromb Haemost 18 : 1618-1625, 2020
12) Kudo D, Goto T, Uchimido R et al : Coagulation phenotypes in sepsis and effects of recombinant human thrombomodulin : an analysis of three multicentre observational studies. Crit Care 25 : 114, 2021
P.291 掲載の参考文献
13) Murao S, Yamakawa K : A systematic summary of systematic reviews on anticoagulant therapy in sepsis. J Clin Med Res 8 : 1869, 2019
14) Kamijo H, Mochizuki K, Nakamura Y et al : Nafamostat mesylate improved survival outcomes of sepsis patients who underwent blood purification : a nationwide registry study in Japan. J Clin Med Res 9 : 2629, 2020
P.292 掲載の参考文献
15) Mochizuki K, Mori K, Kamijo H et al : Beneficial effect modification on survival outcome of sepsis between ART-123 and polymyxin B-immobilised haemoperfusion : a nationwide Japanese registry study. Ann Intensive Care 10 : 57, 2020
16) Iba T, Levy JH, Thachil J et al ; Scientific and Standardization Committee on DIC of the International Society on Thrombosis and Haemostasis : The progression from coagulopathy to disseminated intravascular coagulation in representative underlying diseases. Thromb Res 179 : 11-14, 2019
17) Gando S, Shiraishi A, Wada T et al : A multicenter prospective validation study on disseminated intravascular coagulation in trauma-induced coagulopathy. J Thromb Haemost 18 : 2232-2244, 2020
18) Wada T, Shiraishi A, Gando S et al : Disseminated intravascular coagulation immediately after trauma predicts a poor prognosis in severely injured patients. Sci Rep 11 : 11031, 2021
19) The CRASH-3 trial collaborators : Effects of tranexamic acid on death, disability, vascular occlusive events and other morbidities in patients with acute traumatic brain injury (CRASH-3) : a randomised, placebo-controlled trial. Lancet 394 : 1713-1723, 2019
P.293 掲載の参考文献
20) Rowell SE, Meier EN, McKnight B et al : Effect of out-of-hospital tranexamic acid vs placebo on 6-month functional neurologic outcomes in patients with moderate or severe traumatic brain injury. JAMA 324 : 961-974, 2020
21) Itagaki Y, Hayakawa M, Maekawa K et al : Early administration of fibrinogen concentrate is associated with improved survival among severe trauma patients : a single-centre propensity score-matched analysis. World J Emerg Surg 15 : 7, 2020
22) Hamada SR, Pirracchio R, Beauchesne J et al : Effect of fibrinogen concentrate administration on early mortality in traumatic hemorrhagic shock : a propensity score analysis. J Trauma Acute Care Surg 88 : 661-670, 2020
P.294 掲載の参考文献
1) Rudd KE, Johnson SC, Agesa KM et al : Global, regional, and national sepsis incidence and mortality, 1990-2017 : analysis for the Global Burden of Disease Study. Lancet 395 : 200-211, 2020
2) Zhang Z, Spieth PM, Chiumello D et al : Declining mortality in patients with acute respiratory distress syndrome : an analysis of the acute respiratory distress syndrome network trials. Crit Care Med 47 : 315-323, 2019
P.295 掲載の参考文献
3) Inoue S, Hatakeyama J, Kondo Y et al : Post-intensive care syndrome : its pathophysiology, prevention, and future directions. Acute Med Surg 6 : 233-246, 2019
5) Egi M, Ogura H, Yatabe T et al : The Japanese Clinical Practice Guidelines for Management of Sepsis and Septic Shock 2020 (JSSCG 2020). J Intensive Care 9 : 53, 2021
6) Evans L, Rhodes A, Alhazzani W et al : Surviving sepsis campaign : international guidelines for management of sepsis and septic shock 2021. Intensive Care Med 47 : 1181-1247, 2021
7) Kawakami D, Fujitani S, Morimoto T et al : Prevalence of post-intensive care syndrome among Japanese intensive care unit patients : a prospective, multicenter, observational J-PICS study. Crit Care 25 : 69, 2021
8) Martillo M, Dangayach N, Tabacof L et al : Postintensive care syndrome in survivors of critical illness related to coronavirus disease 2019 : cohort study from a New York City Critical Care Recovery Clinic. Crit Care Med 49 : 1427-1438, 2021
9) Morin L, Savale L, Pham T et al : Fourmonth clinical status of a cohort of patients after hospitalization for COVID-19. JAMA 325 : 1525-1534, 2021
10) Hirshberg EL, Wilson EL, Stanfield V et al : Impact of critical illness on resource utilization : a comparison of use in the year before and after ICU admission. Crit Care Med 47 : 1497-1504, 2019
11) Kamdar BB, Suri R, Suchyta MR et al : Return to work after critical illness : a systematic review and meta-analysis. Thorax 75 : 17-27, 2020
12) Khandelwal N, Hough CL, Downey L et al : Prevalence, risk factors, and outcomes of financial stress in survivors of critical illness. Crit Care Med 46 : e530-e539, 2018
13) Yanagi N, Kamiya K, Hamazaki N et al : Post-intensive care syndrome as a predictor of mortality in patients with critical illness : a cohort study. PloS one 16 : e0244564, 2021
14) Marra A, Pandharipande PP, Girard TD et al : Co-occurrence of post-intensive care syndrome problems among 406 survivors of critical illness. Crit Care Med 46 : 1393-1401, 2018
P.296 掲載の参考文献
15) Parry SM, Nalamalapu SR, Nunna K et al : Six-Minute walk distance after critical illness : a systematic review and meta-analysis. J Intensive Care Med 36 : 343-351, 2021
16) Van Aerde N, Meersseman P, Debaveye Y et al : Five-year impact of ICU-acquired neuromuscular complications : a prospective, observational study. Intensive Care Med 46 : 1184-1193, 2020
17) Puthucheary ZA, Gensichen JS, Cakiroglu AS et al : Implications for post critical illness trial design : sub-phenotyping trajectories of functional recovery among sepsis survivors. Crit Care 24 : 577, 2020
18) Fernandez-Gonzalo S, Navarra-Ventura G, Bacardit N et al : Cognitive phenotypes 1 month after ICU discharge in mechanically ventilated patients : a prospective observational cohort study. Crit Care 24 : 618, 2020
19) Unoki T, Sakuramoto H, Uemura S et al : Prevalence of and risk factors for postintensive care syndrome : Multicenter study of patients living at home after treatment in 12 Japanese intensive care units, SMAP-HoPe study. PloS one 16 : e0252167, 2021
20) Tripathy S, Acharya SP, Singh S et al : Post traumatic stress symptoms, anxiety, and depression in patients after intensive care unit discharge - a longitudinal cohort study from a LMIC tertiary care centre. BMC psychiatry 20 : 220, 2020
21) Boede M, Gensichen JS, Jackson JC et al : Trajectories of depression in sepsis survivors : an observational cohort study. Crit Care 25 : 161, 2021
22) Riegel B, Huang L, Mikkelsen ME et al : Early post-intensive care syndrome among older adult sepsis survivors receiving home care. J Am Geriatr Soc 67 : 520-526, 2019
23) Darvall JN, Bellomo R, Paul E et al : Routine frailty screening in critical illness : a population-based cohort study in Australia and New Zealand. Chest 160 : 1292-1303, 2021
24) Harlan EA, Miller J, Costa DK et al : Emotional experiences and coping strategies of family members of critically ill patients. Chest 158 : 1464-1472, 2020
25) Wintermann GB, Petrowski K, Weidner K et al : Impact of post-traumatic stress symptoms on the health-related quality of life in a cohort study with chronically critically ill patients and their partners : age matters. Crit Care 23 : 39, 2019
P.297 掲載の参考文献
26) Zante B, Camenisch SA, Schefold JC : Interventions in post-intensive care syndrome-family : a systematic literature review. Crit Care Med 48 : e835-e840, 2020
27) Mikkelsen ME, Still M, Anderson BJ et al : Society of Critical Care Medicine's International Consensus Conference on Prediction and Identification of Long-Term Impairments After Critical Illness. Crit Care Med 48 : 1670-1679, 2020
28) Turan Z, Topaloglu M, Ozyemisci Taskiran O : Medical Research Councilsumscore : a tool for evaluating muscle weakness in patients with post-intensive care syndrome. Crit Care 24 : 562, 2020
29) Nakamura K, Kawasaki A, Suzuki N et al : Grip strength correlates with mental health and quality of life after critical care : a retrospective study in a postintensive care syndrome Clinic. J Clin Med 10 : 3044, 2021
30) Nakanishi N, Liu K, Kawakami D et al : Post-intensive care syndrome and its new challenges in coronavirus disease 2019 (COVID-19) pandemic : a review of recent advances and perspectives. J Clin Med 10 : 3870, 2021
31) Whooley MA, Avins AL, Miranda J et al : Case-finding instruments for depression. two questions are as good as many. J Gen Intern Med 12 : 439-445, 1997
32) Levis B, Sun Y, He C et al : Accuracy of the PHQ-2 alone and in combination with the PHQ-9 for screening to detect major depression : systematic review and meta-analysis. Jama 323 : 2290-2300, 2020
33) Hosey MM, Leoutsakos JS, Li X et al : Screening for posttraumatic stress disorder in ARDS survivors : validation of the Impact of Event Scale-6 (IES-6). Crit Care 23 : 276, 2019
P.298 掲載の参考文献
35) Liu K, Nakamura K, Katsukawa H et al : Implementation of the ABCDEF bundle for critically ill ICU patients during the COVID-19 pandemic : a multi-national 1-day point prevalence study. Front Med (Lausanne) 8 : 735860-735860, 2021
36) Hsieh SJ, Otusanya O, Gershengorn HB et al : Staged implementation of awakening and breathing, coordination, delirium monitoring and management, and early mobilization bundle improves patient outcomes and reduces hospital costs. Crit Care Med 47 : 885-893, 2019
P.299 掲載の参考文献
1) Harshman J, Roy M, Cartotto R : Emergency care of the burn patient before the burn center : a systematic review and meta-analysis. J Burn Care Res 40 : 166-188, 2019
P.300 掲載の参考文献
2) 佐々木淳一, 松嶋麻子, 池田弘人他 : 日本熱傷学会熱傷診療ガイドライン〔改訂第3版〕. 熱傷 47 : S1-S108, 2021
P.301 掲載の参考文献
3) Lan X, Huang Z, Tan Z et al : Nebulized heparin for inhalation injury in burn patients : a systematic review and meta-analysis. Burns Trauma 8 : tkaa015, 2020
4) Kubo T, Osuka A, Kabata D et al : Chest physical therapy reduces pneumonia following inhalation injury. Burns 47 : 198-205, 2021
5) Coutris N, Gawaziuk JP, Cristall N et al : Interrupted nutrition support in patients with burn injuries : a single-centre observational study. Plast Surg (Oakv) 27 : 334-339, 2019
6) Carmichael H, Joyce S, Smith T et al : Safety and efficacy of intraoperative gastric feeding during burn surgery. Burns 45 : 1089-1093, 2019
7) Pham CH, Fang M, Vrouwe SQ et al : Evaluating the safety and efficacy of intraoperative enteral nutrition in critically ill burn patients : a systematic review and meta-analysis. J Burn Care Res 41 : 841-848, 2020
8) Karlsson M, Elmasry M, Steinvall I et al : Biosynthetic cellulose compared to porcine xenograft in the treatment of partialthickness burns : a randomised clinical trial. Burns, 2021 [online ahead of print]
9) Manzoor S, Khan FA, Muhammad S et al : Comparative study of conventional and topical heparin treatment in second degree burn patients for burn analgesia and wound healing. Burns 45 : 379-386, 2019
P.302 掲載の参考文献
10) Lin DZ, Kao YC, Chen C et al : Negative pressure wound therapy for burn patients : a meta-analysis and systematic review. Int Wound J 18 : 112-123, 2021
11) Abdel-Aal NM, Allam NM, Eladl HM : Efficacy of whole-body vibration on balance control, postural stability, and mobility after thermal burn injuries : a prospective randomized controlled trial. Clin Rehabil 35 : 1555-1565, 2021
12) Gittings PM, Wand BM, Hince DA et al : The efficacy of resistance training in addition to usual care for adults with acute burn injury : a randomised controlled trial. Burns 47 : 84-100, 2021
13) Davodabady F, Naseri-Salahshour V, Sajadi M et al : Randomized controlled trial of the foot reflexology on pain and anxiety severity during dressing change in burn patients. Burns 47 : 215-221, 2021
14) Alinia-Najjar R, Bagheri-Nesami M, Shorofi SA et al : The effect of foot reflexology massage on burn-specific pain anxiety and sleep quality and quantity of patients hospitalized in the burn intensive care unit (ICU). Burns 46 : 1942-1951, 2020
15) Monsalve-Duarte S, Betancourt-Zapata W, Suarez-Canon N et al : Music therapy and music medicine interventions with adult burn patients : a systematic review and meta-analysis. Burns, 2021 [online ahead of print]
16) Wu TJ, Chen KH, Chiu WK et al : Optimal timing and effect of music therapy in patients with burn injuries : systematic review and meta-analysis of randomized controlled trials. Burns, 2021 [online ahead of print]
17) de Jesus Catala CA, Pan R, Kron-Rodrigues MR et al : Virtual reality therapy to control burn pain : systematic review of randomized controlled trials. J Burn Care Res, 2021 [online ahead of print]
P.303 掲載の参考文献
18) Osuka A, Ishihara T, Shimizu K et al : Natural kinetics of blood cells following major burn : impact of early decreases in white blood cells and platelets as prognostic markers of mortality. Burns 45 : 1901-1907, 2019
19) Sen S, Hsei L, Tran N et al : Early clinical complete blood count changes in severe burn injuries. Burns 45 : 97-102, 2019
20) Ma J, Hu D, Feng Z et al : The effectiveness and safety of beta antagonist in burned patients : a systematic review and meta-analysis. Int Wound J 17 : 1881-1892, 2020
21) Hassoun-Kheir N, Henig O, Avni T et al : The effect of beta-blockers for burn patients on clinical outcomes : systematic review and meta-analysis. J Intensive Care Med 36 : 945-953, 2021
22) Walczak J, Bunn C, Saini P et al : Transient improvement in erythropoiesis is achieved via the chaperone AHSP with early administration of propranolol in burn patients. J Burn Care Res 42 : 311-322, 2021
23) Cheema SA, Ahmed UT, Nasir H et al : Effects of propranolol in accelerating wound healing and attenuation of hypermetabolism in adult burn patients. J Coll Physicians Surg Pak 30 : 46-50, 2020
24) Duan Z, Cai G, Li J et al : Meta-analysis of renal replacement therapy for burn patients : incidence rate, mortality, and renal outcome. Front Med (Lausanne) 8 : 708533, 2021
25) Folkestad T, Brurberg KG, Nordhuus KM et al : Acute kidney injury in burn patients admitted to the intensive care unit : a systematic review and meta-analysis. Crit Care 24 : 2, 2020
26) Gencer M, Sezen O : A study comparing the effect of premedication with intravenous midazolam or dexmedetomidine on ketamine-fentanyl sedoanalgesia in burn patients : a randomized clinical trial. Burns 47 : 101-109, 2021
IV章 トピックス
P.306 掲載の参考文献
1) Rose L, Yu L, Casey J et al : Communication and virtual visiting for families of patients in intensive care during the COVID-19 pandemic : a UK national survey. Ann Am Thorac Soc 18 : 1685-1692, 2021
P.307 掲載の参考文献
2) Azad TD, Al-Kawaz MN, Turnbull AE et al : Coronavirus disease 2019 policy restricting family presence may have delayed end-of-life decisions for critically ill patients. Crit Care Med 49 : e1037-e1039, 2021
3) Hick JL, Einav S, Hanfling D et al : Surge capacity principles : care of the critically ill and injured during pandemics and disasters : CHEST consensus statement. Chest 146 : e1S-e16S, 2014
4) Maves RC, Downar J, Dichter JR et al : Triage of scarce critical care resources in COVID-19 an implementation guide for regional allocation : an expert panel report of the Task Force for Mass Critical Care and the American College of Chest Physicians. Chest 158 : 212-225, 2020
P.308 掲載の参考文献
5) Norisue Y, Deshpande GA, Kamada M et al : Allocation of mechanical ventilators during a pandemic : a mixed-methods study of perceptions among Japanese health care workers and the general public. Chest 159 : 2494-2502, 2021
6) 澤村匡史, 則末泰博, 美馬裕之他 : 新型コロナウイルス感染症 (coronavirus disease 2019, COVID-19) 流行に際しての医療資源配分の観点からの治療の差し控え・中止についての提言. 日集中医誌 27 : 509-510, 2020
7) Wood RM, Pratt AC, Kenward C et al : The value of triage during periods of intense COVID-19 demand : simulation modeling study. Med Decis Mak 41 : 393-407, 2021
8) Kon AA, Davidson JE, Morrison W et al : Shared decision making in ICUs : an American college of critical care medicine and American thoracic society policy statement. Crit Care Med 44 : 188-201, 2016
P.309 掲載の参考文献
9) Bhangu JK, Young BT, Posillico S et al : Goals of care discussions for the imminently dying trauma patient. J Surg Res 246 : 269-273, 2020
10) Pavlish CL, Henriksen J, Brown-Saltzman K et al : A team-based early action protocol to address ethical concerns in the intensive care unit. Am J Crit Care 29 : 49-61, 2020
P.310 掲載の参考文献
11) Higashino M, Hiraoka E, Kudo Y et al : Role of a rapid response system and code status discussion as determinants of prognosis for critical inpatients : an observational study in a Japanese urban hospital. Medicine (Baltimore) 100 : e26856, 2021
P.311 掲載の参考文献
12) Tanaka M, Bito S, Enzo A et al : Crosssectional survey of surrogate decisionmaking in Japanese medical practice. BMC Med Ethics 22 : 1-11, 2021
13) Torke AM, Sachs GA, Helft PR et al : Scope and outcomes of surrogate decision making among hospitalized older adults. JAMA Intern Med 174 : 370-377, 2014
14) Tsuda S, Nakamura M, Aoki S et al : Impact of patients' expressed wishes on their surrogate decision makers' preferred decision-making roles in Japan. J Palliat Med 21 : 354-360, 2018
P.312 掲載の参考文献
15) 人生の最終段階における医療の普及・啓発の在り方に関する検討会 : 人生の最終段階における医療・ケアの決定プロセスに関するガイドライン解説編. pp0-6, 2018,
16) Vink EE, Azoulay E, Caplan A et al : Time-limited trial of intensive care treatment : an overview of current literature. Intensive Care Med 44 : 1369-1377, 2018
17) Chang DW, Neville TH, Parrish J et al : Evaluation of time-limited trials among critically ill patients with advanced medical illnesses and reduction of nonbeneficial ICU treatments. JAMA Intern Med 181 : 786-794, 2021
P.314 掲載の参考文献
1) Naito T, Hayashi K, Hsu HC et al : Validation of National Early Warning Score for predicting 30-day mortality after rapid response system activation in Japan. Acute Med Surg 8 : e666, 2021
2) Kim SH, Choi HS, Jin ES et al : Predicting severe outcomes using national early warning score (NEWS) in patients identified by a rapid response system : a retrospective cohort study. Sci Rep 11 : 18021, 2021
P.315 掲載の参考文献
3) Bhonagiri D, Lander H, Green M et al : Reduction of in-hospital cardiac arrest rates in intensive care-equipped New South Wales hospitals in association with implementation of Between the Flags rapid response system. Intern Med J 51 : 375-384, 2021
4) Ou L, Chen J, Hillman K et al : The effectiveness of a standardised rapid response system on the reduction of cardiopulmonary arrests and other adverse events among emergency surgical admissions. Resuscitation 150 : 162-169, 2020
5) Campbell V, Conway R, Carey K et al : Predicting clinical deterioration with QADDS compared to NEWS, Between the Flags, and eCART track and trigger tools. Resuscitation 153 : 28-34, 2020
6) Hogan H, Hutchings A, Wulff J et al : Type of track and trigger system and incidence of in-hospital cardiac arrest : an observational registry-based study. BMC Health Serv Res 20 : 885, 2020
7) Escobar GJ, Liu VX, Schuler A et al : Automated identification of adults at risk for in-hospital clinical deterioration. N Engl J Med 383 : 1951-1960, 2020
8) Cho KJ, Kwon O, Kwon JM et al : Detecting patient deterioration using artificial intelligence in a rapid response system. Crit Care Med 48 : e285-e289, 2020
9) Lee YJ, Cho KJ, Kwon O et al : A multicentre validation study of the deep learning-based early warning score for predicting in-hospital cardiac arrest in patients admitted to general wards. Resuscitation 163 : 78-85, 2021
10) Ehara J, Hiraoka E, Hsu HC et al : The effectiveness of a national early warning score as a triage tool for activating a rapid response system in an outpatient setting : a retrospective cohort study. Medicine (Baltimore) 98 : e18475, 2019
11) Endo T, Yoshida T, Shinozaki T et al : Efficacy of prehospital National Early Warning Score to predict outpatient disposition at an emergency department of a Japanese tertiary hospital : a retrospective study. BMJ Open 10 : e034602, 2020
P.316 掲載の参考文献
12) Azimirad M, Magnusson C, Wiseman A et al : Nurses' ability to timely activate rapid response systems for deteriorating patients : a comparative case scenario study between Finnish and British nurses. Intensive Crit Care Nurs 60 : 102871, 2020
13) Azimirad M, Magnusson C, Wiseman A et al : A clinical competence approach to examine British and Finnish nurses' attitudes towards the rapid response system model : a study in two acute hospitals. Aust Crit Care, 2021
15) Aoyama T, Tsuneyoshi I, Otake T et al : Rapid response system in Japanese outpatient departments -based on online registry : multicentre observational study. Resusc Plus 5 : 100065, 2021
P.317 掲載の参考文献
16) Kerkham T, Brain M : Goals of care conversations and documentation in patients triggering medical emergency team calls. Intern Med J 50 : 1373-1376, 2020
17) Lyons PG, Edelson DP, Carey KA et al : Characteristics of rapid response calls in the United States : an analysis of the first 402,023 adult cases from the get with the guidelines resuscitation-medical emergency team registry. Crit Care Med 47 : 1283-1289, 2019
18) Higashino M, Hiraoka E, Kudo Y et al : Role of a rapid response system and code status discussion as determinants of prognosis for critical inpatients : an observational study in a Japanese urban hospital. Medicine (Baltimore) 100 : e26856, 2021
19) Park J, Lee YJ, Hong SB et al : The association between hospital length of stay before rapid response system activation and clinical outcomes : a retrospective multicenter cohort study. Respir Res 22 : 60, 2021
20) Olsen SL, Soreide E, Hillman K et al : Succeeding with rapid response systemsa never-ending process : a systematic review of how health-care professionals perceive facilitators and barriers within the limbs of the RRS. Resuscitation 144 : 75-90, 2019
21) O'Neill SM, Clyne B, Bell M et al : Why do healthcare professionals fail to escalate as per the early warning system (EWS) protocol? a qualitative evidence synthesis of the barriers and facilitators of escalation. BMC Emerg Med 21 : 15, 2021
22) Eddahchouri Y, Koeneman M, Plokker M et al : Low compliance to a vital sign safety protocol on general hospital wards : a retrospective cohort study. Int J Nurs Stud 115 : 103849, 2021
P.318 掲載の参考文献
23) Sun L, Joshi M, Khan SN et al : Clinical impact of multi-parameter continuous noninvasive monitoring in hospital wards : a systematic review and meta-analysis. J R Soc Med 113 : 217-224, 2020
24) Areia C, Biggs C, Santos M et al : The impact of wearable continuous vital sign monitoring on deterioration detection and clinical outcomes in hospitalised patients : a systematic review and meta-analysis. Crit Care 25 : 351, 2021
25) Tirkkonen J, Skrifvars MB, Parr M et al : In-hospital cardiac arrest in hospitals with mature rapid response systems-a multicentre, retrospective cohort study. Resuscitation 149 : 109-116, 2020
26) Kurita T, Nakada TA, Kawaguchi R et al : Impact of increased calls to rapid response systems on unplanned ICU admission. Am J Emerg Med 38 : 1327-1331, 2020
27) Hongo T, Naito H, Fujiwara T et al : Prevalence and predictors of direct discharge home following hospitalization of patients with serious adverse events managed by the rapid response system in Japan : a multicenter, retrospective, observational study. Acute Med Surg 8 : e690, 2021
28) Singh MY, Vegunta R, Karpe K et al : Does the time of solitary rapid response team call affect patient outcome? Indian J Crit Care Med 24 : 38-43, 2020
P.320 掲載の参考文献
1) Hendy A, Abozeid A, Sallam G et al : Predective factors affecting stress among nurses providing care at COVID-19 isolation hospitals at Egypt. Nursing Open 8 : 498-505, 2020
P.321 掲載の参考文献
2) Load H, Loveday C, Moxham L et al : Effective communication is key to intensive care nurses' willingness to provide nursing care amidst the COVID-19 pandemic. Intensive Crit Care Nurs 62 : 102946, 2021
3) Gonzalez-Gil MT, Gonzalez-Blazquez C, Parro-Moreno AI et al : Nurses' perceptions and demands regarding COVID-19 care delivery in critical care units and hospital emergency service. Intensive Crit Care Nurs 62 : 102966, 2021
4) William ER, Betty RF, Clareen W : Incleasing critical care nurse engagement of palliative care during the COVID-19 pandemic. Crit Care Nurse 40 : e28-e36, 2021
5) 山田めぐみ, 樋口亮介, 小林 敦他 : モービルcardiac care unitによるECPELLA使用例の搬送. 心臓 33 : 615-621, 2021
P.322 掲載の参考文献
6) 前田晋作, 高松誉明, 西内聡士他 : PCPS装着中に他院への患者搬送を行った経験. 徳島赤十字病院雑誌 23 : 74-79, 2018
7) 黒澤慶子, 石井圭亮, 田邊三思他 : ドクターカーにて経皮的心肺補助装置を運搬し導入することで社会復帰した心原性心停止の1例. 日救急医会誌 25 : 319-324, 2014
8) 井上貴司, 高村圭, 小森卓他 : 多職種連携が集中治療室からの退室に有用であった高度肥満・褥瘡敗血症・重症呼吸不全の1例. 日農医誌 69 : 379-384, 2020
9) 一林亮, 鈴木銀河, 渡辺雅之他 : ICUより気管挿管のまま退室し家族の希望する自宅での看取りを行った1症例. 日臨救急医会誌 23 : 620-625, 2020
P.323 掲載の参考文献
10) HIRAID Research Group : The implementation of an emergency nursing framework (HTRAID) reduces patient deterioration : a multi-centre quasi-experimental study. Int Emerg Nurs 56 : 100976, 2021
11) Zhang Q, Yu Y : Effects of graded emergency nursing on resuscitation outcomes, prognosis, and nursing satisfaction in patients with acute myocardial infarction. Am J Transl Res 13 : 10586-10592, 2021
12) Badr MN, Khalil NS, Mukhtar AM : Effect of national early warning scoring system implementation on cardiopulumonary arrest, unplanned ICU admission, emergency suegery, and acute kidney injury in an emergency hospital, Egypt. J Multidisc Healthc. 14 : 1431-1442, 2021
P.325 掲載の参考文献
1) Annich KG, Lynch RW, MacLaren G et al : ECLS の生理学. "Extracorporeal Cardiopulmonary support in critical care, 4th edition (日本語版)". 市場晋吾, 落合亮一, 竹田晋浩監修. ECMOプロジェクト, 東京, pp9-27, 2015
2) Terragni PP, Del Sorbo L, Mascia L et al : Tidal volume lower than 6ml/kg enhance lung protection. role of extracorporeal carbon dioxide removal. Anesthesiology 111 : 826-835, 2009
3) Bein T, Weber-Carstens S, Glodman A et al : Lower tidal volume strategy (≠ 3ml/kg) combined with extracorporeal CO2 removal versus 'conventional' protective ventilation (6ml/kg) in severe ARDS. the prospective randomized Xtravent-study. Intensive care Med 39 : 847-856, 2013
P.326 掲載の参考文献
4) 厚生労働科学研究費補助金 (新興・再興感染症及び予防接種政策推進研究事業) 「新興・再興感染症のリスク評価と危機管理機能の実装のための研究」分担研究班. 日本COVID-19対策ECMOnet (日本集中治療医学会, 日本呼吸療法医学会, 日本救急医学会) : COVID-19急性呼吸不全への人工呼吸管理とECMO管理 : 基本的考え方. JJAAM 31 : 466-471, 2020
5) Partroniti N, Bonatti G, Senussi T et al : Mechanical ventilation and respiratory monitoring during extracorporeal membrane oxygenation for respiratory support. Ann Transl Med 6 : 386-398, 2018
6) Schmidt M, Pham T, Arcadipane A et al : Mechanical ventilation management during extracorporeal membrane oxygenation for acute respiratory distress syndrome. an international multicenter prospective cohort. Am J Respir Crit Care Med 200 : 1002-1012, 2019
7) Hermann M, Laxar D, Krall C et al : Duration of invasive mechanical ventilation prior to extracorporeal membrane oxygenation is not associated with survival in acute respiratory distress syndrome caused by coronavirus disease 2019. Ann Intensive Care 12 : 1-11, 2022
8) Nishimura M : High-flow nasal cannula oxygen therapy in adults : physiological benefits, indication, clinical benefits, and adverse effects. Respir Care 61 : 529-541, 2016
9) Rittayamai N, Tscheikuna J, Rujiwit P : High-flow nasal cannula versus conventional oxygen therapy after endotracheal extubation. a randomized crossover physiologic study. Respir care 59 : 485-490, 2014
P.327 掲載の参考文献
10) Gustavo A, Luis E, Alberto F et al : Effect of high-flow oxygen therapy vs conventional oxygen therapy on invasive mechanical ventilation and clinical recovery in patients with severe COVID-19. a randomized clinical trial. JAMA 326 : 2161-2171, 2021
11) Ranney LM, Griffeth V, Jha KA : Critical supply shortages-the need for ventilators and personal protective equipment during the Covid-19 pandemic. N Engl J Med 382 : e41 (1) -e41 (3), 2020
12) Duke JD, Clarke LA, Stephens LA et al : A computational fluid dynamics assessment of 3D printed ventilator splitters and restrictors for differential multi-patient ventilation : 3D Print Med 8 : 1-14, 2022
13) Gruslova BA, Katta N, Cabe GA et al : Data automated bag breathing unit for COVID-19 ventilator shortages. Intensive Care Med Exp 9 : 1-14, 2021
P.328 掲載の参考文献
1) 日本集中治療学会集中治療部設置基準検討委員会 : 集中治療部設置のための指針-2002年3月-. 日集中医誌 9 : 159-168, 2002
2) 日本集中治療医学会集中治療における薬剤師のあり方検討委員会 : 集中治療室における薬剤師の活動指針. 日集中医誌 27 : 244-247, 2020
P.329 掲載の参考文献
3) 吉川博, 佐藤智人, 檜山洋子他 : 救急・集中治療病棟薬剤師による治療効果向上を目指した薬剤適正使用に対する介入事例調査. 日臨救急医会誌 23 : 691-695, 2020
4) 小林洋平, 山岡怜央, 三上龍生他 : 救急/集中治療領域における薬剤師介入の実態と有害事象回避による潜在的な医療経済評価. 日臨救急医会誌 23 : 771-779, 2020
5) 本田勝亮, 石塚友一, 柏原道志他 : 集中治療室を中心とした薬剤師による抗菌薬適正使用支援の実践と効果. 日病薬師会誌 57 : 441-445, 2021
6) 西田祥啓, 多賀允俊, 藤本俊祐他 : オープン型集中治療室への薬剤師配置が気管挿管患者に対する鎮痛薬・鎮静薬の使用動向に与える影響. 日病薬師会誌 57 : 788-794, 2021
7) 西村文宏, 牛島智子, 三嶋あかね他 : 心臓血管外科手術後せん妄発症のリスク因子の解析とせん妄チェックシートの開発. 日集中医誌 26 : 438-44, 2019
P.330 掲載の参考文献
8) 吉廣尚大, 冨田隆志, 櫻谷正明他 : 集中治療室退室後患者の医薬品自己管理能力を推定する要因調査 : 単施設後ろ向き研究. 日集中医誌 28 : 437-43, 2021
9) Imanaka S, Kuwabara T, Ikeda H et al : Emergency intensive care unit pharmacist's intervention may reduce time to four-factor prothrombin complex concentrate administration : a retrospective study. J Pharm Health Care Sci 6 : 7, 2020
10) Hosoya R, Ichijo M, Shima S et al : Pharmacists' impact on door-to-rtPA time in patient with acute ischemic stroke. 日臨救急医会誌 23 : 600-607, 2020
11) 齋藤靖弘, 成田拓弥, 徳留章他 : Emergency room (ER) 専従薬剤師のvancomycin (VCM) 初期投与量設計への寄与. 日集中医誌 28 : 23-24, 2021
12) Lee H, Ryu K, Sohn Y et al : Impact on patient outcomes of pharmacist participation in multidisciplinary critical care teams : a systematic review and meta-analysis. Crit Care Med 47 : 1243-1250, 2019
P.331 掲載の参考文献
13) Cvikl M, Sinkovic A : Interventions of a clinical pharmacist in a medical intensive care unit-a retrospective analysis. Bosn J Basic Med Sci 20 : 495-501, 2020
14) Chiang LH, Huang YL, Tsai TC : Clinical pharmacy interventions in intensive care unit patients. J Clin Pharm Ther 46 : 128-133, 2021
15) English S, Hort A, Sullivan N et al : Is ward round participation by clinical pharmacists a valuable use of time and money? a time and motion study. Res Social Adm Pharm 16 : 1026-1032, 2020
16) Leache L, Aquerreta I, Aldaz A et al : Clinical and economic impact of clinical pharmacist interventions regarding antimicrobials on critically ill patients. Res Social Adm Pharm 16 : 1285-1289, 2020
17) Kim SH, Yoon JG, Park HJ et al : Effects of a comprehensive antimicrobial steward-ship program in a surgical intensive care unit. Int J Infect Dis 108 : 237-243, 2021
18) Wang R, Kong L, Xu Q et al : On-ward participation of clinical pharmacists in a Chinese intensive care unit for patients with COVID-19 : a retrospective, observational study. Res Social Adm Pharm 17 : 1853-1858, 2021
19) Alwhaibi A, Alrwaished A, Binobydaan SM et al : Role of pharmacist during COVID-19 pandemic : a retrospective study focused on critically ill COVID-19 patients. Saudi Pharm J 29 : 1050-1055, 2021
20) Lemtiri J, Matusik E, Cousein E et al : The role of the critical care pharmacist during the COVID-19 pandemic. Ann Pharm Fr 78 : 464-468, 2020
P.332 掲載の参考文献
21) Schmidt LE, Patel S, Stollings JL : The pharmacist's role in implementation of the ABCDEF bundle into clinical practice. Am J Health Syst Pharm 77 : 1751-1762, 2020
22) Maison O, Tardy C, Offrey JM et al : Compliance with sedation analgesia protocols : do clinical pharmacists have an impact? J Clin Pharm Ther 45 : 59-64, 2020
23) Andrews JL, Louzon PR, Torres X et al : Impact of a pharmacist-Led intensive care unit sleep improvement protocol on sleep duration and quality. Ann Pharmacother 55 : 863-869, 2021
24) Denny KJ, Gartside JG, Alcorn K et al : Appropriateness of antibiotic prescribing in the emergency department. J Antimicrob Chemother 74 : 515-520, 2019
25) Kulwicki BD, Brandt KL, Wolf LM et al : Impact of an emergency medicine pharmacist on empiric antibiotic prescribing for pneumonia and intra-abdominal infections. Am J Emerg Med 37 : 839-844, 2019
26) Payne-Cardona M, Luis VAS, Aazami R et al : Pharmacist driven antibiotic redosing in the emergency department. Am J Emerg Med 50 : 160-166, 2021
27) Xu P, Yi Q, Wang C et al : Pharmacist-led intervention on the inappropriate use of stress ulcer prophylaxis pharmacotherapy in intensive care units : a systematic review. Front Pharmacol 12 : 741724, 2021
P.333 掲載の参考文献
28) Lat I, Paciullo C, Daley MJ et al : Position paper on critical care pharmacy services : 2020 update. Crit Care Med 48 : e813-e834, 2020
P.334 掲載の参考文献
1) Devlin JW, Skrobik Y, Gelinas C et a : Clinical Practice Guidelines for the Prevention and Management of Pain, Agitation & Sedation, Delirium, Immobility, and Sleep Disruption in Adult Patients in the ICU. Crit Care Med 46 : e825-e873, 2018
2) Lang JK, Paykel MS, Haines KJ et al : Clinical Practice Guidelines for Early Mobilization in the ICU : a systematic review. Crit Care Med 48 : e1121-e1128, 2020
3) Nydahl P, Sricharoenchai T, Chandra S et al : Safety of patient mobilization and rehabilitation in the intensive care unit. systematic review with meta-analysis. Ann Am Thorac Soc 14 : 766-777, 2017
4) Vanhorebeek I, Latronico N, Berghe GV den : ICU-acquired weakness. Intens Care Med 46 : 637-653, 2020
P.335 掲載の参考文献
5) Cottereau G, Messika J, Megarbane B et al : Handgrip strength to predict extubation outcome : a prospective multicenter trial. Ann Intensive Care 11 : 144, 2021
6) Thille AW, Boissier F, Muller M et al : Role of ICU-acquired weakness on extubation outcome among patients at high risk of reintubation. Crit Care 24 : 86, 2020
7) Sidiras G, Patsaki I, Karatzanos E et al : Long term follow-up of quality of life and functional ability in patients with ICU acquired weakness-a post hoc analysis. J Crit Care 53 : 223-230, 2019
8) Jaitovich A, Dumas CL, Itty R et al : ICU admission body composition : skeletal muscle, bone, and fat effects on mortality and disability at hospital discharge-a prospective, cohort study. Crit Care 24 : 566, 2020
P.336 掲載の参考文献
9) Tee Y-S, Cheng C-T, Wu Y-T et al : The psoas muscle index distribution and influence of outcomes in an Asian adult trauma population : an alternative indicator for sarcopenia of acute diseases. Eur J Trauma Emerg Surg 1-9, 2020
10) Baggerman MR, Dijk DPJ van, Winkens B et al : Edema in critically ill patients leads to overestimation of skeletal muscle mass measurements using Computed Tomography scans. Nutrition 89 : 111238, 2021
11) Kim D, Sun JS, Lee YH et al : Comparative assessment of skeletal muscle mass using computerized tomography and bio-electrical impedance analysis in critically ill patients. Clin Nutr 38 : 2747-2755, 2019
12) Nakanishi N, Oto J, Ueno Y et al : Change in diaphragm and intercostal muscle thickness in mechanically ventilated patients : a prospective observational ultrasonography study. J Intensive Care 7 : 56, 2019
P.337 掲載の参考文献
13) Nakanishi N, Tsutsumi R, Okayama Y et al : Monitoring of muscle mass in critically ill patients : comparison of ultrasound and two bioelectrical impedance analysis devices. J Intensive Care 7 : 61, 2019
14) Nydahl P, Schuchhardt D, Juttner F et al : Caloric consumption during early mobilisation of mechanically ventilated patients in intensive care units. Clin Nutr 39 : 2442-2447, 2019
15) Potter K, Miller S, Newman S : Environmental factors affecting early mobilization and physical disability post-intensive care : an integrative review through the Lens of the World Health Organization International Classification of Functioning, Disability, and Health. Dimensions Critical Care Nurs 40 : 92-117, 2021
P.338 掲載の参考文献
16) Wang YT, Lang JK, Haines KJ et al : Physical rehabilitation in the ICU : a systematic review and meta-analysis. Crit Care Med, 2021 [online ahead of print]
17) Okada Y, Unoki T, Matsuishi Y et al : Early versus delayed mobilization for inhospital mortality and health-related quality of life among critically ill patients : a systematic review and meta-analysis. J Intensive Care 7 : 57, 2019
18) Paton M, Lane R, Paul E et al : Mobilization during critical illness : a higher level of mobilization improves health status at 6 months, a secondary analysis of a prospective cohort study. Crit Care Med 49 : e860-e869, 2021
19) Scheffenbichler FT, Teja B, Wongtangman K et al : Effects of the level and duration of mobilization therapy in the surgical ICU on the loss of the ability to live independently : an international prospective cohort study. Crit Care Med 49 : e247-e257, 2021
20) Franca EET, Gomes JPV, Lira JMBD et al : Acute effect of passive cycle-ergometry and functional electrical stimulation on nitrosative stress and inflammatory cytokines in mechanically ventilated critically ill patients : a randomized controlled trial. Braz J Med Biol Res 53 : e8770, 2020
P.339 掲載の参考文献
21) Nakano H, Naraba H, Hashimoto H et al : Novel protocol combining physical and nutrition therapies, Intensive Goal-directed REhabilitation with Electrical muscle stimulation and Nutrition (IGREEN) care bundle. Crit Care 25 : 415, 2021
22) Liu K, Nakamura K, Katsukawa H et al : ABCDEF bundle and supportive ICU practices for patients with coronavirus disease 2019 infection : an international point prevalence study. Crit Care Explor 3 : e0353, 2021
23) Liu K, Nakamura K, Katsukawa H et al : Implementation of the ABCDEF bundle for critically ill ICU patients during the COVID-19 pandemic : a multi-national 1-day point prevalence study. Front Med 8 : 735860, 2021
24) Aerde NV, Berghe GV den, Wilmer A et a : Intensive care unit acquired muscle weakness in COVID-19 patients. Intensive Care Med 46 : 2083-2085, 2020
25) McWilliams D, Weblin J, Hodson J et al : Rehabilitation levels in patients with COVID-19 admitted to intensive care requiring invasive ventilation. an observational study. Ann Am Thorac Soc 18 : 122-129, 2021
P.341 掲載の参考文献
1) Egi M, Ogura H, Yatabe T et al : The Japanese Clinical Practice Guidelines for Management of Sepsis and Septic Shock 2020 (J-SSCG 2020). J Intensive Care 9 : 53, 2021
2) Evans L, Rhodes A, Alhazzani W et al : Surviving Sepsis Campaign : International Guidelines for Management of Sepsis and Septic Shock 2021. Crit Care Med 49 : e1063-e1143, 2021
P.342 掲載の参考文献
3) Vincent JL, Sakr Y, Singer M et al ; EPIC III Investigators : Prevalence and outcomes of infection among patients in intensive care units in 2017. JAMA 323 : 1478-1487, 2020
4) Vincent JL, Bihari DJ, Suter PM et al : The prevalence of nosocomial infection in intensive care units in Europe. Results of the European Prevalence of Infection in Intensive Care (EPIC) Study. EPIC International Advisory Committee. JAMA 274 : 639-644, 1995
5) Vincent JL, Rello J, Marshall J et al ; EPIC II Group of Investigators : International study of the prevalence and outcomes of infection in intensive care units. JAMA 302 : 2323-2329, 2009
6) Tabah A, Bassetti M, Kollef MH et al : Antimicrobial de-escalation in critically ill patients : a position statement from a task force of the European Society of Intensive Care Medicine (ESICM) and European Society of Clinical Microbiology and Infectious Diseases (ESCMID) Critically Ill Patients Study Group (ESGCIP). Intensive Care Med 46 : 245-265, 2020
7) De Bus L, Depuydt P, Steen J et al ; DIANA study group : Antimicrobial deescalation in the critically ill patient and assessment of clinical cure : the DIANA study. Intensive Care Med 46 : 1404-1417, 2020
8) Paskovaty A, Pastores SM, Gedrimaite Z et al : Antimicrobial de-escalation in septic cancer patients : is it safe to back down? Intensive Care Med 41 : 2022-2023, 2015
P.343 掲載の参考文献
9) Onorato L, Macera M, Calo F et al : The effect of an antimicrobial stewardship programme in two intensive care units of a teaching hospital : an interrupted time series analysis. Clin Microbiol Infect 26 : 782.e1-782.e6, 2020
10) Kim SH, Yoon JG, Park HJ et al : Effects of a comprehensive antimicrobial stewardship program in a surgical intensive care unit. Int J Infect Dis 108 : 237-243, 2021
11) Rashidzada Z, Cairns KA, Peel TN et al : Early antimicrobial stewardship team intervention on appropriateness of antimicrobial therapy in suspected sepsis : a randomized controlled trial. JAC Antimicrob Resist 3 : dlab097, 2021
P.344 掲載の参考文献
12) Richter DC, Dietrich M, Lalev LD et al : Prolonged infusion of β-lactams decreases mortality in patients with septic shock : a retrospective before-and-after study. Antibiotics (Basel) 10 : 687, 2021
13) Ahmed N, Jen SP, Altshuler D et al : Evaluation of meropenem extended versus intermittent infusion dosing protocol in critically ill patients. J Intensive Care Med 35 : 763-771, 2020
14) Liebchen U, Salletmeier H, Kallee S et al : Optimal loading dose of meropenem before continuous infusion in critically ill patients : a simulation study. Sci Rep 11 : 17211, 2021
15) Guilhaumou R, Benaboud S, Bennis Y et al : Optimization of the treatment with beta-lactam antibiotics in critically ill patients-guidelines from the French Society of Pharmacology and Therapeutics (Societe Francaise de Pharmacologie et Therapeutique-SFPT) and the French Society of Anaesthesia and Intensive Care Medicine (Societe Francaise d'Anesthesie et Reanimation-SFAR). Crit Care 23 : 104, 2019
P.345 掲載の参考文献
16) Lipman J, Brett SJ, De Waele JJ et al : A protocol for a phase 3 multicentre randomised controlled trial of continuous versus intermittent β-lactam antibiotic infusion in critically ill patients with sepsis : BLING III. Crit Care Resusc 21 : 63-68, 2019
17) McHugh MP, Parcell BJ, MacKenzie FM ; Scottish Microbiology And Virology Network Smvn Molecular Diagnostics Evaluation Group : Rapid molecular testing for Staphylococcus aureus bacteraemia improves clinical management. J Med Microbiol 69 : 552-557, 2020
18) Moradi T, Bennett N, Shemanski S et al : Use of procalcitonin and a respiratory polymerase chain reaction panel to reduce antibiotic use via an electronic medical record alert. Clin Infect Dis 71 : 1684-1689, 2020
19) Niwa T, Yonetamari J, Hayama N et al : Clinical impact of matrix-assisted laser desorption ionization-time of flight mass spectrometry combined with antimicrobial stewardship interventions in patients with bloodstream infections in a Japanese tertiary hospital. Int J Clin Pract 73 : e13332, 2019
P.346 掲載の参考文献
20) Ulldemolins M, Vaquer S, Llaurado-Serra M et al : Beta-lactam dosing in critically ill patients with septic shock and continuous renal replacement therapy. Crit Care 18 : 227, 2014
21) Schoenenberger-Arnaiz JA, Ahmad-Diaz F, Miralbes-Torner M et al : Usefulness of therapeutic drug monitoring of piperacillin and meropenem in routine clinical practice : a prospective cohort study in critically ill patients. Eur J Hosp Pharm 27 : e30-e35, 2020
22) Abdul-Aziz MH, Alffenaar JC, Bassetti M et al ; Infection Section of European Society of Intensive Care Medicine (ESICM) ; Pharmacokinetic/pharmacodynamic and Critically Ill Patient Study Groups of European Society of Clinical Microbiology and Infectious Diseases (ESCMID) ; Infectious Diseases Group of International Association of Therapeutic Drug Monitoring and Clinical Toxicology (IATDMCT) ; Infections in the ICU and Sepsis Working Group of International Society of Antimicrobial Chemotherapy (ISAC) : Antimicrobial therapeutic drug monitoring in critically ill adult patients : a Position Paper. Intensive Care Med 46 : 1127-1153, 2020
P.347 掲載の参考文献
23) Alvarez Otero J, Lamas Ferreiro JL, Sanjurjo Rivo A et al : Treatment duration of complicated urinary tract infections by extended-spectrum beta-lactamases producing enterobacterales. PLoS One 15 : e0237365, 2020
24) De Pascale G, Posteraro B, D'Arrigo S et al : (1,3) -β-D-Glucan-based empirical antifungal interruption in suspected invasive candidiasis : a randomized trial. Crit Care 24 : 550, 2020
P.348 掲載の参考文献
25) Hirabayashi A, Yahara K, Kajihara T et al : Geographical distribution of Enterobacterales with a carbapenemase IMP-6 phenotype and its association with antimicrobial use : an analysis using comprehensive national surveillance data on antimicrobial resistance. PLoS One 15 : e0243630, 2020
26) Satoh K, Makimura K, Hasumi Y et al : Candida auris sp. nov., a novel ascomycetous yeast isolated from the external ear canal of an inpatient in a Japanese hospital. Microbiol Immunol. 53 : 41-44, 2009
27) Shastri PS, Shankarnarayan SA, Oberoi J et al : Candida auris candidaemia in an intensive care unit - Prospective observational study to evaluate epidemiology, risk factors, and outcome. J Crit Care 57 : 42-48, 2020
最近チェックした商品履歴
Loading...